<SEC-DOCUMENT>0000355019-22-000055.txt : 20221114
<SEC-HEADER>0000355019-22-000055.hdr.sgml : 20221114
<ACCEPTANCE-DATETIME>20221114171356
ACCESSION NUMBER:		0000355019-22-000055
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		59
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221114
DATE AS OF CHANGE:		20221114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			FONAR CORP
		CENTRAL INDEX KEY:			0000355019
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				112464137
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-10248
		FILM NUMBER:		221387599

	BUSINESS ADDRESS:	
		STREET 1:		110 MARCUS DR
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
		BUSINESS PHONE:		6316942929

	MAIL ADDRESS:	
		STREET 1:		110 MARCUS DRIVE
		CITY:			MELVILLE
		STATE:			NY
		ZIP:			11747
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>fonar_10q.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-roles="http://fasb.org/us-roles/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:FONR="http://fonar.com/20220930">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02B_US%2DGAAP%2D2022 -->
<!-- Field: Set; Name: xdx; ID: xdx_03D_FONR_fonar.com_20220930 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20220701_20220930 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0000355019 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DCurrentFiscalYearEndDate_06/30 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DDocumentFiscalYearFocus_2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DDocumentFiscalPeriodFocus_Q1 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityCentralIndexKey">0000355019</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">06/30</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:DocumentFiscalYearFocus">2023</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:DocumentFiscalPeriodFocus">Q1</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0032" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0034" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2022-06-30" id="xdx2ixbrl0065" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParties" contextRef="AsOf2022-06-30" id="xdx2ixbrl0128" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-09-30" id="xdx2ixbrl0175" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2022-06-30" id="xdx2ixbrl0176" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-09-30" id="xdx2ixbrl0194" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PreferredStockValue" contextRef="AsOf2022-06-30" id="xdx2ixbrl0195" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:Commonstockvalue2" contextRef="AsOf2022-09-30" id="xdx2ixbrl0232" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:Commonstockvalue2" contextRef="AsOf2022-06-30" id="xdx2ixbrl0233" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:Commonstockvalue3" contextRef="AsOf2022-09-30" id="xdx2ixbrl0251" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:Commonstockvalue3" contextRef="AsOf2022-06-30" id="xdx2ixbrl0252" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265" id="xdx2ixbrl0410" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0413" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0414" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember" id="xdx2ixbrl0419" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0421" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265" id="xdx2ixbrl0424" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0425" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember" id="xdx2ixbrl0426" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265" id="xdx2ixbrl0431" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0432" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0434" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281" id="xdx2ixbrl0452" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0453" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0455" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" id="xdx2ixbrl0456" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0460" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember" id="xdx2ixbrl0461" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0462" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281" id="xdx2ixbrl0466" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0467" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember" id="xdx2ixbrl0468" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember" id="xdx2ixbrl0469" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0519" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2021-07-012021-09-30" id="xdx2ixbrl0565" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0674" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" id="xdx2ixbrl0678" unitRef="Shares" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0702" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0708" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" id="xdx2ixbrl0732" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" id="xdx2ixbrl0845" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl0974" unitRef="USD" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" id="xdx2ixbrl1004" unitRef="USD" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="fonr-20220930.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-07-01to2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-07_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-07_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-07_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-07_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_PreferredClassAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonClassCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CommonStockMember266973265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CommonStockMember266973296">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_CommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_custom_AccumulatedDeficitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-09-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2015-07-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2022-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_ControllingInterestMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_DoubtfulMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MedicareMedicaidMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_OtherRevenueSourceMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_OperatingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_FinancingLeasePaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-07-01</xbrli:startDate>
        <xbrli:endDate>2022-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_MedicalEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-07-01</xbrli:startDate>
        <xbrli:endDate>2021-09-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-09-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-09-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-10-012022-10-31_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-10-01</xbrli:startDate>
        <xbrli:endDate>2022-10-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-01-06_us-gaap_SubsequentEventMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000355019</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-01-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FORM
<span id="xdx_903_edei--DocumentType_c20220701__20220930_zYjcPVEbt5Ld"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:DocumentType">10-Q</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SECURITIES
AND EXCHANGE COMMISSION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Washington,
D.C. 20549</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_edei--DocumentQuarterlyReport_c20220701__20220930" title="Document Quarterly Report"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:booleantrue" name="dei:DocumentQuarterlyReport">[X]</ix:nonNumeric></span>
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 31.5pt; text-align: center; text-indent: -0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;For
the quarterly period ended <span id="xdx_903_edei--DocumentPeriodEndDate_c20220701__20220930_zIaPSE25i5kh"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">SEPTEMBER 30, 2022</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commission
file number <span id="xdx_909_edei--EntityFileNumber_c20220701__20220930_zYMq15vhifV2"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityFileNumber">0-10248</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;<img src="fonar-logo.jpg" alt="" style="height: 23px; width: 150px" /></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90C_edei--EntityRegistrantName_c20220701__20220930_za7k6eioRg3i"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityRegistrantName">FONAR CORPORATION</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Exact
name of registrant as specified in its charter)</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_903_edei--EntityIncorporationStateCountryCode_c20220701__20220930_zdCqhMsXS6Xg" style="text-transform: uppercase"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">delaware</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_906_edei--EntityTaxIdentificationNumber_c20220701__20220930_zBf3AE6vchJb"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityTaxIdentificationNumber">11-2464137</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(State
    or other jurisdiction of <br />
    incorporation or organization)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(I.R.S.
    Employer <br />
    Identification No.)</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_edei--EntityAddressAddressLine1_c20220701__20220930" title="Entity Address, Address Line One"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityAddressAddressLine1">110 Marcus Drive</ix:nonNumeric></span>&#160;&#160;<span id="xdx_900_edei--EntityAddressCityOrTown_c20220701__20220930" title="Entity Address, City or Town"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityAddressCityOrTown">Melville</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressStateOrProvince_c20220701__20220930" title="Entity Address, State or Province"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">New York</ix:nonNumeric></span></span></td>
    <td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 45%; padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_902_edei--EntityAddressPostalZipCode_c20220701__20220930" title="Entity Address, Postal Zip Code"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:EntityAddressPostalZipCode">11747</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Address
    of principal executive offices)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Zip
    Code)</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Registrant's
telephone number, including area code: <span id="xdx_904_edei--CityAreaCode_c20220701__20220930_zMaoy1zi9OWa"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:CityAreaCode">(631)</ix:nonNumeric></span> <span id="xdx_900_edei--LocalPhoneNumber_c20220701__20220930_zWoTO1DGcXy7"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:LocalPhoneNumber">694-2929</ix:nonNumeric></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90E_edei--EntityCurrentReportingStatus_c20220701__20220930" title="Entity Current Reporting Status"><span style="-sec-ix-hidden: xdx2ixbrl0032">YES</span></span>
_X_ NO ___</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for shorter period that the registrant was required
to submit such files <span id="xdx_909_edei--EntityInteractiveDataCurrent_c20220701__20220930" title="Entity Interactive Data Current"><span style="-sec-ix-hidden: xdx2ixbrl0034">YES</span></span> _X_ NO ___</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting
company, or an emerging growth company. See definition of accelerated filer, large accelerated filer, smaller reporting company and
emerging growth company in Rule 12b-2 of the Exchange Act. (Check one):Large accelerated filer___ Accelerated filer ___ <span id="xdx_904_edei--EntityFilerCategory_c20220701__20220930"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Non-accelerated
filer</ix:nonNumeric></span></span> <span style="font: normal 10pt Arial, Helvetica, Sans-Serif">_X_ Smaller reporting company _<span id="xdx_902_edei--EntitySmallBusiness_c20220701__20220930_zmXjJG3fcbg1"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:booleantrue" name="dei:EntitySmallBusiness">X</ix:nonNumeric></span>_ </span><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Emerging
growth company ___<span id="xdx_909_edei--EntityEmergingGrowthCompany_c20220701__20220930_zOhfVigQIWI3" style="display: none"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span><span></span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ___ <span id="xdx_90A_edei--EntityShellCompany_c20220701__20220930" title="Entity Shell Company"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt:booleanfalse" name="dei:EntityShellCompany">NO</ix:nonNumeric></span> _X_</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Securities
registered pursuant to Section 12(b) of the Act:&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; width: 30%; padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Title
    of each class</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 28%; padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Trading
    symbol</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 28%; padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Name
    of each exchange on which registered</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_905_edei--Security12bTitle_c20220701__20220930_zyVHtUxA3K2h"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:Security12bTitle">Common
    Stock</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_edei--TradingSymbol_c20220701__20220930_zP8cS1BXYkrf"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" name="dei:TradingSymbol">FONR</ix:nonNumeric></span></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-left: 5.4pt; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_907_edei--SecurityExchangeName_c20220701__20220930_zuC91dEvsAal"><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ</ix:nonNumeric></span>
    Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Indicate
the number of shares outstanding of each of the issuer's classes of common stock, as of the close of the latest practicable date.</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 50%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class</span></td>
    <td style="width: 11%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 39%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Outstanding
    at November 7, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common Stock,
    par value $.0001</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90D_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20221107__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z4ianSXOWZYh" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-11-07_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,538,148</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class B Common
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_90A_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20221107__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zUo8Zh8Czz49" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-11-07_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class C Common
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_901_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20221107__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7sQzvaDWfx5" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-11-07_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">382,513</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class A Preferred
    Stock, par value $.0001</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: -0.1pt; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_909_edei--EntityCommonStockSharesOutstanding_iI_pn3n3_c20221107__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zIzkM1avlNse" title="Entity Common Stock, Shares Outstanding"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2022-11-07_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313,438</ix:nonFraction></span></span></td></tr>
  </table>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">INDEX</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="height: 25pt; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PART
    I - FINANCIAL INFORMATION</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">PAGE</span></td></tr>
  <tr style="height: 25pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Item
    1. Financial Statements</span></td><td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font-size: 11pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font-size: 11pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 30pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; width: 70%; text-align: left; text-indent: -9pt; padding-left: 45.05pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#BalanceSheet">Condensed Consolidated Balance Sheets - September 30, 2022 (Unaudited) and June 30, 2022</a></span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 18%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 30pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-indent: -9pt; padding-left: 45.05pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#IncomeStatement">Condensed Consolidated Statements of Income for the Three Months Ended September 30, 2022 and September 30, 2021 (Unaudited)</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 40pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 45.05pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#FinancialStatements">Condensed Consolidated Statements of Changes in Equity for the Three Months Ended September 30, 2022 and September 30, 2021 (Unaudited)</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 40pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-indent: -9pt; padding-left: 45.05pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#CashFlow">Condensed Consolidated Statements of Cash Flows for the Three Months Ended September 30, 2022 and September 30, 2021 (Unaudited)</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 45.05pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#NotesToFinancialStatements">Notes to Condensed Consolidated Financial Statements (Unaudited)</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 30pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MDA">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#QualitativeDisclosures">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">28</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#ControlsAndProcedures">Item 4. Controls and Procedures</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">29</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 25pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -4.45pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#PartII">PART II - OTHER INFORMATION</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right">29</td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#LegalProceedings">Item 1. Legal Proceedings</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">29</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#RiskFactors">Item 1A. Risk Factors</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">29</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#UseOfProceeds">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">31</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline"><a href="#LegalMatters">Item 3. Defaults Upon Senior Securities</a></span></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">31</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#MoreInformation">Item 4. Mine Safety Disclosures</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">31</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#CautionaryNote">Item 5. Other Information</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">31</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-decoration: underline; text-align: left; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Exhibits">Item 6. Exhibits</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">32</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="height: 20pt; vertical-align: bottom; background-color: White">
    <td style="text-decoration: underline; text-indent: -9pt; padding-left: 40pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="#Signatures">Signatures</a></span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">32</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>


<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="BalanceSheet"></span>CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASSETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_307_111_pn3n3_zkJi6XT2oygg" summary="xdx: Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_493_20220930" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_490_20220630" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, <br /> 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022 *</span></td></tr>
  <tr id="xdx_407_eus-gaap--AssetsCurrentAbstract_iB_zifJg1Y4WGja" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    Assets:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashAndCashEquivalentsFairValueDisclosure_i01I_maCzgIK_zqRhJJ69SGM" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    and cash equivalents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,696</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,723</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--ShortTermInvestments_i01I_maCzgIK_zbx1og6K9kOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Short
    term investments</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ShortTermInvestments" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--AccountsReceivableServiceAndRepairFees_i01I_maCzgIK_zo87IaB5ouh3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accounts
    receivable &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,161</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,336</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--AccountReceivableRelatedParties_i01I_maCzgIK_zHZ0pxDfIlbh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accounts
    receivable - related party</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountReceivableRelatedParties" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0065">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_ecustom--MedicalReceivable_i01I_maCzgIK_zqjz93SMy4uk" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Medical
    receivable &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,216</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--ManagementAndOtherFees_i01I_maCzgIK_zDMvnY7hlF9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Management
    and other fees receivable &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,582</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,419</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_i01I_maCzgIK_zMff1pZDsGi4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable &#8211; related medical practices &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,723</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_i01I_maCzgIK_zs2C80rgpKF7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,458</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,360</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_i01I_maCzgIK_zVN677k5myli" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Prepaid
    expenses and other current assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,108</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,104</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--AssetsCurrent_i01TI_mtCzgIK_maCzzTv_zAq5ss1aFRo3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;Total
    Current Assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">119,066</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">118,686</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--AccountsReceivableNetLongTerm_i01I_maCzzTv_zZBuDukCh5ml" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable &#8211; long term</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,575</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetLongTerm" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,872</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--DeferredTaxAssetsDeferredIncome_i01I_maCzzTv_zTMRiMOrQvMg" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Deferred
    income tax asset</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,697</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredTaxAssetsDeferredIncome" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,843</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--PropertyPlantAndEquipmentNet_i01I_maCzzTv_zL2bGz0pAyKh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Property
    and equipment &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,207</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:PropertyPlantAndEquipmentNet" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,282</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OperatingLeaseRightOfUseAsset_i01I_maCzzTv_zXwbvEoiZs3k" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Right-of-use
    Asset &#8211; operating lease</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,180</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,232</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--FinanceLeaseRightOfUseAsset_i01I_maCzzTv_zWhHqbNTm7zj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Right-of-use
    Asset &#8211; financing lease</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">878</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseRightOfUseAsset" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">928</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--Goodwill_i01I_maCzzTv_zufvQt9HJW1c" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Goodwill</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Goodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,269</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_i01I_maCzzTv_za1hCfPivwpj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    intangible assets &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,624</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherAssets_i01I_maCzzTv_zstyox7wZvB2" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">526</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAssets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">526</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--Assets_i01TI_mtCzzTv_zuVFl0y6iiA6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;Total
    Assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,022</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,342</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, <br /> 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022 *</span></td></tr>
  <tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_iB_zSTU63895QA9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    Liabilities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LongTermDebtAndCapitalLeaseObligationsCurrent_i01I_maCzhfE_znzb3FkmD0R1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Current
    portion of long-term debt and capital leases</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">42</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">40</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableCurrent_i01I_maCzhfE_zf1bWPVjacee" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">773</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,552</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_i01I_maCzhfE_zIDF0Bh0Jgr5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,201</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,417</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--DeferredRevenueCurrent_i01I_maCzhfE_z2iljwRcfjsl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,123</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,289</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--UnearnedRevenueOnServiceContractsRelatedParties_i01I_maCzhfE_zqtAcMe4gJU6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts &#8211; related party</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:UnearnedRevenueOnServiceContractsRelatedParties" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">82</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0128">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maCzhfE_zT6oEyOsDgjd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Operating
    lease liability - current portion</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,908</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,880</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--FinanceLeaseLiabilityCurrent_iI_maCzhfE_ziZxJQbhlu0l" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Financing
    lease liability - current portion</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">212</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">210</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--CustomerDeposits_iI_maCzhfE_zZMFLdvOAkXc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">532</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CustomerDeposits" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">361</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--LiabilitiesCurrent_iTI_mtCzhfE_maCzCEW_z8uKBsp5nsz1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Current Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14,873</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,749</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--LiabilitiesNoncurrentAbstract_iB_zvrdJ3Yeg7Vi" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long-Term
    Liabilities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--DeferredRevenueNoncurrent_i01I_pn3n3_maCz7gO_zz8AjQluJ0r8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Unearned
    revenue on service contracts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,576</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredRevenueNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,857</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_i01I_maCz7gO_zHZUwUP2Yvk3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Deferred
    income tax liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--AccountsPayableRelatedPartiesNoncurrent_i01I_maCz7gO_zFElT7fg8mE1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Due
    to related medical practices</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsPayableRelatedPartiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">93</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OperatingLeaseLiabilityNoncurrent_i01I_maCz7gO_zl0gPrDwkZoa" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Operating
    lease liability &#8211; net of current portion</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,112</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,091</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--FinanceLeaseLiabilityNoncurrent_i01I_maCz7gO_zMOFKymizyL5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Financing
    lease liability &#8211; net of current portion</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">784</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">838</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--LongTermDebtAndCapitalLeaseObligations_i01I_maCz7gO_zS1tV2Kvzm1f" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Long-term
    debt and capital leases, less current portion</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LongTermDebtAndCapitalLeaseObligations" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">155</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--OtherLiabilities_i01I_maCz7gO_zdZiolMcDY7d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Other
    liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">107</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--LiabilitiesNoncurrent_i01TI_mtCz7gO_maCzCEW_z2YwIdT9xBIb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 20pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Long-Term Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,019</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">36,357</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--Liabilities_i01TI_mtCzCEW_maCzfuf_z3Oa56Mb4XEj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,892</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">53,106</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">CONDENSED
CONSOLIDATED BALANCE SHEETS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">LIABILITIES
AND STOCKHOLDERS&#8217; EQUITY (Continued)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr id="xdx_40D_eus-gaap--StockholdersEquityAbstract_iB_zPPKtkgisIfa" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">STOCKHOLDERS'
    EQUITY:</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br /> 2022 *</span></td></tr>
  <tr id="xdx_403_eus-gaap--CommonStockValue_iI_maCzC1z_zHaLi768QV0c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    A non-voting preferred stock $<span id="xdx_90A_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zU0a9fQWIYyc" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_z0k1Lo5AWmZi" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zd62wOKQozRd" title="Preferred Stock, Shares Authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zLt2cS0uUBh5" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">453</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2022 and June 30, 2022, <span id="xdx_909_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zepQpGs0WlXk" title="Preferred Stock, Shares Issued"><span id="xdx_90C_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zZOAFN4ZA17e" title="Preferred Stock, Shares Outstanding"><span id="xdx_901_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zlVist5oCIg5" title="Preferred Stock, Shares Issued"><span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__custom--ClassANonVotingPreferredStockMember_zXxHLonexSEh" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">313</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and outstanding
    at September 30, 2022 and June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0175">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0176">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--PreferredStockValue_iI_maCzC1z_zKofMEX7cfQj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Preferred
    stock $<span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zCHqNUTJmNBe" title="Preferred Stock, Par or Stated Value Per Share"><span id="xdx_90C_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zG3M9OEGXkV5" title="Preferred Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:PreferredStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" decimals="INF" scale="0" unitRef="USDPShares">.001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_z793c9iPeM28" title="Preferred Stock, Shares Authorized"><span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zVYAqJwd5P1d" title="Preferred Stock, Shares Authorized"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2022 and June 30, 2022, issued and outstanding &#8211; <span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zEEVbcLo4WFe" title="Preferred Stock, Shares Issued"><span id="xdx_903_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zbrsWoiO65c9" title="Preferred Stock, Shares Outstanding"><span id="xdx_900_eus-gaap--PreferredStockSharesIssued_iI_pn3n3_dn_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zj2E4OCW9xx5" title="Preferred Stock, Shares Issued"><span id="xdx_908_eus-gaap--PreferredStockSharesOutstanding_iI_pn3n3_dn_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredStockMember_zb6fnHrYR6Ba" title="Preferred Stock, Shares Outstanding"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:PreferredStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember" format="ixt-sec:numwordsen" decimals="-3" scale="3" unitRef="Shares">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0194">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0195">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--Commonstockvalue1_iI_maCzC1z_zqcpZyJdFI4c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zxdJuiW38rw2" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zu4Dwv53kqek" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zdcpKAjgvHOg" title="Common Stock, Shares Authorized"><span id="xdx_906_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z7o72ZCkB459" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">8,500</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2022 and June 30, 2022, <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zo4lyzgILA8b" title="Common Stock, Shares, Issued"><span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z0tvnPzc8yjc" title="Common Stock, Shares, Issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,566</ix:nonFraction></ix:nonFraction></span></span> issued at September 30, 2022 and June
    30, 2022, <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znf0msodfxH5" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span> and <span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zn3aZHJiMKk" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span> outstanding at September 30, 2022 and June 30, 2022, respectively</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:Commonstockvalue1" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:Commonstockvalue1" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--Commonstockvalue2_iI_maCzC1z_z6etBy4wFL68" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    B Common Stock (10 votes per share) $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zirY9gEmD5Gg" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zh9zY2yviutb" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zQEEpTCIevz7" title="Common Stock, Shares Authorized"><span id="xdx_90B_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zlc2WpLhEQnj" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">227</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2022 and June 30, 2022; .<span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_z7nqOQjmbtM3" title="Common Stock, Shares, Issued"><span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zpF577VXnKSa" title="Common Stock, Shares, Outstanding"><span id="xdx_902_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_za7Q9GmDysk1" title="Common Stock, Shares, Issued"><span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassBMember_zTj2McY9taA5" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">146</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued
    and outstanding at September 30, 2022 and June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0232">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0233">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_ecustom--Commonstockvalue3_iI_maCzC1z_zyeHhE7E0KSb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Class
    C Common Stock (25 votes per share) $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zY9Pao1lquPh" title="Common Stock, Par or Stated Value Per Share"><span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pip0_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zaDNrKCk2n2f" title="Common Stock, Par or Stated Value Per Share"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" decimals="INF" scale="0" unitRef="USDPShares">.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zlehP9L9wMzf" title="Common Stock, Shares Authorized"><span id="xdx_900_eus-gaap--CommonStockSharesAuthorized_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zLc3thNKUMm2" title="Common Stock, Shares Authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">567</ix:nonFraction></ix:nonFraction></span></span> shares authorized at September 30, 2022 and June 30, 2022, <span id="xdx_90D_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zabunaFFsgm6" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zSy25OLpWKY4" title="Common Stock, Shares, Outstanding"><span id="xdx_909_eus-gaap--CommonStockSharesIssued_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgtHfzn5Qms7" title="Common Stock, Shares, Issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_pn3n3_c20220630__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zQF9PnoCP4ie" title="Common Stock, Shares, Outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span></span></span></span> issued and
    outstanding at September 30, 2022 and June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0251">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0252">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AdditionalPaidInCapital_iI_maCzC1z_zPts8avrmtHb" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Paid-in
    capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AdditionalPaidInCapital" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RetainedEarningsAccumulatedDeficit_iI_maCzC1z_zNIulOV16pj1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Accumulated
    deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,520</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,567</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--TreasuryStockValue_iNI_di_msCzC1z_zCoed1lNdCP" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    stock, at cost &#8211; <span id="xdx_907_eus-gaap--TreasuryStockShares_iI_pn3n3_c20220930_zHvGNvZ6ldyf" title="Treasury Stock, Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">20</ix:nonFraction></span> shares of common stock at September 30, 2022 and <span id="xdx_900_eus-gaap--TreasuryStockShares_iI_pn3n3_c20220630_zOwpR02tedkb" title="Treasury Stock, Shares"><ix:nonFraction name="us-gaap:TreasuryStockShares" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">12</ix:nonFraction></span> shares of common stock at June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">797</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:TreasuryStockValue" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">675</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--StockholdersEquity_iTI_mtCzC1z_maCzQ76_zuLBSLNr1MHg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Fonar Corporation&#8217;s Stockholders&#8217; Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">152,215</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150,290</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--MinorityInterest_iI_maCzQ76_ziuPvlgeZrPl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Noncontrolling
    interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,085</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,054</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iTI_mtCzQ76_maCzfuf_zsDLQZITzrOb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Stockholders' Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,130</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,236</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquity_iTI_mtCzfuf_zwGbjfwAygdl" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Total
    Liabilities and Stockholders' Equity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">198,022</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">199,342</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">*Condensed
from audited financial statements.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="IncomeStatement"></span>CONDENSED
CONSOLIDATED STATEMENTS OF INCOME</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_30A_113_pn3n3_zNGrMcM7iwQf" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49D_20220701_20220930" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20210701__20210930_zncEmRI3ZTqd" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FOR
    THE THREE MONTHS ENDED SEPTEMBER 30,</span></td></tr>
  <tr id="xdx_40B_eus-gaap--RevenuesAbstract_iB_zBqYsqOww0N2" style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">REVENUES</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2021</span></td></tr>
  <tr id="xdx_40A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_i01_maCzj7K_zQkR2oT0xwp7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    fee revenue &#8211; net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,076</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,851</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--ProductSalesNet_i01_maCzj7K_zJYyZacw5bcd" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Product
    sales &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">30</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProductSalesNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">148</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--ServiceAndRepairFeesNet_i01_maCzj7K_zJ2LxnAFriEf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,820</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,936</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--ServiceAndRepairFeesRelatedPartiesNet_i01_maCzj7K_zWpp32fwdKv9" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
    and repair fees - related parties &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ServiceAndRepairFeesRelatedPartiesNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">28</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--ManagementAndOtherFeesNet_i01_maCzj7K_zug7IQTdSb92" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">12,250</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,972</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ManagementAndOtherFeesRelatedMedicalPracticesNet_i01_maCzj7K_zYey99xVmqJ5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees - related medical practices &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,987</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,795</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--Revenues_iT_mtCzj7K_maCzKYQ_zELlLsmtrI08" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Revenues &#8211; Net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,191</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:Revenues" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,730</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--CostsAndExpensesAbstract_iB_zbntOG0SNmy5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">COSTS
    AND EXPENSES</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--OtherCostOfOperatingRevenue_i01_maCzOsi_zcjwfOS0Xawl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to patient fee revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,800</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherCostOfOperatingRevenue" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,156</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CostsRelatedToProductSales_i01_maCzOsi_zrFaMUFyxXal" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to product sales</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">169</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToProductSales" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">109</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--CostsRelatedToServiceAndRepairFees_i01_maCzOsi_zHzhJrxlobs" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">718</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFees" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">724</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_ecustom--CostsRelatedToServiceAndRepairFeesRelatedParties_i01_maCzOsi_zGUplfI2X3dh" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to service and repair fees - related parties</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToServiceAndRepairFeesRelatedParties" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">10</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_ecustom--CostsRelatedToManagementAndOtherFees_i01_maCzOsi_z0yrMp7oI2Tf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,501</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFees" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,877</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_ecustom--CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_i01_maCzOsi_zuVvX2Vrhotg" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
    related to management and other fees &#8211; related medical practices</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,398</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,637</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--ResearchAndDevelopmentExpense_i01_maCzOsi_zmFGHVtRw1i8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Research
    and development</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">349</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ResearchAndDevelopmentExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">386</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--SellingGeneralAndAdministrativeExpense_i01_maCzOsi_z9Bjv4qBpIMd" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Selling,
    general and administrative</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,334</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SellingGeneralAndAdministrativeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,090</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--CostsAndExpenses_i01T_mtCzOsi_msCzKYQ_z8BzmCa9KZN6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: 27pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Costs and Expenses</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,280</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CostsAndExpenses" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,989</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_iT_mtCzKYQ_maCzJRl_zy8FG9E7sEXg" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    From Operations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,911</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,741</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eus-gaap--OtherNonoperatingIncomeExpense_maCzJRl_zGZpXdJiQ5Q5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherNonoperatingIncomeExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">811</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--InterestExpenses_iN_di_msCzJRl_zdBKeAhmtmZ3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Interest
    Expense</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:InterestExpenses" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:InterestExpenses" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--InvestmentIncomeNet_maCzJRl_zFaT3vt3FTC3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Investment
    Income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">151</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InvestmentIncomeNet" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">63</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_iT_mtCzJRl_maCzztk_z3HzfwqyWXab" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    Before Provision for Income Taxes and Noncontrolling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,059</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,598</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--IncomeTaxExpenseBenefit_iN_di_msCzztk_zT06BcYt2Flc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision
    for Income Taxes</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,409</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefit" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40C_eus-gaap--ProfitLoss_iT_mtCzztk_zXtYF2wmolT3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,650</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,182</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_iN_di_zTyLoycjuHXg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income - Noncontrolling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40B_eus-gaap--NetIncomeLoss_zjBjAT16zhr8" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income &#8211; Attributable to FONAR</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z2JkqCZCmqY" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,923</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zkb1RuhIv1M8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,652</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class A Non-Voting Preferred Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_zs5bXzQ3jD64" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">92</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--PreferredClassAMember_znnyDZjmz9W4" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_PreferredClassAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">175</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    Income Available to Class C Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zPCTgKeSe7T" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_eus-gaap--NetIncomeLoss_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zpYxwb4R6Pc6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eus-gaap--EarningsPerShareBasic_pip0_zhNXONGrGGZ" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--EarningsPerShareDiluted_pip0_z04ZPDSAeEF1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    Net Income Per Common Share Available to Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.55</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    and Diluted Income Per Share &#8211; Class C Common</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--EarningPerShareBasicAndDiluted_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z0lA42NWqzEe" title="Earning per share basic and diluted" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningPerShareBasicAndDiluted" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--EarningPerShareBasicAndDiluted_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zOJWVdvkJJck" title="Earning per share basic and diluted" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningPerShareBasicAndDiluted" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic Shares Outstanding &#8211; Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z1ZuUSYhSqii" title="Weighted Average Number of Shares Outstanding, Basic" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zj6txH0E8aPk" title="Weighted Average Number of Shares Outstanding, Basic" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pn3n3_zzii2AH7ol3f" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Diluted Shares Outstanding - Common Stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,673</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,682</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9pt; padding-left: 18.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    Average Basic and Diluted Shares Outstanding &#8211; Class C Common</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zDOp0QkkQa7c" title="Weighted average basic and diluted" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7HjEnS0p9Nd" title="Weighted average basic and diluted" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;<br /></span></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="FinancialStatements"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending September 30, 2022</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_304_114_pn3n3_z1fz8hT3bSN5" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B9_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_z2yUiTbsw0eh" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4BC_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zAYlk8Etsnp7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_custom--AccumulatedDeficitMember_zx6oPfPfwvA5" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B7_us-gaap--StatementEquityComponentsAxis_us-gaap--TreasuryStockMember_zA1S9k0Vd5na" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4BB_us-gaap--StatementEquityComponentsAxis_us-gaap--NoncontrollingInterestMember_zANC3Jlvalja" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_4B7_zFeGnY8Tjmw1" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr id="xdx_430_c20220701__20220930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zquYgMmJ99c9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; June 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_CommonStockMember266973265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">33,567</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">4,054</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">146,236</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_i_pn3n3" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0410">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0411">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0413">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0414">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eus-gaap--StockRepurchasedDuringPeriodValue_iN_di_z1eLxfp1EVfi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchase
    of Treasury stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0417">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0418">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0419">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0421">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_403_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zbHIG6BtAYy4" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0424">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0425">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0426">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0427">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zjiQWZdLXXD8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0431">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0432">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0433">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0434">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">603</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_43D_c20220701__20220930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z9yix3m67lp6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; padding-left: 0.05in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_CommonStockMember266973296" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">184,531</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">31,520</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">(<span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">797</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">5,085</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">147,130</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the Three Months Ending September 30, 2021</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Paid
    in capital in excess of par value</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accumulated
    Deficit</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Treasury
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non
    Controlling Interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td></tr>
  <tr id="xdx_43B_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iS_zG20QcRnSjH5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    - June 30, 2021</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">46,008</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,049</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">135,370</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetIncomeLoss_zfE0qyVRswId" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0452">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0453">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0455">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0456">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_iN_di_zJMdhGc4JOge" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Distributions
    - Non controlling</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0459">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0460">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0461">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0462">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40D_eus-gaap--NetIncomeLossAttributableToNoncontrollingInterest_zCoZPEsWLHQ1" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Income
    - Non controlling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0466">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0467">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0468">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0469">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,295</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_431_c20210701__20210930_eus-gaap--StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_iE_z8CADrbFuhOe" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -2.25pt; padding-left: 2.25pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Balance
    &#8211; September 30, 2021</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">185,101</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_custom_AccumulatedDeficitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">42,121</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">675</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">2,834</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">139,472</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="CashFlow"></span>CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_301_112_pn3n3_zvZR6Mb7tYYc" summary="xdx: Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_495_20220701__20220930_z3wgaOOsOLk" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_494_20210701__20210930_zBJkIChZCg68" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FOR
    THE THREE MONTHS <br />ENDED SEPTEMBER 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2021</span></td></tr>
  <tr id="xdx_40F_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zv01Q3QppE6f" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    Flows from Operating Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eus-gaap--ProfitLoss_maCz4ri_zNXFLUtH3xv6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Net
    income</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,650</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ProfitLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,182</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_iB_zS5zXEooV5zl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Adjustments
    to reconcile net income to net cash provided by operating activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--OtherDepreciationAndAmortization_i01_maCz4ri_zKU3M7Wnn4U6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherDepreciationAndAmortization" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,169</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OperatingLeaseRightOfUseAssetAmortizationExpense_i01_maCz4ri_zXM3CKObff9c" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
    on right-of-use assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,061</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">648</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_ecustom--ProvisionForBadDebts_i01_maCz4ri_z3LdK7l4nwX2" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Provision
    for bad debts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,398</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ProvisionForBadDebts" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">502</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--DeferredIncomeTaxExpenseBenefit_i01_maCz4ri_zXpzJf7jnmtl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Deferred
    income tax &#8211; net</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,146</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DeferredIncomeTaxExpenseBenefit" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,195</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--GainOnForgivenessOfPppLoan_i01N_di_msCz4ri_z89yy3BYS0oa" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gain
    on forgiveness of PPP loan</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0501">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:GainOnForgivenessOfPppLoan" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">701</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInOperatingAssetsAbstract_iB_zKRToK6W9GWh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Increase)
    decrease in operating assets, net:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInAccountsReceivable_i01N_di_msCz4ri_zec7yHtMpznj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts,
    medical and management fee receivable(s)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,407</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsReceivable" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,730</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInReceivables_i01N_di_msCz4ri_zTHYhmwgqyef" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Notes
    receivable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncreaseDecreaseInReceivables" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">11</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInInventories_i01N_di_msCz4ri_zXhRmp74jWGb" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">98</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInInventories" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">172</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_402_eus-gaap--IncreaseDecreaseInPrepaidExpense_i01N_di_msCz4ri_zU2NtDXeJbSa" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Prepaid
    expenses and other current assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">14</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">188</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_407_eus-gaap--IncreaseDecreaseInOtherNoncurrentAssets_i01N_di_msCz4ri_ztupxDIQXYn7" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    assets</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0519">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--IncreaseDecreaseInOperatingLiabilitiesAbstract_iB_zqJCnSy3xLa1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Increase
    (decrease) in operating liabilities, net:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--IncreaseDecreaseInAccountsPayable_i01_maCz4ri_zgRlKprocR8i" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    payable</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">779</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccountsPayable" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">733</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--IncreaseDecreaseInOtherCurrentLiabilities_i01_maCz4ri_zkS9ueZMcwBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    current liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,580</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOtherCurrentLiabilities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">3,383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_40A_eus-gaap--IncreaseDecreaseInOperatingLiabilities_i01_maCz4ri_zUQ6W4HsHEx6" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    lease liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">912</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInOperatingLiabilities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">547</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInFinancingLiabilities_i01N_di_msCz4ri_zN8wA33uLve9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    lease liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:IncreaseDecreaseInFinancingLiabilities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_409_ecustom--IncreaseDecreaseInCustomerAdvance_i01_maCz4ri_zimeYtxyW8rj" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    deposits</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">171</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IncreaseDecreaseInCustomerAdvance" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">58</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i01_maCz4ri_zhgF37Xr7yV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    liabilities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_406_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtCz4ri_maCzqv5_zE3hQ13QWmnc" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -22.5pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash provided by operating activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,697</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,241</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zZD86Img96g6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Investing Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--PaymentsToAcquirePropertyPlantAndEquipment_i01N_di_msCzBrM_zINF583MCiK5" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchases
    of property and equipment</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">939</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,180</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eus-gaap--PaymentsToAcquireIntangibleAssets_i01N_di_msCzBrM_zLPms6HSLCih" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cost
    of patents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsToAcquireIntangibleAssets" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">29</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtCzBrM_maCzqv5_zE0MeV9ijQRh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash used in investing activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">963</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,209</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zTGQoVRtBtvd" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Cash
    Flows from Financing Activities:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eus-gaap--RepaymentsOfNotesPayable_i01N_di_msCzr2r_zDDSMuqWc5e" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Repayment
    of borrowings and capital lease obligations</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:RepaymentsOfNotesPayable" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_401_eus-gaap--PaymentsForRepurchaseOfConvertiblePreferredStock_i01N_di_msCzr2r_zVeHuSutPpyc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchase
    of treasury stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0565">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eus-gaap--PaymentsOfDividendsMinorityInterest_i01N_di_msCzr2r_zfwSeeVWhveg" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9pt; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Distributions
    to noncontrolling interests</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,634</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsMinorityInterest" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,080</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtCzr2r_maCzqv5_z9QnIIRAh27d" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -0.25in; padding-left: 26.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    cash used in financing activities</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,761</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,087</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_i01T_mtCzqv5_z06swf1Z7oyc" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;Net
    Decrease in Cash and Cash Equivalents</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">27</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">1,055</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr id="xdx_408_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01S_zs1OdBfKm1Q4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -9.9pt; padding-left: 0.25in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - Beginning of Period</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,723</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">44,460</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_i01E_z2J1nhZrvv4j" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -9.9pt; padding-left: 0.25in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
    and Cash Equivalents - End of Period</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">48,696</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" contextRef="AsOf2021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">43,405</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">See
accompanying notes to condensed consolidated financial statements.&#160;&#160;</span></p>


<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="NotesToFinancialStatements"></span>NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zomOqPW1rqB1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_827_zPqSR7Go8Qm2">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zrsMEisrp1J9" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">24.2</ix:nonFraction></span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_902_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zDgomMJcHnkk" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"><ix:nonFraction name="FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" contextRef="AsOf2015-07-01_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">45.8</ix:nonFraction></span>% in HDM, and the original
investors in HDM retained a <span id="xdx_90A_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zQDwIm3QPn86" title="The ownership interest of the original investors of HDM"><ix:nonFraction name="FONR:OwnershipInterestOfOriginalInvestorsOfHdm" contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30.0</ix:nonFraction></span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_909_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuJuHI9L2Zf" title="Direct purchase of Noncontrolling Interests"><ix:nonFraction name="FONR:DirectPurchaseOfNoncontrollingInterests" contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">546,000</ix:nonFraction></span>. Currently the Company has a direct ownership interest
of <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zmA0wFNtJOSb" title="Direct ownership interest percentage"><ix:nonFraction name="us-gaap:EquityMethodInvestmentOwnershipPercentage" contextRef="AsOf2022-06-30_custom_ControllingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">70.8</ix:nonFraction></span>% and the investors&#8217; have a <span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zKKMnnawY0P7" title="Investors ownership interest percentage"><ix:nonFraction name="FONR:InvestorsOwnershipInterest" contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">29.2</ix:nonFraction></span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Since
March 2020, the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and
economies which has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations.
Generally, COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel
to travel for marketing purposes or to service our customers. At the end of fiscal year ending June 30, 2020, the Company was able to
enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8220;PPP&#8221;) and Medicare
advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant disruption of the
business and the volume has recently risen back almost to pre- COVID-19 levels. Although we are unable to predict if there will be additional
consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with positive cash flows, low debt
and cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zmksrMnwZJj3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zQcrlQzqs5N1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zRKln3GHEeol" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zMWkPbvUi7Jj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zL9mpAEmcQJj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zzE74uot9fJj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zs2mmQHqLRK7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zFA2y6FveWza" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_82F_z7J3XfelRr75">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ConsolidationPolicyTextBlock"><p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zZqUeLbjL8t7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86A_zSPe9ftYLH11">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:RevenueRecognitionPolicyTextBlock"><p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zFkfmYW1UJi9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zNojIKhqRfIg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:BusinessCombinationsPolicy"><p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zzUJtloDScG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86F_zrwc8kbaWza5">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zVqVHhN4TIea" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zIYPq07YVnW1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zNNXBjhlIkEa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zDPr4bMT5sUj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zDq9UkxuVTl9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zrBCQmBKbjt7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zX9x3czhvSJ4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_znjYd1W3mMmi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z06KT1T02Rfi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zHDs3gVpTrv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_860_zYu9CAZVtc7d">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2022 and 2021.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2022 and 2021, diluted EPS for
common shareholders includes <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zMeJg2SsDwA8" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zIHYhF8BivT9" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares"><ix:nonFraction name="us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></ix:nonFraction></span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_zwi3vROioEQc" style="display: none">Quarterly Financial Data</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br /> September 30, 2021</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br /> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br /> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,047</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,923</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">32</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,887</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,652</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" title="Basic Numerator: Net income available to common stockholders" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">60</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" title="Basic Denominator: Weighted average shares outstanding" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.31</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.29</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.08</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.59</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.56</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" title="Basic income per common share" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:EarningsPerShareBasics" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="INF" scale="0" unitRef="USDPShares">0.16</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br /> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" title="Diluted Denominator: Weighted average shares outstanding" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,545</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" title="Diluted Denominator: Weighted average shares outstanding" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" title="Diluted Denominator: Weighted average shares outstanding" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">6,554</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" title="Diluted Denominator: Weighted average shares outstanding" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:WeightedAverageNumberOfDilutedSharesOutstandings" contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">383</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ConvertibleClassCStock" contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">128</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" title="Convertible Class C Stock" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,673</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze1UxGim4le9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_865_zdcJBeT4Mjni">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2022 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_237_z1nz2UfVDMsd" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><br /></span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z9IYgxQ8flr1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_ztMlNtQozjoj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_za3zfzf2G0Ng" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zs0CWX6DTTtf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zY3b1s0DsAI3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z4gBuZ8DveD4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_231_zsHVv7Ct9vAa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"><p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zDCr5x8keM76" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_822_zh1GUBKJDNEh">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at September 30, 2022, and June 30, 2022:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_ziCJYFNmkl63" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z6ZWc9zPwJw" style="display: none">Financing Receivable, Noncurrent, Allowance for Credit Loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,366</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--AccountsReceivableServiceAndRepairFees_c20220930_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,161</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zTXKTzGHM9Bj" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0702">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--AccountsReceivableNetRelatedParty_c20220930_pn3n3" title="Accounts receivable - Related party" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableNetRelatedParty" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">90</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--MedicalReceivable_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,216</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--MedicalReceivable_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zxa2sY00ZPU7" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_c20220930_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">19,216</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">52,331</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">17,749</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">34,582</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,687</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,964</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,723</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,541</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">205</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" title="Accounts receivable" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:AccountsReceivableServiceAndRepairFees" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,336</ix:nonFraction></span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrRRrCsSt7Jg" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" title="Medical Receivables" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:MedicalReceivable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,109</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50,047</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,628</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630_pn3n3" title="Management and other fees receivable" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagementAndOtherFees_NonRelatedParties" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">33,419</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13,290</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,687</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630_pn3n3" title="Management and other fees receivable from related medical practices (&quot;PC&#39;s&quot;)" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">8,603</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A5_zeJlMWJylyA9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_234_zgKCcm7KwNCc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z2D5KyUqn4f7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zZ5iQVU28rm1" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zOzF5x54YPd4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zKisyswjWpY3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zB8vleo1O6I7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z4G8Zo4h7ji6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z79ZOpt76Gec" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zIq98EWRMwA4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zpn9h2xEaLu8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zlUvLTtN3Wgl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of September 30, 2022 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="FONR:TotalFacilitiesOwnedOrManagedTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zJ0KtngUHJRg" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_8B3_zhaSgGVkFlI6" style="display: none">Schedule of Facilities Owned Or Managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20220930_zZPzI6vIxtc3" title="2024" style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueOneToTwoYears" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,072</ix:nonFraction></span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: top"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20220930_zaYSJvS3eRf4" title="2025" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueTwoToThreeYears" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">420</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20220930_zfH1gz10n0Tj" title="2026" style="border-bottom: Black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:ContractReceivableDueThreeToFourYears" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">84</ix:nonFraction></span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220930_pn3n3" title="Total" style="border-bottom: Black 2.5pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,576</ix:nonFraction></span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_z8PCvEocf2R2" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">69.0</ix:nonFraction></span>%
and <span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20210930_zzzRpMovET18" title="Percentage of net revenue derived from no-fault and personal injury protection claim"><ix:nonFraction name="FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">66.7</ix:nonFraction></span>% of the PCs&#8217; net revenues for the three months ended September 30, 2022 and 2021, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zvFge6A6WCm7" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.9</ix:nonFraction></span>% and <span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20210930_zux8MPqExS13" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"><ix:nonFraction name="FONR:PercentageOfConsolidatedNetRevenueFromManagementFees" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.8</ix:nonFraction></span>% of the consolidated net
revenues for the three months ended September 30, 2022 and 2021, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_231_zy3LK58OiRHi" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zVELkuFFzbsb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zMCIt0hU6N2k" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z2Jd7YfOLuC2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23A_zsCeGeRn5q7k" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zRncGGfjzeod" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zu1OId1Tdkc6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zWoEz2vgCnBe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_z0Iz651ubpA7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zAIBmYa88ZT3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable (Continued)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zPkpkwcWpW87" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2022 and 2021
are summarized in the following table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="FONR:ScheduleOfPatientFeeRevenueTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_z2tkiblHGlN3" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zR9cdlyJcHC8" style="display: none">Schedule Of Patient Fee Revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br />September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">911</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,086</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">238</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_MedicareMedicaidMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">249</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,235</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,124</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-012022-09-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">692</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30_custom_OtherRevenueSourceMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,392</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,076</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930_pn3n3" title="Patient fee revenue, net of contractual allowances and discounts" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,851</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:LesseeOperatingLeasesTextBlock"><p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_z4j6oEUwcyC5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_829_zVV6uuVeGdXj">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 14 -->
    <div id="xdx_232_zHhJuooI5E74" style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" id="xdx_23B_z4EESvo8zmr8" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td id="xdx_239_zqFP8jZkyUve" style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div id="xdx_231_zzofIalCsRz8" style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zMl9XfBRSiF8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zJW4ApIZCSSk" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_z6gAPGvWQi43" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_z2IFIrtmUkgl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zj91QdqtAKq5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zzmrG7vC6ixe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_zNv2iCNTzgId" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zzBfREn7NFo3" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; OPERATING &amp; FINANCING LEASES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zaD4ZBZrTe0c" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2022 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zyejPdOLEzYa" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zog7zBJRno9i" style="display: none">Lessee Operating Leases Liability Maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br />September 30,</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br />Payments</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziAGgjiTK0fb" title="2023" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,525</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zyvFhxggZQ49" title="2023" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpZyzCY2Zctb" title="2024" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,427</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPFs9veGRgue" title="2024" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z23RFqEzpaw3" title="2025" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,315</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1V2ER8AzFw9" title="2025" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z0qMvSx2KM2j" title="2026" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,865</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z9dznTsIHu7e" title="2026" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">244</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z5b4OCb1ctrb" title="2027" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,596</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zVl2duC35pta" title="2027" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">102</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zw02DQKtnjVf" title="Thereafter" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">22,380</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPhHZgo8jPJc" title="Thereafter" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0845">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscount_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zY05KY6enTG4" title="Present value discount" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscount" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">10,088</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z0IMDRR3sxc4" title="Present value discount" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="FONR:PresentValueDiscountFinancingLease" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">82</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zuTaBmrgh9C6" title="Total lease liability" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OperatingLeaseLiability" contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">37,020</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zwtvaw3NTf9g" title="Total lease liability" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FinanceLeaseLiability" contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">996</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:InventoryDisclosureTextBlock"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbPk0WSrY913" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_821_zx1CEjtXnos5">INVENTORIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zqJyUDhbf3w7" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B1_zUksbCVW7Fjc" style="display: none">Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49D_20220930_zBCjcu8QBAW7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49E_20220630_z71Hl6dbyoP3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, <br />2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br />2022</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzXq3_zmWhz94fYS86" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,182</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherInventorySupplies" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,126</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzXq3_zdUg9SpQYl1i" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">276</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">234</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzXq3_zFYtMcUyAZK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,458</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:InventoryFinishedGoodsAndWorkInProcess" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,360</ix:nonFraction></span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:IntangibleAssetsDisclosureTextBlock"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zNFFoptuVnLf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_82B_zlvXSdqXm3ll">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zueSOH2CKYbb" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B1_zhuUt2gjsOL6" style="display: none">Other Intangible Assets - Net</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" title="Gross other intangible assets" style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">7,005</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,357</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,333</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,150</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Gross other intangible assets" style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,900</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,412</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" title="Gross other intangible assets" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsGross" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20,388</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220930_pn3n3" title="Less: Accumulated amortization" style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,788</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" title="Less: Accumulated amortization" style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">16,684</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220930_pn3n3" title="Other intangible assets-net" style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,624</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" title="Other intangible assets-net" style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IntangibleAssetsNetExcludingGoodwill" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,704</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:exclude><p id="xdx_23E_zhyl6ov2SEe4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p></ix:exclude>


<ix:exclude><!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_236_zolsKLGmhVj7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zvOcae719VB6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_znGfSbLElSB9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zNRMWoKrlDpf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zkEn9RwcA2k4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zPcFuIlgvX9l" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zvDBRV2jVvjb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23D_zBR4cOI7DdK6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; OTHER INTANGIBLE ASSETS (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_232_z8OBgg4yc1n5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended September 30, 2022 and 2021 amounted to $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">54</ix:nonFraction></span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zrGt20WSdSYj" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">47</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the three months ended September 30, 2022, and 2021 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012022-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">0</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">13</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended September 30, 2022 and 2021 amounted to $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"><ix:nonFraction name="us-gaap:AmortizationOfIntangibleAssets" contextRef="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">50</ix:nonFraction></span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ze5VfT95XDQg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_82F_zmhjWTTOfQKk">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjFwUZswbog9" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span id="xdx_8BF_zD8fGA9u2bTc" style="display: none">Other Current Liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20220930_zjAkICBldQSf" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_497_20220630_zkQqr8E7jfij" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzmgj_zNG0R4wOkjvj" style="vertical-align: bottom">
    <td style="width: 60%; padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,037</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedSalariesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,653</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzmgj_zPaB4XnAbnDl" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">269</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SalesAndExciseTaxPayableCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">249</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzmgj_zYKiOHmy7Bp8" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">250</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:StateIncomeTaxesPayable" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">382</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzmgj_z9kzlYBj2Zm3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">20</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzmgj_z0Z8gYPzrn2h" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">76</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">120</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzmgj_zxOjt87ohX3e" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzmgj_zIBxQtkJnXZ3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherAccruedLiabilitiesNoncurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">59</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzmgj_zpN8ssEOoDYi" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general &amp; administrative expenses</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,445</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherSundryLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">854</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzmgj_zcpzZhxKAhY7" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,201</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,417</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_807_eus-gaap--SegmentReportingDisclosureTextBlock_z7CzVQaD6pNc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_829_z8uwefxGfBjc">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23C_zwAKqXdaRmKc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_zRgjhZdrxKxl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zgFcL7PsEzPl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_z9SkFGtvU7nc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zkEC3Pboe9q5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zoAvCRbe2uri" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zwhQtgTLfr5e" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zFjnsPbYLPfa" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - SEGMENT AND RELATED INFORMATION (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zCwtSnnepJ5a" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_889_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_znf9HDYDKO" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B5_zX2kODdwcrFb" style="display: none">Summarized Segment Financial Information</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br />
    Equipment</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br />
    of Diagnostic <br />
    Imaging <br />
    Centers</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 49%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,878</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,313</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930_pn3n3" title="Net revenues from external customers" style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,191</ix:nonFraction></span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930_pn3n3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">245</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">802</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">4,713</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">3,911</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">72</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,046</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,118</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">24</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_988_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">939</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">963</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2021</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">2,112</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">21,618</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" title="Net revenues from external customers" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:NetRevenuesFromExternalCustomers" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">23,730</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1004">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_983_ecustom--IntersegmentNetRevenues_c20210701__20210930_pn3n3" title="Inter-segment net revenues" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="FONR:IntersegmentNetRevenues" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">236</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="USD">490</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">6,231</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" title="(Loss) Income from operations" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:IncomeLossFromContinuingOperations" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">5,741</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">67</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,102</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" title="Depreciation and amortization" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:DepreciationDepletionAndAmortization" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,169</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">121</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,088</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" title="Capital expenditures" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><ix:nonFraction name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,209</ix:nonFraction></span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table></ix:nonNumeric>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock"><p id="xdx_80A_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zVXAouvO9FY2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_829_zIEBWX59BQwg">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $<span id="xdx_90D_eus-gaap--InterestPaid_c20220701__20220930_pn3n3" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--InterestPaid_c20210701__20210930_pn3n3" title="Interest paid"><ix:nonFraction name="us-gaap:InterestPaid" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">189</ix:nonFraction></span> for interest, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $<span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20220701__20220930_pn3n3" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">395</ix:nonFraction></span> and $<span id="xdx_90F_eus-gaap--IncomeTaxesPaid_c20210701__20210930_pn3n3" title="Income taxes paid"><ix:nonFraction name="us-gaap:IncomeTaxesPaid" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">221</ix:nonFraction></span> for income taxes, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRohQSYjQOa8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_828_zxmdJ2Fv0L3">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_23F_z1Vd4CVRhyBl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_23F_zfK5wnkmHfkf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zR4obroXVi68" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zCMqcFYqHKkb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_236_zyggMI2hGyu9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_230_zmp9kLoAmH9i" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zh1sePFHsBgc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_234_zV1JiZyBDv25" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; COMMITMENTS AND CONTINGENCIES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_235_zRUXyQtMUAl6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90F_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zW1EScCi9NYa" title="Stock purchase plan"><ix:nonFraction name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" contextRef="AsOf2022-09-26" format="ixt:numdotdecimal" decimals="-3" scale="6" unitRef="USD">9</ix:nonFraction></span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the quarter ended September 30, 2022, the Company
repurchased <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_z3hiwXMF6yJ9" title="Number of shares repurchased"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodShares" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">9</ix:nonFraction></span> shares at a cost of $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zYwIyA4Aiac1" title="Number of shares repurchased, value"><ix:nonFraction name="us-gaap:StockRepurchasedDuringPeriodValue" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">122</ix:nonFraction></span>.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_903_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20220930_pn3n3" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances"><ix:nonFraction name="FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">150</ix:nonFraction></span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2022 and June 30, 2022, the Company had approximately $<span id="xdx_907_eus-gaap--SelfInsuranceReserve_c20220930_pn3n3" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">45</ix:nonFraction></span> and $<span id="xdx_908_eus-gaap--SelfInsuranceReserve_c20220630_pn3n3" title="Self-funded health insurance reserve"><ix:nonFraction name="us-gaap:SelfInsuranceReserve" contextRef="AsOf2022-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">79</ix:nonFraction></span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:IncomeTaxDisclosureTextBlock"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zsNBjRNsWMqg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_82F_zR1F6waqtpQl">INCOME TAXES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, Income Taxes &#8211; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2022 and 2021, the Company recorded income tax expense of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20220930_pn3n3" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,409</ix:nonFraction></span> in 2022 as compared
to $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20210930_pn3n3" title="Income tax expense"><ix:nonFraction name="us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" contextRef="From2021-07-012021-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,416</ix:nonFraction></span> in 2021. The 2022 provision is comprised of a current income tax component of $<span id="xdx_901_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - current"><ix:nonFraction name="us-gaap:CurrentFederalTaxExpenseBenefit" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">263</ix:nonFraction></span> and a deferred income tax component of $<span id="xdx_905_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - deferred"><ix:nonFraction name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">1,146</ix:nonFraction></span>.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:exclude><p id="xdx_235_zJtJc2iIx225" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p></ix:exclude>

<ix:exclude><p id="xdx_238_zA3ZXR1QxS21" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></p></ix:exclude>

<ix:exclude><p id="xdx_23E_zpmeBxYicOL1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">SEPTEMBER
30, 2022 and 2021</span></p></ix:exclude>

<ix:exclude><p id="xdx_23C_zKkNUGemDvZ4" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Amounts
and shares in thousands, except per share amounts)</span></p></ix:exclude>

<ix:exclude><p id="xdx_23B_z5JL3lyDkv93" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(UNAUDITED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_zSQd1EcAPMeg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_237_zhv0ttRR3Qu1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<ix:exclude><p id="xdx_233_z2g9eICwOMj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - INCOME TAXES (CONTINUED)</span></p></ix:exclude>

<ix:exclude><p id="xdx_239_zyTgKvWxXuvj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p></ix:exclude>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_90B_eus-gaap--DeferredTaxAssetsNet_c20220930_pn3n3" title="Deferred tax asset"><ix:nonFraction name="us-gaap:DeferredTaxAssetsNet" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">11,697</ix:nonFraction></span> and a deferred tax liability of $<span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220930_pn3n3" title="Deferred tax liability"><ix:nonFraction name="us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">216</ix:nonFraction></span> as of September 30, 2022, primarily relating to
net operating loss carryforwards of approximately $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_c20220930_pn3n3" title="Operating Loss Carryforwards"><ix:nonFraction name="us-gaap:OperatingLossCarryforwards" contextRef="AsOf2022-09-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="USD">15,640</ix:nonFraction></span> available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2022, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b style="font-style: normal; font-weight: normal">The Inflation Reduction Act (&#8220;IRA&#8221;)
was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_909_ecustom--ExciseTax_dp_c20220701__20220930_zfYObwtVb5Ae" title="Excise tax"><ix:nonFraction name="FONR:ExciseTax" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1</ix:nonFraction></span>% excise tax on share repurchases that occur after December 31,
2022 and introduces a <span id="xdx_903_ecustom--CorporateMinimumTax_dp_c20220701__20220930_zyezC1XKpQc3" title="Corporate minimum tax"><ix:nonFraction name="FONR:CorporateMinimumTax" contextRef="From2022-07-01to2022-09-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting the IRA to have a material impact to
the Company&#8217;s financial statements.</b></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><ix:nonNumeric contextRef="From2022-07-01to2022-09-30" escape="true" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zEB9mukrQ6bl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_824_zJ0erQNyFbE3">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to September 30, 2022 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
October 2022, the Company cancelled <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pn3n3_c20221001__20221031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYmITS4nJtq9" title="Cancelled shares"><ix:nonFraction name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" contextRef="From2022-10-012022-10-31_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="Shares">16</ix:nonFraction></span> shares of common stock which were held as treasury stock at September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
October 2022, the Company amended the revolving credit agreement. The agreement was extended to January 6, 2023. The interest rate on
borrowings is at the current prime rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230101__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zns5dnap3emd" title="Interest rate"><ix:nonFraction name="us-gaap:DebtInstrumentInterestRateDuringPeriod" contextRef="From2023-01-012023-01-06_us-gaap_SubsequentEventMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.25</ix:nonFraction></span>% along with certain financial covenants.</span></p>

</ix:nonNumeric><p id="xdx_811_zEwkfKUltPJ9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="MDA"></span>Item
2. &#8211; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the three month period ended September 30, 2022, we reported a net income of $2.7 million on revenues of $23.2 million as compared to
net income of $5.2 million on revenues of $23.7 million for the three month period ended September 30, 2021. Operating income decreased
from $5.7 million for the three month period ended September 30, 2021 to $3.9 million for the three month period ended September 30,
2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue decrease, from $23.7 million for the first three months of fiscal 2022 to $23.2 million for the first three months of fiscal
2023, was primarily due to decreases in patient fee revenue of $775,000, from $6.9 million for the first three months of fiscal 2022
to $6.1 million for the first three months of fiscal 2023. Revenues from product sales and service and repair fees decreased by 11.1%
from $2.1 million for the first three months of fiscal 2022 to $1.9 million for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">While
our revenues decreased, our costs and expenses increased, but by a greater amount resulting in our operating income decreasing to $3.9
million for the three months ended September 30, 2022 as compared to $5.7 million for the three months ended September 30, 2021. In terms
of percentages, costs and expenses increased 7.2% from $18.0 million for the first three months of fiscal 2022 to $19.3 million for the
first three months of fiscal 2023, while revenues increased 2.3%, from $23.7 million for the first three months of fiscal 2022 to $23.2
million for the first three months of fiscal 2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar&#8217;s
wholly owned subsidiary, Health Management Corporation of America (&#8220;HMCA&#8221;), has the controlling interest, in Health Diagnostics
Management, LLC (&#8220;HDM&#8221;). HMCA presently has a direct ownership interest of 70.8% in HDM, and the investors in HDM have a
29.2% ownership interest, as compared to HMCA&#8217;s 70% ownership interest and the investors&#8217; 30% ownership interest in HDM in
fiscal 2021. This change resulted from the Company&#8217;s purchase of non-controlling interests from the minority shareholders for $546,000
in the second quarter of fiscal 2022. The management of the diagnostic imaging centers business segment is being conducted by HDM, operating
under the name &#8220;Health Management Company of America&#8221;. For the sake of simplicity, HMCA, and HDM are referred to as &#8220;HMCA&#8221;,
unless otherwise indicated.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
most significant adverse impact on our Company in fiscal 2022 and the first quarter of fiscal 2023 has been the continuing COVID-19 pandemic.
Although it had seemed the worst had passed, by August 2020, subsequent events have shown a spike in new cases and the emergence of new
strains of the virus. This is by no means a problem confined to our Company, but despite our best efforts and improved ability to cope
with the pandemic and the availability of new vaccines, the impact on our results of operation and financial condition is potentially
volatile and severe.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Since
March 2020 the global pandemic of COVID-19 has caused disruptions in the United States and international markets which have adversely
affected our workforce, financial condition, profitability and business operations. Generally COVID-19 caused us to require that a portion
of our workforce work from home and restricted the ability of our personnel to travel for marketing purposes or to service our customers.
During the fourth quarter of fiscal 2020, the Company was able to enact certain decisions to allow the Company to survive during the
global pandemic and prevent further losses or additional decreases in scan volume. Although we are unable to predict if there will be
additional consequences on our operations from the continuing global pandemic of COVID-19 and its variants, the Company believes with
its strong cash position and general financial condition, it will be able to continue operations going forward.</span></p>


<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">One
of the concerns we have had is the increased strictness in enforcement of certain COVID-19 mandates, which directly impact the conduct
of our business, such as the requirement that employees in healthcare facilities be vaccinated. Another concern we have is the newer
variants that are more transmissible. We are in fact facing some of these challenges now. As a result, between absences due to illness
and the loss of unvaccinated employees whose duties required them to be in contact with patients, we were sometimes unable to keep a
scanning facility open for all shifts. Also at the end of the first quarter of fiscal 2023, our Florida locations were effected by Hurricane
Ian and had to be shut down for several days. During the first quarter of fiscal 2023, the aggregate number of scans performed by the
sites we manage or own declined to 44,471 scans from 48,469 scans in the first quarter of fiscal 2022. Nevertheless, we have been able
to navigate through these challenges and avoid any significant disruption to our business</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Forward
Looking Statements</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Certain
statements made in this Quarterly Report on Form 10-Q are &#34;forward-looking statements&#34; (within the meaning of the Private Securities
Litigation Reform Act of 1995) regarding the plans and objectives of Management for future operations. Such statements involve known
and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different
from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements
included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based,
in part, on assumptions involving the expansion of business. Assumptions relating to the foregoing involve judgments with respect to,
among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond our control. Although we believe that our assumptions underlying the forward-looking
statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking
statement included herein, the inclusion of such information should not be regarded as a representation by us or any other person that
our objectives and plans will be achieved.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Results
of Operations</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
operate in two industry segments: the manufacture and servicing of medical (MRI) equipment, which is conducted by Fonar, and diagnostic
facilities management services, which is conducted through HMCA.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Manufacturing
and Service of MRI Equipment</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenues
from MRI product sales decreased to $30,000 for the first three months of fiscal 2023 from $148,000 for the first three months of fiscal
2022. Costs related to product sales increased from $109,000 for the three month period ended September 30, 2021 to $169,000 for the
three month period ended September 30, 2022. Economic uncertainty and lower reimbursement rates for MRI scans, have depressed the market
for our MRI scanner products, notwithstanding our scanners&#8217; unique technological capabilities (e.g. multi positional scanning).
Due to the low sales volumes of our MRI product, period to period comparisons are not necessarily indicative of any trends.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Service
revenues decreased to $1.8 million for the three month period ended September 30, 2022 as compared to $2.0 million for the three month
period ended September 30, 2021.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Costs
relating to providing service were $734,000 in the first three months of fiscal 2022 and $729,000 in the first three months of fiscal
2023. Because of our ability to monitor the performance of customers&#8217; scanners from our facilities in Melville, New York on a daily
basis and to detect and repair any irregularities before more serious and costly problems develop, we have been able to contain our costs
of providing service.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were approximately $99,000 in foreign revenues for the first three months of fiscal 2023 as compared to approximately $82,000 in foreign
revenues for the first three months of fiscal 2022, representing an decrease in foreign revenues of 20.7%. We do not regard this as a
material trend, but as part of a normal although sometimes volatile variation resulting from low volumes of foreign sales.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
recognize MRI scanner sales revenues on the &#8220;percentage of completion&#8221; basis, which means the revenues are recognized as
the scanner is manufactured. Revenues recognized in a particular quarter do not necessarily reflect new orders or progress payments made
by customers in that quarter. We build the scanner as the customer meets certain benchmarks in site preparation and our installation
of the scanner, in order to minimize the time lag between incurring costs of manufacturing and our receipt of the cash progress payments
from the customer which are due upon delivery. Consequently, there can be a disparity between the revenues recognized in a fiscal period
and the number of product sales. Generally, the revenues from a scanner sale are recognized in a fiscal quarter or quarters following
the quarter in which the sale was made.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Revenues
for the medical equipment segment decreased to $1.9 million for the first three months of fiscal 2023 from $2.1 million for the first
three months of fiscal 2022. Operating losses for our medical equipment segment increased to an operating loss of $802,000, for the first
three months of fiscal 2023 as compared to an operating loss of $490,000 for the first three months of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diagnostic
Facilities Management Services</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA
revenues decreased in the first three months of fiscal 2023 by 1.4% to $21.3 million from $21.6 million for the first three months of
fiscal 2022. The percentage of our revenues derived from our diagnostic facilities management segment relative to the percentage of our
revenues derived from our medical equipment segment increased slightly to 91.9% for the first three months of fiscal 2023, from 91.1%
for the first three months of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
current strategy is to counter the effects of lower reimbursement rates by increasing the scan volume of the facilities it owns or manages
by adding additional scanners at current centers and increasing our marketing efforts. As a result of the COVID-19 virus, however, the
Company had seen decreases in its scan volume. Nevertheless, the Company continued its program of adding additional scanners. The scan
volume decreased slightly in the first quarter of 2023. Other factors that have led to the slight decrease can also be attributable to
Hurricane Ian which cause the Florida locations to be closed for several days. The continuation of the COVID-19 virus and its various
variants that are more transmittable may delay the completion of the installation of some of the scanners. If scan volumes decrease however,
and remain at lower volumes, the Company, notwithstanding its ample cash reserves, may need to consider reducing the size of its operations
temporarily as a last resort.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">New
York State mandated that as of October 7, 2021, all workers at hospitals, long-term care facilities and diagnostic centers be COVID-19-vaccinated.&#160;
Workers who were not vaccinated either resigned, were transferred to a non-diagnostic facility within the company, or were dismissed.
The resulting reduction in the number of workers available at sites owned or managed by HMCA, has been challenging and has significantly
reduced the pool of qualified and vaccinated workers. Also this is combined with the emergence of the new highly transmissible variants.
HMCA owned or managed sites struggling with reduced staff either have cut their business hours and therefore scan fewer patients or,
when possible, maintain regular business hours by paying employees who are willing to work extra hours at overtime rates.&#160;</span></p>


<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Although
the COVID-19 virus and government mandates have adversely affected our marketing efforts our scan volumes in fiscal 2020 and the beginning
of fiscal 2021, the number of scans performed at our centers and at our client&#8217;s centers has recovered to pre-COVID-19 levels and
has decreased from approximately 48,000 in the first three months of fiscal 2022 to approximately 44,000 in the first three months of
fiscal 2023. The decrease in scans was due to a shortage of MRI technologists who operate the scanners, which was an industry-wide issue,
caused our centers to be open for fewer hours. We believe that the worst part of this shortage has past and we will be back to full employment
by December.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
now manage or own a total of 41 MRI scanners. Twenty-six (26) MRI scanners are located in New York and fifteen (15) are located in Florida.
HMCA experienced an operating income of $4.7 million for the first three months of fiscal 2023 compared to operating income of $6.2 million
for the first three months of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ability of HMCA to maintain its profitability is principally due to HMCA&#8217;s success in marketing the scanning services of the facilities
managed or owned by HMCA, notwithstanding the decrease in reimbursement rates paid for MRI scans by insurers, Medicare and other government
programs and the lockdowns imposed as a result of the COVID-19 virus. The reductions in reimbursement rates are not unique to HMCA or
HMCA&#8217;s clients but are being experienced by the industry in general.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">HMCA&#8217;s
cost of revenues for the first three months of fiscal 2023 as compared to the first three months of fiscal 2022 remained constant at
$11.7 million.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Consolidated</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
the first three months of fiscal 2023, our consolidated net revenues decreased by 2.3% to $23.2 million from $23.7 million for the first
three months of fiscal 2022, and total costs and expenses increased by 7.2% to $19.3 million from $18.0 million for the first three months
of fiscal 2023 and for the first three months of fiscal 2022 respectively. As a result, our operating income decreased to $3.9 million
in the first three months of fiscal 2023 as compared to $5.7 million in the first three months of fiscal 2022. An increase in selling,
general and other administrative costs in particular resulted in the increase of cost and expenses as compared to the increase in net
revenues.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Selling,
general and administrative expenses increased to $6.3 million in the first three months of fiscal 2023 from $5.1 million in the first
three months of fiscal 2022. This increase in selling, general and administrative expenses was due mainly to more reserves taken on management
fees. Some of these reserves had been taken in the ordinary course of business and some in connection with the impact of the COVID-19
virus. The compensatory element of stock issuances, which is included in selling, general and administrative expenses, remained constant
at $0 for the first three months of fiscal 2023 and fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Research
and development expenses decreased by 9.6% to $349,000 for the first three months of fiscal 2023 from $386,000 for the first three months
of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Interest
expense in the first three months of fiscal 2023 decreased by 17.6% to $17,000 from $14,000 in the first three months of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
increased to $2.5 million at September 30, 2022 as compared to $2.4 million at June 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
management fee and medical receivables increased by 0.6% to $62.5 million at September 30, 2022 from $62.1 million at June 30, 2022 as
a result of slower collections and increased scan volume. The slower collections were primarily due to an increase in no-fault and workers&#8217;
compensation revenue, which typically takes longer to collect.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
results of operations for the first three months of fiscal 2023 reflect a decrease in revenues from management, patient and other fees,
as compared to the first three months of fiscal 2022 ($21.3 million for the first three months of fiscal 2023 as compared to $21.6 million
for the first three months of fiscal 2022), and a decrease in the MRI equipment segment revenues ($1.9 million for the first three months
of fiscal 2023 as compared to $2.1 million for the first three months of fiscal 2022). Revenues were 8.1% from the MRI as compared to
91.9% from HMCA, for the first three months of fiscal 2023, as compared to 8.9% from the MRI equipment segment and 91.1% from HMCA for
the first three months of fiscal 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
March 27, 2020, the CARES Act was signed into law and is intended to provide over $2 trillion in stimulus benefits for the U.S. economy.
The CARES Act provides for certain federal income tax changes, including an increase in the interest expense tax deduction limitation,
the deferral of the employer portion of Social Security payroll taxes, refundable payroll tax credits, net operating loss carryback periods,
alternative minimum tax credit refunds and bonus depreciation of qualified improvement property. The federal income tax changes brought
about by the CARES Act are complex and further guidance is expected. We received a cash benefit from the ability to receive a full reimbursement
of $1.3 million of tax credits relating to the alternative minimum tax credits in the prior fiscal years plus additional cash benefits
from the deferral of the employer portion of Social Security payroll taxes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
a result of the Patient Protection and Affordable Care Act (PPACA) we have experienced a reduction of reimbursement rates and less interest
in our MRI equipment. Any changes to the PPACA may result in further changes in the healthcare industry and our business.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
are committed to improving our operating results and dealing with the challenges posed by legislative and regulatory requirements. Nevertheless,
factors beyond our control, such as the COVID-19 virus, the timing and rate of market growth, economic conditions, the availability of
credit and payor reimbursement rates, or unexpected expenditures and the timing of such expenditures, make it difficult to forecast future
operating results.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
mentioned, one of the effects of the PPACA on our business has been the reduction in Medicare reimbursement rates for MRI scans. This
also has resulted in a reduction in the reimbursement rates by commercial insurers and government programs which tie their reimbursement
rates to the Medicare rates. Nevertheless, the patient volume of the scanning centers we manage or own has enabled us to maintain healthy
operating results in spite of these challenges. We believe we are pursuing the correct policies to cope with these problems and the problems
caused by the COVID-19 pandemic, and to improve the Company&#8217;s operating results.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
Upright&#174; MRI (also referred to as the Stand-Up&#174; MRI), together with our works-in-progress, are intended to significantly improve
our competitive position.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI scanner, which operates at 6000 gauss (.6 Tesla) field strength, allows patients to be scanned while standing, sitting,
reclining and in multiple flexion and extension positions. It is common in visualizing the spine that abnormalities are visualized in
some positions and not others. This enables surgical corrections that heretofore would not have been addressable for lack of visualizing
the symptom causing the pathology and therefore, in general enables the treating physician to achieve a better treatment outcome for
his patient. A floor-recessed elevator brings the patient to the height appropriate for the targeted image region. A custom-built multi-position
adjustable bed will allow patients to sit or lie on their backs, sides or stomachs at any angle. This allows the MRI technologist to
ask the patient to position himself/herself in the exact position that generates his/her pain so that images of the patient in the position
that explicitly generates the patient&#8217;s pain can be nailed down. Full-range-of-motion studies of the joints in virtually any direction
are possible, a particularly promising feature for sports injuries.</span></p>


<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
addition, FONAR had announced the publication of a book &#8220;THE CRANIOCERVICAL SYNDROME and MRI&#8221; that highlights the unique
attributes of FONAR UPRIGHT&#174; MRI Imaging (S. Karger, A.G. based in Basel, Switzerland- www.karger.com/Book/Home/261956) which has
been published by S. Karger, an approximately 125 year old company and an academic publisher of scientific and medical journals and books.
The seven chapter monograph examines the rapid advances in MRI made possible by the FONAR UPRIGHT&#174; Multi-Position MRI that are transforming
the treatment of patients suffering from the craniocervical syndrome (CCS). It is written by leading international experts in the field
to practitioners with a better understanding of the subtle anatomy and MRI appearances at the craniocervical junction, along with insight
into the clinical significance of cerebrospinal fluid (CSF) flow measurements and its potential role in generating the devastating impairments
of the neurodegenerative diseases: Alzheimer&#8217;s (5.1 million patients in the United States), childhood and adult Autism (3.0 million),
Parkinson&#8217;s (1.0 million), Multiple Sclerosis (250,000-350,000) and Amyotrophic Lateral Sclerosis (ALS) (30,000). It calls attention
to the revolutionary importance of FONAR&#8217;s UPRIGHT&#174; MRI imaging technology and the prospect of significantly relieving the
suffering of the above totaled 9.38 million patients afflicted with these disorders.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar
also had announced a major diagnostic breakthrough in multiple sclerosis achieved with advanced Upright&#174; MRI. Medical researchers
at FONAR published a paper reporting a diagnostic breakthrough in multiple sclerosis (MS), based on observations made possible by the
Company&#8217;s unique Upright&#174; Multi-Position&#8482; MRI scanner. The findings reveal that the cause of multiple sclerosis may be
biomechanical and related to earlier trauma to the neck, which can result in obstruction of the flow of cerebrospinal fluid (CSF), which
is produced and stored in the central anatomic structures of the brain known as the ventricles. Since the ventricles produce a large
net volume of CSF each day (500 cc), the obstruction can result in a build up of pressure within the ventricles, resulting in leakage
of the CSF and the antigenic polypeptides it contains into the surrounding brain tissue. This leakage could be responsible for generating
the brain lesions of multiple sclerosis.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
paper, titled &#8220;The Possible Role of Cranio-Cervical Trauma and Abnormal CSF Hydrodynamics in the Genesis of Multiple Sclerosis,&#34;
appears in the journal Physiological Chemistry and Physics and Medical NMR (Sept. 20, 2011).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">This
capability of the Fonar Upright&#174; technology has demonstrated its key value on patients with the Arnold-Chiari syndrome [Cerebellar
Tonsil Extopia (CTE)], which is believed to affect 200,000 to 500,000 Americans. In this syndrome, brain stem compression and subsequent
severe neurological symptoms occur in these patients, because the brain stem descends and is compressed at the base of the skull in the
foramen magnum, which is the circular bony opening at the base of the skull where the spinal cord exits the skull. Conventional lie-down
MRI scanners cannot make an adequate evaluation of this pathology since the patient's pathology is most visible and the symptoms most
acute when the patient is scanned in the upright fully weight-bearing position.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
combined study of 1,200 neck pain patients published in &#8220;Brain Injury&#8221; (July 2010) by eight university medical centers reported
that cerebellar tonsil ectopia (CTE) of 1mm or greater was found and visualized 2.5 times (250%) more frequently when patients who had
sustained automobile whiplash injuries were scanned upright rather than lying down.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 4pt 0 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Upright&#174; MRI has also demonstrated its value for patients suffering from scoliosis. Scoliosis patients have been typically subjected
to routine x-ray exams for years and must be imaged upright for an adequate evaluation of their scoliosis. Because the patient must be
standing for a complete evaluation of the extent of the patient&#8217;s scoliosis, an x-ray machine has been the only modality that could
provide that service. The Upright&#174; MRI is the only MRI scanner which allows the patient to stand during the MRI exam. Fonar has developed
an RF receiver and scanning protocol that for the first time allows scoliosis patients to obtain diagnostic pictures of their spines
without the risks of x-rays. A study by the National Cancer Institute (2000) of 5,466 women with scoliosis reported a 70% increase in
breast cancer resulting from 24.7 chest x-rays these patients received on the average in the course of their scoliosis treatment. The
Upright&#174; MRI examination of scoliosis enables the needed imaging evaluation of the degree of spine scoliosis without exposing the
patient to the risk of breast cancer from x-radiation. Currently scoliosis affects more than 3,000,000 American women.</span></p>


<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
addition, the University of California, Los Angeles (UCLA) reported their results of their study of 1,302 patients utilizing the Fonar
Upright&#174; MRI at the 22nd Annual Meeting of the North American Spine Society on October 23, 2007. The UCLA study showed the superior
ability of the Fonar Upright&#174; MRI to detect spine pathology, including spondylolisthesis, disc herniations and disc degeneration,
as compared to visualizations of the spine produced by traditional single position static MRIs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;The
UCLA study by MRI of 1,302 back pain patients when they were in the Fonar Upright&#174; MRI and examined in a full range of flexion and
extension positions made possible by Fonar&#8217;s new Upright&#174; technology established that significant &#8220;misses&#8221; of pathology
were occurring with static single position MRI imaging. At L4-5, the vertebral level responsible for 49.8% of lumbar disc herniations,
35.1% of the spondylolistheses (vertebral instabilities) visualized by the Upright&#174; MRI, were being missed by static single position
MRI (510 patients). Since this vertebral segment is responsible for the majority of all disc herniations, the finding may reveal a significant
cause of failed back surgeries. The UCLA study further showed the &#8220;miss-rate&#8221; of vertebral instabilities by static only MRI
was even higher, 38.7%, at the L3-4 vertebral segment. Additionally, the UCLA study showed that MRI examinations of the cervical spine
that did not perform extension images of the neck &#8220;missed&#8221; disc bulges 23.75% of the time (163 patients).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
UCLA study further reported that they were able to quantitatively measure the dimensions of the central spinal canal with the &#8220;highest
accuracy&#8221; using the FONAR Upright&#174; MRI thereby enabling the extent of spinal canal stenosis that existed in patients to be
measured. Spinal canal stenosis gives rise to the symptom complex intermittent neurogenic claudication manifest as debilitating pain
in the back and lower extremities, weakness and difficulties in ambulation and leg paresthesias. Spinal canal stenosis is a spinal compression
syndrome separate and distinct from the more common nerve compression syndrome of the spinal nerves as they exit the vertebral column
through the bony neural foramen.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Fonar Upright&#174; MRI can also be useful for MRI directed emergency neuro-surgical procedures as the surgeon would have unhindered access
to the patient&#8217;s head when the patient is supine with no restrictions in the vertical direction. This easy-entry, mid-field-strength
scanner could prove ideal for trauma centers where a quick MRI-screening within the first critical hour of treatment will greatly improve
patients&#8217; chances for survival and optimize the extent of recovery.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;MRI
has brought a new dimension to MEDICAL TREATMENT, the power to VISUALIZE ANATOMIC DETAIL in the body's VITAL SOFT TISSUES (brain, heart,
kidney, liver, spleen, lungs, pancreas, intestines) plus MRI's new power to non-invasively QUANTIFY (e.g. measure T1, T2, diffusion,
chemical spectra) the response of these VITAL TISSUES to treatment.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Liquidity
and Capital Resources</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
and cash equivalents, and short term investments remained constant at $48.7 million at June 30, 2022 and at September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
provided by operating activities for the first three months of fiscal 2023 was $2.7 million. Cash provided by operating activities was
attributable principally to net income of $2.6 million, depreciation and amortization of $1.1 million, amortization on right-to-use assets
of $1.1 million, provision for bad debts of $1.4 million and deferred income tax of $1.1 million, offset by an increase in accounts,
management fee receivables and medical receivables of $1.4 million and a decrease in other current liabilities of $1.6 million.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
used in investing activities for the first three months of fiscal 2023 was $963,000. Cash used in investing activities during the first
three months of fiscal 2023 consisted of patent costs of $24,000 and the purchase of property and equipment of $939,000.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Cash
used in financing activities for the first three months of fiscal 2023 was $1.8 million. The principal uses of cash in financing activities
during the first three months of fiscal 2022 were the repayment of principal on long-term debt and capital lease obligations of $5,000,
the purchase of treasury stock of $122,000 and distributions to non-controlling interests of $1.6 million.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
liabilities decreased by 4.2% to $50.9 million at September 30, 2022 from $53.1 million at June 30, 2022. &#8220;Other&#8221; current
liabilities decreased by 18.9% to $5.2 million at September 30, 2022 from $6.4 million at June 30, 2022. The current portion of our service
contract liabilities decreased by 2.0% to $4.2 million at September 30, 2022 as compared to $4.3 million at June 30, 2022. Customer deposits
increased from $361,000 at June 30, 2022 to $532,000 at September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">As
of September 30, 2022, the total of $5.2 million in &#8220;other&#8221; current liabilities included accrued salaries and payroll taxes
of $3.0 million, state income taxes payable of $250,000 and other general and administrative expenses of $1.4 million.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
working capital increased to $104.2 million at September 30, 2022 from $101.9 million at June 30, 2022. This resulted from an increase
in current assets ($118.7 million at June 30, 2022 as compared to $119.1 million at September 30, 2022), and a decrease in current liabilities
from $16.7 million at June 30, 2022 to $14.9 million at September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry, and tax planning strategies in making this assessment. At the present, the Company
believes that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized.
In recognition of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, (principally
related to research and development tax credits and allowance for doubtful accounts). A valuation allowance will be maintained until
sufficient positive evidence exists to support the reversal of any portion or all of the valuation allowance.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s effective income tax rate is based on expected income, statutory rates and tax planning opportunities available in the
various jurisdictions in which it operates. For interim financial reporting, the Company estimates the annual income tax rate based on
projected taxable income for the full year and records a quarterly income tax provision or benefit in accordance with the anticipated
annual rate. The Company refines the estimates of the year&#8217;s taxable income on a periodic basis as new information becomes available,
including actual year-to-date financial results. This continual estimation process often results in a change to the expected effective
income tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in
estimate occurs so that the year-to-date provision reflects the expected income tax rate. Significant judgment is required in determining
the effective tax rate and in evaluating tax positions.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
March 27, 2020 Congress enacted the CARES Act (Coronavirus Aid, Relief and Economic Security Act). The Act provides numerous tax provisions
and other stimulus measures, including temporary changes regarding prior and future operating losses, temporary changes to the prior
and future limitations on interest deductions, temporary suspension of certain payment requirements for the employer portion of Social
Security taxes, technical corrections to prior tax legislation for tax depreciation of certain qualified improvement property and the
creation of refundable employee retention credits. At the present time, the only impact of the CARES Act to the Company is allowing a
full reimbursement of $1.3 million of tax credits relating to the alternative minimum tax credits in prior fiscal years. Before the CARES
Act, these credits were to be refunded over a period of 3 years. We also realized a cash benefit from the deferral of Social Security
payroll taxes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
June 30, 2020, we entered into a $701,000 loan agreement under the Paycheck Protection Program (PPP) under the CARES Act that provides
for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses. The Company applied for this
additional loan exclusively for the Florida locations during June 2020 due to the fact that the COIVD-19 virus was increasing in Florida.
The loans and accrued interest are forgivable after 24 weeks as long as the proceeds are used for eligible purposes, including payroll,
benefits, rent and utilities and maintains certain payroll levels. The amount of loan forgiveness will be reduced if the borrower terminates
employees or reduces salaries during the 24 week period. This loan was forgiven during August 2021 in its entirety.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Fonar
is committed to making capital expenditures for the remainder of the 2023 fiscal year, for placing a scanner at a new stand-alone facility
located in Florida. The current estimated costs of these capital expenditures is approximately $1.0 million.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Critical
to our business plan are the improvement and expansion of the MRI facilities managed or owned by HMCA, and increasing the number of scans
performed at those facilities. In addition, our business plan calls for a continuing commitment to providing our customers with enhanced
equipment service and maintenance capabilities and delivering state-of-the-art, innovative and high quality equipment and upgrades at
competitive prices.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
is seeking to promote wider market recognition of Fonar&#8217;s scanner products, and to increase demand for Upright&#174; scanning at
the facilities HMCA owns or manages. Given the liquidity and credit constraints in the markets, the uncertainty resulting from the Patient
Protection and Affordable Care Act or its repeal or modification, and the impact of the COVID-19 virus on the economy in general, the
sale of medical equipment has and may continue to suffer.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company believes that its business plan has been responsible for the past nine consecutive fiscal years and first fiscal quarter of fiscal
2023 of profitability and that its capital resources will be adequate to support operations through at least November 14, 2023. The future
effects on our business of healthcare legislation, the impact of the COVID-19 virus, the Deficit Reduction Act, the 2.3% excise tax on
sales of medical equipment, reimbursement rates, public health conditions and the general economic and business climate are not known
at the present time. Nevertheless, there is a possibility of adverse consequences to our business operations from these causes. Although
the Company cannot predict the full effect of COVID-19 for the first three fiscal quarters or any later period, the Company believes
that it has adequate revenues, cash reserves and other assets that will enable it to continue to operate until at least November 14,
2023.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="QualitativeDisclosures"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains its funds in liquid accounts. None of our investments are in fixed rate instruments.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">All
of our revenue, expense and capital purchasing activities are transacted in United States dollars.</span></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="ControlsAndProcedures"></span>Item
4. Controls and Procedures.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Disclosure
Controls and Procedures</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">We
carried out an evaluation as of the end of the period covered by this Quarterly Report on Form 10-Q, under the supervision and with
the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of the
design and operation of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended (the &#8216;&#8216;Exchange Act&#8217;&#8217;). Disclosure controls and procedures include, without
limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it
files or submits under the Exchange Act is accumulated and communicated to the issuer&#8217;s management, including its principal
executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions
regarding required disclosure. Based upon our evaluation, our chief executive officer and chief financial officer have concluded
that the Company&#8217;s disclosure controls and procedures were effective as of the September 30, 2022, in ensuring that material
information that we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed,
summarized and reported within the same time periods specified in the Securities and Exchange Commission rules and forms.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Changes
in Internal Control over Financial Reporting</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no changes in our system of internal control over financial reporting during our most recently completed fiscal quarter that have
materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="PartII"></span>PART
II &#8211; OTHER INFORMATION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="LegalProceedings"></span>Item
    1 &#8211; Legal Proceedings:&#9;There were no material changes in litigation from that reported in our Form 10-K for the fiscal year
    ended June 30, 2022 and Form 10-Q for the fiscal quarter ended September 30, 2022. </span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="RiskFactors"></span>Item
1A &#8211; Risk Factors: An investment in the securities of the Company is subject to various risks, the most significant of which are
summarized below.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1.
Reduced Reimbursement Rates. Most of our revenues are derived from our scanning center business conducted by HMCA. Our scanning center
clients and the Florida facilities owned by HMCA are experiencing lower reimbursement rates from Medicare, other government programs
and private insurance companies. To date, the impact of these reductions has been countered by increasing scanning volume notwithstanding
the COVID-19 pandemic, and reducing our operating expenses, thereby maintaining profitability in this business segment. There is, however,
no assurance that we will be able to continue to do so.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2.
Demand for MRI Scanners. The reduced reimbursement rates also affects our sales of MRI scanners negatively. With lower revenue projections,
prospective customers would demand lower prices for scanners. Although the reduced reimbursements may not affect foreign demand, a lower
number of sales in the aggregate could reduce economies of scale and consequently, profit margins.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3.
Manufacturing Competition. Many if not most of our competing scanner manufacturers have significantly greater financial resources, production
capacity, and other resources than we do. Such competitors would include General Electric, Siemens, Hitachi and Phillips. Although Fonar
is the only company which can manufacture and sell the unique Stand-Up&#174; (Upright&#174;) MRI scanner, potential customers must be convinced
that the purchase of a Fonar scanner is their best choice. We believe that with time, that objective will be reached, particularly with
customers scanning patients having neck, back, knee and various orthopedic issues who would benefit from being scanned in weight-bearing
positions.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4.
Dependence on Referrals. HMCA derives substantially all of its revenue, directly or indirectly, from fees charged for the diagnostic
imaging services performed at the facilities. We depend on referrals of patients from unaffiliated physicians and other third parties
to the facilities we manage or own for the services we perform. If these physicians and other third parties were to reduce the number
of patients they refer or discontinue referring patients, scan volumes could decrease, which would reduce our net revenue and operating
margins.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5.
Pressure to Control Healthcare Costs. One of the principal objectives of health maintenance organizations and preferred provider organizations
is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic
imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting
has become very competitive. The expansion of health maintenance organizations, preferred provider organizations and other managed care
organizations in New York or Florida could have a negative impact on the utilization and pricing of services performed at the facilities
HMCA manages or owns to the extent these organizations exert control over patients&#8217; access to diagnostic imaging services, selections
of the provider of such services and reimbursement rates for those services.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6.
Scanning Facility Competition. The market for diagnostic imaging services is highly competitive. The facilities we manage or own compete
for patients on the basis of reputation, location and the quality of diagnostic imaging services. Groups of radiologists, established
hospitals, clinics and other independent organizations that own and operate imaging equipment are the principal competitors.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7.
Eligibility Changes to Insurance Programs. Due to potential decreased availability of healthcare through private employers, the number
of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will continue to increase
the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift
in payor mix from managed care and other private payors to government payors or an increase in the number of uninsured patients may result
in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding
decrease in net revenue. Policies now being offered under various insurance plans are expected to reduce demand for MRI scans as they
become less affordable. Changes in the eligibility requirements for governmental programs such as the Medicaid program and state decisions
on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs
and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase
patient financial responsibility, resulting in a greater risk of uncollectible receivables. These factors and events could have a material
adverse effect on our business, financial condition, and results of operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8.
Possible changes in Florida Insurance Law. In early 2019, two senate bills and one house bill in Florida were introduced, all of them
calling for the repeal of PIP and replacing PI with $25,000 Bodily Injury Coverage and Property Damage Liability Coverage. Another Florida
senate bill was introduced that would preserve PIP but dramatically cut reimbursement rates. None of the proposed bills ever made it
onto the 2019 legislative agenda. During Fonar&#8217;s fiscal 2021, the Florida house and senate reached an agreement and passed similar
legislation. It was, however, vetoed by the Governor. We cannot predict whether such efforts by the Florida legislature will continue
or be successful. Currently, drivers and passengers get car damages and PIP, paid for up to $10,000, no matter who is at fault in an
accident. Drivers have to pay an additional cost to insurance companies to pay for bodily injuries which covers them if they are at fault.
While PIP is required, coverage for bodily injury is not.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Over
the past several years there have been various bills introduced by a number of Florida legislators to eliminate PIP and instead mandate
coverage including some combination of a minimum of bodily injury and a reduced or no amount of medical payments (Medpay coverage). Eliminating
PIP would mean that the $10,000 drivers now get paid toward medical costs through their insurers might not be there for them to pay for
injured drivers. Importantly, payments would be reduced by approximately 60% due to claims being paid at commercial rates or through
legal settlements instead of at the presently prevailing PIP fee schedule. This would negatively impact our Florida diagnostic imaging
facilities (both those we own and those we manage) with more unpaid bills, lower reimbursement rates and elongated waiting times. To
date proponents of these changes have been unsuccessful.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">9.
Federal and state privacy and information security laws. We must comply with numerous federal and state laws and regulations governing
the collection, dissemination, access, use, security and privacy of Protected Health Information (&#8216;PHI&#8217;), including Health
Insurance Portability and Accountability Act (&#8216;HIPAA&#8217;) and its implementing privacy and security regulations, as amended
by the federal Health Information Technology for Economic and Clinical Health (&#8216;HITECH&#8217;) Act and collectively referred to
as HIPAA. If we fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity
of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business, reputation, results
of operations, financial position and cash flows could be materially and adversely affected.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Information
security risks have significantly increased in recent years because of the proliferation of new technologies, the use of the internet
and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers,
terrorists and other external parties, including foreign state agents. Our operations rely on the secure processing, transmission and
storage of confidential, proprietary and other information in our computer systems and networks.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">10.
COVID-19. Although we believe we have taken the proper steps and are making a good recovery from the impact of the first wave of the
COVID-19 virus, new strains of the disease have developed and future variants may continue to develop. The relatively recent new variants
are particularly contagious and coupled with New York State requirements that medical employees must be vaccinated if they care for patients,
including our technicians and support staff caring for scanning patients, has resulted in fewer available employees and adversely affected
our ability to staff a full number of shifts. The course and severity of the virus, and the ultimate and economic and medical impact
it will have worldwide and at home, is uncertain.</span></p>

<p style="font: 11pt Calibri, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">11.
Other changes in Domestic and Worldwide Economic Conditions. We are subject to risk arising from adverse changes in general domestic
and global economic and other conditions, including recessions or economic slowdowns, disruptions of credit markets and military conflicts.
Turbulence and uncertainty in the United States and international markets and economies may adversely affect our workforce, liquidity,
financial condition, revenues, profitability and business operations generally.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="UseOfProceeds"></span>Item
2 &#8211; Unregistered Sales of Equity Securities and Use of Proceeds: None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="LegalMatters"></span>Item
3 - Defaults Upon Senior Securities: None</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="MoreInformation"></span>Item
4 - Mine Safety Disclosure: Not Applicable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="CautionaryNote"></span>Item
5 - Other Information: None&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION AND SUBSIDIARIES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Exhibits"></span>Item
6 - Exhibits and Reports on Form 8-K:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; width: 89%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-31.htm">Exhibit 31.1 Certification. See Exhibits.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">b)&#160;&#160;&#160;&#160;&#160;&#160;</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="fonar_exhibit-32.htm">Exhibit 32.1 Certification. See Exhibits.</a></span></td></tr>
  <tr style="vertical-align: top">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">c)</span></td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/355019/000035501922000050/fonar_8-k.htm">Report on Form 8-K filed on September 29, 2022, Item 2.02: Results of Operations and Financial Condition for the fiscal year ended June 30, 2022.</a></span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="Signatures"></span>SIGNATURES</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FONAR
CORPORATION</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Registrant)</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">________________</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">By:
/s/ Timothy Damadian</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Timothy
Damadian</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Chairman
of the Board of Directors, President,</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Principal Executive Officer and Treasurer</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">________________</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">/s/
Luciano Bonanni</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Luciano
Bonanni</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Executive
Vice President, Chief Operating Officer,</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 3.5in; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Acting Principal Financial Officer</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Dated:
November 14, 2022</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="font: normal 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>fonar_exhibit-31.htm
<DESCRIPTION>SECTION 302 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
31.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION</FONT></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
Damadian and Luciano Bonanni each certify that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">1.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have reviewed this report on Form 10-Q of Fonar Corporation;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">2.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, this report does not contain any untrue statement of a material fact or
                                            omit to state a material fact necessary to make the statements made, in light of the circumstances
                                            under which such statements were made, not misleading with respect to the period covered
                                            by this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">3.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Based
                                            on my knowledge, the financial statements, and other financial information included in this
                                            report, fairly present in all material respects the financial condition, results of operations
                                            and cash flows of the registrant as of, and for, the periods presented in this report;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">4.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            am responsible for establishing and maintaining disclosure controls and procedures (as defined
                                            in Exchange Act Rules 13a-15(e) and 15(e)) and internal control over financial reporting
                                            (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f) for the registrant and have:</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such disclosure controls and procedures or caused such disclosure controls over procedures
                                            to be designed under my supervision to ensure that material information relating to the registrant,
                                            including its consolidated subsidiaries, is made known to us by others within those entities,
                                            particularly during the period in which this report is being prepared;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">designed
                                            such internal control over financial reporting, or caused such internal control over financial
                                            reporting to be designed under my supervision, to provide reasonable assurance regarding
                                            the reliability of financial reporting and the preparation of financial statements for external
                                            purposes in accordance with generally accepted accounting principles;</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">c)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">evaluated
                                            the effectiveness of the registrant&rsquo;s disclosure controls and procedures and presented
                                            in this report my conclusions about the effectiveness of the disclosure controls and procedures
                                            as of the end of the period covered by this report; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">disclosed
                                            in this report any change in the registrant&rsquo;s internal control over financial reporting
                                            that occurred during the registrant&rsquo;s most recent fiscal quarter (the registrant&rsquo;s
                                            fourth fiscal quarter in the case of an annual report) that has materially affected, or is
                                            reasonably likely to materially affect, the registrant&rsquo;s internal control over financial
                                            reporting; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">5.</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">I
                                            have disclosed, based on my most recent evaluation of internal control over financial reporting,
                                            to the registrant&rsquo;s auditors and the audit committee of the registrant&rsquo;s board
                                            of directors (or persons performing the equivalent functions):</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(a)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">all
                                            significant deficiencies and material weaknesses in the design or operation of internal control
                                            over financial reporting which are reasonably likely to adversely affect the registrant&rsquo;s
                                            ability to record, process, summarize and report financial information; and</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt 1in; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Any
                                            fraud, whether or not material, that involves management or other employees who have a significant
                                            role in the registrant&rsquo;s internal control over financial reporting.</FONT></TD></TR></TABLE>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: -0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"><P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">November
    14, 2022</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; width: 50%; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Timothy Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
Bonanni,</FONT></P>

<P STYLE="margin-bottom: 0pt"></P>

<P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Acting
Principal Financial Officer&nbsp;</FONT></P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0 0 0pt; text-align: justify; text-indent: 3.5in"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>3
<FILENAME>fonar_exhibit-32.htm
<DESCRIPTION>SECTION 906 CERTIFICATION
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Exhibit
32.1</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">CERTIFICATION
PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">18
U.S.C. SECTION 1350,</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">AS
ADOPTED PURSUANT TO</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">In
connection with the Quarterly Report of FONAR Corporation and Subsidiaries (the &ldquo;Company&rdquo;) on Form 10-Q for the fiscal
quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the
&ldquo;Report&rdquo;), I, Timothy Damadian, Principal Executive Officer, and I, Luciano Bonanni, Acting Principal
Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act
of 2002, that:</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">The
information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="width: 50%; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Timothy
    Damadian</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Principal Executive Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">/s/
    Luciano Bonanni</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">________________________________</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></TD>
    <TD STYLE="font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; padding-left: 5.4pt"><P STYLE="margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">Luciano
                                                                                                 Bonanni&nbsp;</FONT></P>
                                                                                                 <P STYLE="margin-bottom: 0pt"><FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT>Acting Principal Financial Officer&nbsp;</P>
<FONT STYLE="font: normal 10pt Arial, Helvetica, Sans-Serif"></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 11pt/115% Calibri, Helvetica, Sans-Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;November
14, 2022</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; font-style: normal; font-weight: normal">A
signed original of this written statement required by Section 906 has been provided to Fonar Corporation and will be retained by Fonar
Corporation and furnished to the Securities and Exchange Commission or its staff upon request.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: 0.5in"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>fonar-logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 fonar-logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "8 ^<# 2(  A$! Q$!_\0
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M$:C^%I9B?S ']:SF^+7B GY;730/0Q2'_P!G%<)16+Q-5]3T8Y/@E_R[_/\
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M;$VMOF.(=C@\G\:Y>O.JXN2DU'8^LP>0TIT8RK7YF>V_\+5\.?\ 3Y_WX_\
MKT?\+5\.?]/G_?C_ .O7B=%9_7*AU?ZO83N_O_X![9_PM7PY_P!/G_?C_P"O
M1_PM7PY_T^?]^/\ Z]>)T4?7*@?ZO83N_O\ ^ >V?\+5\.?]/G_?C_Z]'_"U
M?#G_ $^#_MC_ /7KQ.BCZY4#_5["=W]__ /:_P#A:OAS_I\_[\?_ %ZZ'0/$
M>G>)+62XT]W*QML=77:P/TKYSKIO OB Z#XAC,CE;6XQ%-D\#T/X'^=:4\7)
MR2EL<V,R"E"C*5&_,NY[[2TU2& 8<@]"*6O1/DA:*** "BBB@ HHHH 2LC7_
M !'8>&[:*>_\W9(Q5?+3<<UKUYU\7?\ D#6'_7<_RK.K)P@Y(ZL#1C7Q$*<M
MFR[_ ,+5\.?]/G_?G_Z]'_"U?#OI>?\ ?G_Z]>*45YWURH?6?ZO83N_O_P"
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M)\[6HU*,^2HK,6BBBJ,CP7XB_P#(]7_TC_\ 05KE>WX?TKJ?B+_R/5_](_\
MT%:Y7M^%>)6_B2/TC+_]UI^B_(7O1V_S[4=Z!T'^?2LSK#_"BD[4M !1110
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M #[P?]_EH_X5AXF_Y]X/^_RUVG_"VM$_Y]KW_OA?\:/^%M:)_P ^U[_WPO\
MC1[+#?S?B'U[-_\ GW^'_!.+_P"%8>)O^?>#_O\ +1_PK#Q-_P ^\'_?Y:[3
M_A;6A_\ /M>_]\+_ (T?\+:T/_GVO?\ OA?\:/98;^;\0^O9O_S[_#_@G%_\
M*P\3?\^\'_?Y:/\ A6/B;_GW@_[_ "UVG_"VM$_Y]KW_ +X7_&C_ (6UH?\
MS[7O_?"_XT>RPW\WXA]>S?\ Y]_A_P $XO\ X5CXF_Y]X/\ O\M'_"L?$W_/
MO!_W^6NT_P"%M:'_ ,^U[_WPO^-'_"VM#_Y]KW_OVO\ C1[+#?S?B'U[-_\
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ML&[X>#\E^04445!TA1110!Z]\(?^0)J'_7P/_017HPKSKX0_\@2__P"O@?\
MH(KT2O9P_P#"1^>9K_OM3U_R%HHHK8\\**** "DHJO>W<5A9374Q"Q1(78_2
MAZ#2;=D<-\4/$7V'3%TJW?$]SS(0>53_ .O7CM:.NZO-KFL7%_*3^\;Y ?X5
M["LZO&KU/:3N?H668-87#J+W>K"BBBL3T HHH )( !))P *!;&OH/AO4/$<L
ML=A&I\H LSG &?>K&O>#M5\.VT=Q>QIY3MMW(V<'WKU[P-H(T+P["CJ!<SCS
M)3[GH/P%:>OZ3%K>BW-A*!^\7Y3Z,.AKT%A$Z=WN?*U,^G'%<JMR7L?-]%37
M=M)9W<MM,I62)BC#T(J&O/:MHSZJ,E))H****!A7L7PO\1?;],;2KE\W%K_J
M\GEH^WY=/RKQVM+0=8ET+6K;4(LGRV^=1_$IZBMJ%3V<[GGYG@UBL.X]5JCZ
M1HJ"SNHKZTANH&#12H'4CN#4]>RC\]::=F+1110(**** "O.?B[_ ,@6P_Z[
MG^5>C5YS\7?^0-8?]=S_ "K'$?PF>AE7^^4_7_,\AHHHKQC]#"BBB@ I55G8
M*H))["DK>\%@-XQTQ6 (,O0_0U48WE8SK5/9TY3[(QOLL_\ SQ?_ +Y-'V6?
M_GD__?)KZ:^S0?\ /&/_ +X%)]F@_P">,?\ WP*[?J*[GS'^LK_Y]_B?,WV6
M?_GD_P#WS1]EG_YY/_WR:^F?LT'_ #QC_P"^!1]F@_YXQ_\ ? I_45W#_65_
M\^_Q/F;[+/\ \\7_ .^:/LL__/%_^^:^F?LT'_/&/_O@4?9H/^>,?_? H^HK
MN'^LK_Y]_B?,WV6?_GD__?-'V6?_ )XO_P!\U],_9H/^>,?_ 'P*/LT'_/&/
M_O@4?45W#_65_P#/O\3YE-O,O6)\?[IJ.OIUK2W=2K01$'J"@KE?$'P\TC5X
M'>UA2SO,?+)&,*3Z$?X5$\%)*\6;T.(Z<I6JPLN^YX915K4=/N=*U":QNTV3
M0MM8=C[CV-5:XFFG9GT49*:4HNZ84444%!1110!Z]\(]0,VCWU@Y)-O,KK[*
MX/\ 53167\'F_P")AJPSP8HC^K?XT5[&&=Z2/S_-X*&-FEZG/_$7_D>K_P#[
M9_\ H(KE.WX5U7Q%_P"1ZO\ _MG_ .@K7+=OPKRZW\21]IE_^ZT_1!WH[#_/
MI1WH'3_/M69V"=J6CM10![/\)O\ D5)_^OQ__0$KO*X/X3?\BG/_ -?;_P#H
M*5WE>U0_AQ]#\YS'_>ZGJQ:***U.(**** "BBB@ HHHH **** "BBD/2@"C-
MK&G6\S0S7L$<B_>5G (IG]O:3_T$;7_OX*\$\5R&?Q9JLC')-PPS[#@?RK'P
M/05P2QC3:L?4T>'H5*<9N;U2Z'TG_;VD_P#01MO^_@H_M[2?^@C;?]_!7S9@
M>@HP/2I^O/L:?ZM0_P"?C^X^D_[>TG_H(VW_ '\%']O:3_T$;;_OX*^;,#T%
M&!Z"CZ\^P?ZM0_Y^/[CZ6BUG39I5CBOK=W8X"JX))J]7@GP\MUG\:V(*@A-S
M_DIKWL5UT*KJ1YFCPLRP4<'55.,KZ7%HHHK8\\**** "BBB@ HHHH **** $
MK/?6]+C=D?4+964X(,@R#6A7SKXNA6'Q;J:!0H\XD #Z5A7K.DDTCTLLP$<;
M4<'*UE<]Y_M[2?\ H(VW_?P4?V]I/_01MO\ OX*^;,#T%&!Z"N7Z\^Q[?^K4
M/^?C^X^D_P"WM)_Z"-M_W\%']O:3_P!!&V_[^"OFS ]!1@>@H^O/L'^K4/\
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MAK K?\$_\CEI?_77^AJZ?QHYL9_N\_1_D?0M%%%>X?FH4444 %%%% !1110
M4444 >3_ !=T]([G3]010&D#0N?7&"O\S7F=>J?&"[7R-+LQC>7>4^P  '\S
M^5>5UY&*255V/O<D<G@H\WG]P4445SGK!1110!Z-\(#_ ,3?4QGCR$_]"-%2
M?!^%C?ZK/_"L4:?4DL?_ &6BO7PO\)'P6=M/&RMY?D<]\1?^1ZO_ *1_^@K7
M*]OPKJOB+_R/5_\ 2/\ ]!6N6[?A_2O,K?Q)'V67_P"ZT_1?D'>@=!_GTH[T
M=A69UA12=J6@#JO#?CJ]\-::]E;VT,JM*9,N3U( _I6Q_P +;U3_ )\;;\S7
MGM%:JO4BK)G!4RS"5).<X*[/0O\ A;>J?\^-M^9H_P"%MZI_SXVWYFO/:*KZ
MS5[D?V1@O^?:_'_,]"_X6YJG_/C;?F:/^%N:I_SXVWYFO/:*7UFKW#^R,%_S
M[7X_YGH7_"W-4_Y\;;\S1_PMS5/^?&V_,UY[11]9J]P_LC!?\^U^/^9Z%_PM
MO5/^?&V_,T?\+;U3_GQMOS->>T4_K-7N']D8+_GVOQ_S/0O^%N:I_P ^-M^9
MH_X6WJG_ #XVWYFO/:*7UFKW#^R,%_S[7X_YGH7_  MO5/\ GQMOS->KV%RU
MYI=M=, K30K(0.Q*@_UKYFKZ3T+_ )%_3O\ KUC_ /0179A*DIM\S/ SW!T,
M.H.E&U[GSUKC[M?U D\_:7_]"-4,CUKZ1?P]H\CL[Z;;,['))C&2:3_A&M%_
MZ!=K_P!^Q42P4F[W.FGQ%3A!1Y'IZ'S?D49'J*^D/^$:T3_H%VO_ '[%'_"-
MZ)_T"[7_ +]BE]1EW+_UDI_R/\#YOR/6C(]:^D/^$:T3_H%VO_?L4?\ "-Z)
M_P! NU_[]BCZC+N'^LE/^1_@>0?#'!\:P?\ 7*3_ -!->YU0M=%TRRF$UM8P
M0R@8#(F#5^NNA3=./*SP,RQBQ=;VL5;2PM%%%;' %%%% !1110 4444 %%%%
M "5\]^-\#QEJ6"/]9_05]"5G3:#I5S,\TVGV\DCG+,R DUA7I.K&R/2RS'1P
M=1SDKW5CYLR/449'J*^D/^$:T3_H%VO_ '[%'_"-:)_T"[7_ +]BN7ZC+N>Y
M_K)3_D?X'S?D>HHR/45](?\ "-Z)_P! NU_[]BC_ (1O1/\ H%VO_?L4?49=
MP_UDI_R/\#YOR/6NJ^'//C>RQC[K_P#H->S?\(UHO_0+M?\ OV*EMM$TRSG$
M]M8P12KT=$ (JH8-QDI7,,3G].M1E34'JK%^O.OB]_R!;#_KY/\ Z":]%KSK
MXO?\@6P_Z^3_ .@FNG$?PY'D97_OE/U/(:.U%%>,?H84>E%% !7H'PD?;XAO
M%_O6_P#6O/\ UKM_A6Y7Q=M_O0-^E;8?2JCSLV5\'4]#VRO*?B7X2V.=<L8_
ME/\ Q\HH[_WJ]6J.:))X7BE4-&ZE64]"#7JU::J1Y6?$8+%SPM95(?/S1\P4
M5TOC3PO)X;U8A%)LIR6A;T_V3]*YJO&G%PDXL_0J%>%>FJD'HPHHHJ38****
M -SPIXCF\-ZPERI+6[_+-&/XE]?J*^@+2ZAO;6*YMW#Q2*&5@>HKYCKT/X;>
M+?L%RNC7K_Z/*W[EC_ WI]#79A:_*^1['SN>9=[6/UBFO>6_FO\ @'L-%&:*
M],^./#/B<FSQE+_M1(?TKCJ[CXJ1E?%:OV>!?TKAZ\6O_%D?HF5N^#I^@444
M5D=X4444 >O_  B_Y =__P!? _\ 017HE>=_"'_D!W__ %\#_P!!%>B5[.'_
M (43\\S7_?:GK_D+1116QYXE!HK(\2ZU%H&ASWTA^8#;&/5STI-I*[*IPE4D
MH16K/.?BEXA^TWB:-;M^[@(:8@]7[#\*\YJ2>>2YN))YF+22,68D]2:CKQ:M
M1SDY,_1L%A8X:A&FOGZA11169UA1Z44?2@1U7@#0?[:\1QM(N;:VQ))D<$]A
M^?\ *O>  !@=!7+^ M _L/P[$)%Q<W'[V4^A/0?@*ZFO8PU/DAYL^ S;&?6<
M0VOA6B%HHHK<\P2O*/BKX?\ +EBUN!/E<B.? []C7J]4M6TZ'5M+N+&<925"
MN?0]C656G[2#B=F Q3PU>-1;=?0^::*LZC8RZ;J$]G.NV2)RK"JU>*U9V9^B
MQDI14H[,****"@KTCX6>(O(NI-$G;]W+F2 D]&[K^/6O-ZEMKF:SNHKFW<I+
M$P9&'8BM*51TYJ1R8W"QQ5"5)_+U/IZBLKP[K,6O:+;W\1&77#C^ZPZBM6O:
M3NKH_.9PE"3A+="T444R0KSKXN_\@2P_Z^#_ .@UZ+7G/Q=_Y EA_P!?!_\
M0:QQ'\)GH95_OE/U_P SR&BBBO&/T,**** "M[P3_P CEI?_ %V_H:P:LZ??
MSZ9?PWMJRB:%MR%AD9^E5!I23,<1!U*4H1W:9]-T5X7_ ,+/\3_\][7_ +\#
M_&C_ (6=XG_Y[VW_ 'X'^->G]<IGQG]@8SR^\]THKPO_ (6?XG_Y[VW_ 'X'
M^-+_ ,+/\3_\][;_ +\#_&CZY3'_ &!C/+[SW.BO"_\ A9WB?_GO:_\ ?@?X
MT?\ "SO$_P#SWMO^_ _QH^N4P_L#&>7WGNE%>%_\+.\3_P#/>V_[\#_&C_A9
M_B?_ )[VW_?@?XT?7*8O[ QGE]Y[G56_U"VTRSDNKN58X8QN)8_R]:\5;XF^
M)F&/M%N/I *P-3US4]9<-?WDD^.BD\#\*B6-A;W5<WH</5Y2_>M)?>6?%.OR
M>(]<FO2"L7W(4/\ "@Z?C_C6-117G2DY.[/KJ5*-*"IQV04444C0**/QK6\-
MZ%-XBUJ&PB4A"=TKC^!!U/\ 3ZTXQ<G9&=6I&E!SF[)'K'PPTQK'PJ+EUP]Y
M(9?^ ]%_D3^-%=A;P1VUM%;Q*%CB0(BCL ,"BO<IQY(J)^:XFLZ]:55]6>%?
M$;_D>K_Z1_\ H(KE>WX5U7Q%_P"1ZO\ Z1_^@K7+=OP_I7C5OXDC]#R__=:?
MHOR#O1VH[T=JS.L**** "BBB@ HHHH **** "BBB@ HHHH **** "OI+1#CP
M[I^/^?2/_P! %?-M?2>B?\B[I_\ UZQ_^@"N[!;R/F.)/AI_/]#PZ\\7^($O
MKE%U6X"K*Z@9Z ,:A_X3+Q%_T%KC_OJL[54,6L7R-P5N) ?^^C52N652=WJ>
MY3PN'<$^1;+HC<_X3+Q%_P!!:X_[ZH_X3+Q%_P!!:X_[ZK#HI>TGW+^J8?\
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M"O.OB[_R!+#_ *^#_P"@UZ(:\[^+O_($L?\ KX/_ *#6.(_A,]#*O]\I^O\
MF>04445XQ^AB4M%% !1110 =**** "BBB@ HHHH **** "BBB@ HHH- !10,
M Y(S6UHU]H=K,C:II<MR >JRX'Y=Z<5=[V,JM1PBY*+?H5]&T#4=>NU@L8&;
MGYI",(GU->Z>%O"]IX8T_P B ^9,YW2S,.6./T''2JWAKQ)X;O8%M=*>&V('
M$! 0_P#UZZ:O4P]&$%S)W9\5FN8XBO+V<X\L5T_S%HHHKJ/&/!/B+_R/5_\
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M_06_\A?_ %Z/JM7L']MX+^;\&>845ZA_PI]O^@M_Y"_^O1_PI]O^@M_Y"_\
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M']^W'H/N445H\/"45%[(XZ>9UZ=:5:-N:6^A4_X53XD_OZ?_ -_V_P#B:/\
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E')M2;4HXT$ZQA-D@;.TOG^8HHHKIIP4(\J/(Q5>>(JNK/=G_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>fonr-20220930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 8KlZs7xRiXgen8uCandcSauJ+cPtxJFzqZkhv2pxfZlqHygor3bFuyAEz9MmIR8O -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:srt="http://fasb.org/srt/2022" xmlns:srt-types="http://fasb.org/srt-types/2022" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:FONR="http://fonar.com/20220930" elementFormDefault="qualified" targetNamespace="http://fonar.com/20220930">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://fonar.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" id="CondensedConsolidatedBalanceSheets">
	  <link:definition>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" id="CondensedConsolidatedBalanceSheetsParenthetical">
	  <link:definition>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" id="CondensedConsolidatedStatementsOfIncome">
	  <link:definition>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" id="CondensedConsolidatedStatementsOfChangesInEquity">
	  <link:definition>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" id="CondensedConsolidatedStatementsOfCashFlows">
	  <link:definition>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" id="DescriptionOfBusinessAndBasisOfPresentation">
	  <link:definition>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
	  <link:definition>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable">
	  <link:definition>00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases" id="OperatingFinancingLeases">
	  <link:definition>00000010 - Disclosure - OPERATING &amp; FINANCING LEASES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories" id="Inventories">
	  <link:definition>00000011 - Disclosure - INVENTORIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets" id="OtherIntangibleAssets">
	  <link:definition>00000012 - Disclosure - OTHER INTANGIBLE ASSETS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities" id="OtherCurrentLiabilities">
	  <link:definition>00000013 - Disclosure - OTHER CURRENT LIABILITIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation" id="SegmentAndRelatedInformation">
	  <link:definition>00000014 - Disclosure - SEGMENT AND RELATED INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformation" id="SupplementalCashFlowInformation">
	  <link:definition>00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
	  <link:definition>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000017 - Disclosure - INCOME TAXES</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000018 - Disclosure - SUBSEQUENT EVENTS</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
	  <link:definition>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
	  <link:definition>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables">
	  <link:definition>00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" id="OperatingFinancingLeasesTables">
	  <link:definition>00000022 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/InventoriesTables" id="InventoriesTables">
	  <link:definition>00000023 - Disclosure - INVENTORIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" id="OtherIntangibleAssetsTables">
	  <link:definition>00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" id="OtherCurrentLiabilitiesTables">
	  <link:definition>00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" id="SegmentAndRelatedInformationTables">
	  <link:definition>00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" id="DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative">
	  <link:definition>00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" id="SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details">
	  <link:definition>00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" id="SummaryOfSignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails">
	  <link:definition>00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1">
	  <link:definition>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails">
	  <link:definition>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" id="AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative">
	  <link:definition>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" id="OperatingFinancingLeases-LeasePaymentsDetails">
	  <link:definition>00000034 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/Inventories-InventoriesDetails" id="Inventories-InventoriesDetails">
	  <link:definition>00000035 - Disclosure - INVENTORIES - Inventories (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" id="OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails">
	  <link:definition>00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" id="OtherIntangibleAssetsDetailsNarrative">
	  <link:definition>00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" id="OtherCurrentLiabilities-OtherCurrentLiabilities-Details">
	  <link:definition>00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" id="SegmentAndRelatedInformation-SumarizedSegments-Details">
	  <link:definition>00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" id="SupplementalCashFlowInformationDetailsNarrative">
	  <link:definition>00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" id="CommitmentsAndContingenciesDetailsNarrative">
	  <link:definition>00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000042 - Disclosure - INCOME TAXES (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="fonr-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" />
    <import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" />
    <import namespace="http://fasb.org/us-types/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd" />
    <import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd" />
    <import namespace="http://fasb.org/srt-types/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd" />
    <element id="FONR_ClassANonVotingPreferredStockMember" name="ClassANonVotingPreferredStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccumulatedDeficitMember" name="AccumulatedDeficitMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ControllingInterestMember" name="ControllingInterestMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CommercialInsuranceManagedCareMember" name="CommercialInsuranceManagedCareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicareMedicaidMember" name="MedicareMedicaidMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WorkersCompensationPersonalInjuryMember" name="WorkersCompensationPersonalInjuryMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OtherRevenueSourceMember" name="OtherRevenueSourceMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OperatingLeasePaymentsMember" name="OperatingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_FinancingLeasePaymentsMember" name="FinancingLeasePaymentsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatentsAndCopyrightsMember" name="PatentsAndCopyrightsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalEquipmentMember" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementOfDiagnosticImagingCentersMember" name="ManagementOfDiagnosticImagingCentersMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableServiceAndRepairFees" name="AccountsReceivableServiceAndRepairFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountReceivableRelatedParties" name="AccountReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MedicalReceivable" name="MedicalReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees" name="ManagementAndOtherFees" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" name="ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetLongTerm" name="AccountsReceivableNetLongTerm" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_UnearnedRevenueOnServiceContractsRelatedParties" name="UnearnedRevenueOnServiceContractsRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CustomerDeposits" name="CustomerDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Commonstockvalue1" name="Commonstockvalue1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Commonstockvalue2" name="Commonstockvalue2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_Commonstockvalue3" name="Commonstockvalue3" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProductSalesNet" name="ProductSalesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesNet" name="ServiceAndRepairFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ServiceAndRepairFeesRelatedPartiesNet" name="ServiceAndRepairFeesRelatedPartiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesNet" name="ManagementAndOtherFeesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" name="ManagementAndOtherFeesRelatedMedicalPracticesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToProductSales" name="CostsRelatedToProductSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFees" name="CostsRelatedToServiceAndRepairFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" name="CostsRelatedToServiceAndRepairFeesRelatedParties" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFees" name="CostsRelatedToManagementAndOtherFees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" name="CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InterestExpenses" name="InterestExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EarningPerShareBasicAndDiluted" name="EarningPerShareBasicAndDiluted" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ProvisionForBadDebts" name="ProvisionForBadDebts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_GainOnForgivenessOfPppLoan" name="GainOnForgivenessOfPppLoan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInFinancingLiabilities" name="IncreaseDecreaseInFinancingLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IncreaseDecreaseInCustomerAdvance" name="IncreaseDecreaseInCustomerAdvance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DisclosureOperatingFinancingLeasesAbstract" name="DisclosureOperatingFinancingLeasesAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" name="TotalFacilitiesOwnedOrManagedTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" name="ScheduleOfPatientFeeRevenueTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" name="LesseeOperatingLeasesLiabilityMaturityTableTextBlock" nillable="true" xbrli:periodType="duration" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" name="HmcaOwnershipSizeOfImperialManagementServicesPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" name="OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" name="OwnershipInterestOfOriginalInvestorsOfHdm" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_DirectPurchaseOfNoncontrollingInterests" name="DirectPurchaseOfNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_InvestorsOwnershipInterest" name="InvestorsOwnershipInterest" nillable="true" xbrli:periodType="instant" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_EarningsPerShareBasics" name="EarningsPerShareBasics" nillable="true" xbrli:periodType="duration" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" name="WeightedAverageNumberOfDilutedSharesOutstandings" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ConvertibleClassCStock" name="ConvertibleClassCStock" nillable="true" xbrli:periodType="duration" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_AccountsReceivableNetRelatedParty" name="AccountsReceivableNetRelatedParty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ManagementAndOtherFees_NonRelatedParties" name="ManagementAndOtherFees_NonRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" name="PatientFeeRevenueNetOfContractualAllowancesAndDiscount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" name="PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" name="PercentageOfConsolidatedNetRevenueFromManagementFees" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscount" name="PresentValueDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_PresentValueDiscountFinancingLease" name="PresentValueDiscountFinancingLease" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_StateIncomeTaxesPayable" name="StateIncomeTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_NetRevenuesFromExternalCustomers" name="NetRevenuesFromExternalCustomers" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_IntersegmentNetRevenues" name="IntersegmentNetRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" name="MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_ExciseTax" name="ExciseTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
    <element id="FONR_CorporateMinimumTax" name="CorporateMinimumTax" nillable="true" xbrli:periodType="duration" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>fonr-20220930_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue1" xlink:label="loc_FONRCommonstockvalue1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_FONRCommonstockvalue1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue2" xlink:label="loc_FONRCommonstockvalue2" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_FONRCommonstockvalue2" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue3" xlink:label="loc_FONRCommonstockvalue3" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_FONRCommonstockvalue3" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapRevenues" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCostsAndExpenses" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_FONRInterestExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapProfitLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000010 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000012 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000013 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000014 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000022 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000023 - Disclosure - INVENTORIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000034 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000035 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherLiabilitiesCurrent" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>fonr-20220930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_60" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_60" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_60" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_60" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_60" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_60" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_60" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_60" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_60" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_60" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_60" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_60" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_60" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_60" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_60" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_60" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_60" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_60" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_60" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_60" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_60" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_60" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_60" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_60" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_60" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_60" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_60" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_60" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_60" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_60" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_60" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_60" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_60" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_60" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_60" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_60" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_60" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_60" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_60" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_60" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_60" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_60" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_60" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_60" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_60" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_60" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_60" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_60" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_60" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_60" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_60" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_60" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_60" xlink:type="arc" order="57" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRProductSalesNet_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesNet_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesNet_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapRevenuesAbstract_90" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues_90" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract_90" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue_90" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToProductSales_90" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees_90" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties_90" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees_90" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_90" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapResearchAndDevelopmentExpense_90" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense_90" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapCostsAndExpensesAbstract_90" xlink:to="loc_us-gaapCostsAndExpenses_90" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_90" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense_90" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInterestExpenses_90" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet_90" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_90" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit_90" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss_90" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_90" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_90" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic_90" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted_90" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningPerShareBasicAndDiluted" xlink:label="loc_FONREarningPerShareBasicAndDiluted_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningPerShareBasicAndDiluted_90" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_90" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding_90" xlink:type="arc" order="31" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapCommonStockMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccumulatedDeficitMember" xlink:label="loc_FONRAccumulatedDeficitMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRAccumulatedDeficitMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapTreasuryStockMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_70" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest_70" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000010 - Disclosure - OPERATING &amp; FINANCING LEASES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000012 - Disclosure - OTHER INTANGIBLE ASSETS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000013 - Disclosure - OTHER CURRENT LIABILITIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000014 - Disclosure - SEGMENT AND RELATED INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000022 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000023 - Disclosure - INVENTORIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_60" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm_60" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests_60" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage_60" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest_60" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningsPerShareBasics" xlink:label="loc_FONREarningsPerShareBasics_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningsPerShareBasics_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount_110" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000034 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive_30" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive_30" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount_30" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease_30" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability_30" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability_30" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000035 - Disclosure - INVENTORIES - Inventories (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill_110" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets_70" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers_70" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues_70" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations_70" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization_70" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid_70" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapSubsequentEventTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod_30" xlink:type="arc" order="1" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>fonr-20220930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockMember_lbl" xml:lang="en-US">Common Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="us-gaap_CommonClassBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassBMember" xlink:to="us-gaap_CommonClassBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassBMember_lbl" xml:lang="en-US">Common Class B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="us-gaap_CommonClassCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonClassCMember" xlink:to="us-gaap_CommonClassCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonClassCMember_lbl" xml:lang="en-US">Common Class C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="FONR_ClassANonVotingPreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ClassANonVotingPreferredStockMember_lbl" xml:lang="en-US">Class A Non Voting Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="us-gaap_PreferredStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockMember" xlink:to="us-gaap_PreferredStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockMember_lbl" xml:lang="en-US">Preferred Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="us-gaap_PreferredClassAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredClassAMember" xlink:to="us-gaap_PreferredClassAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredClassAMember_lbl" xml:lang="en-US">Preferred Class A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US">Equity Components [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccumulatedDeficitMember" xlink:label="FONR_AccumulatedDeficitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccumulatedDeficitMember" xlink:to="FONR_AccumulatedDeficitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccumulatedDeficitMember_lbl" xml:lang="en-US">Accumulated Deficit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="us-gaap_TreasuryStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockMember" xlink:to="us-gaap_TreasuryStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockMember_lbl" xml:lang="en-US">Treasury Stock [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="us-gaap_NoncontrollingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncontrollingInterestMember" xlink:to="us-gaap_NoncontrollingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncontrollingInterestMember_lbl" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ControllingInterestMember" xlink:label="FONR_ControllingInterestMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ControllingInterestMember" xlink:to="FONR_ControllingInterestMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ControllingInterestMember_lbl" xml:lang="en-US">Controlling Interest [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_lbl" xml:lang="en-US">Receivable Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="us-gaap_AccountsReceivableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableMember" xlink:to="us-gaap_AccountsReceivableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableMember_lbl" xml:lang="en-US">Accounts Receivable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DoubtfulMember" xlink:label="us-gaap_DoubtfulMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DoubtfulMember" xlink:to="us-gaap_DoubtfulMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DoubtfulMember_lbl" xml:lang="en-US">Doubtful [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:to="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_HealthCareOrganizationRevenueSourcesAxis_lbl" xml:lang="en-US">Health Care Organization, Revenue Sources [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="FONR_CommercialInsuranceManagedCareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CommercialInsuranceManagedCareMember_lbl" xml:lang="en-US">Commercial Insurance / Managed Care</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicareMedicaidMember" xlink:label="FONR_MedicareMedicaidMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicareMedicaidMember_lbl" xml:lang="en-US">Medicare/Medicaid</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="FONR_WorkersCompensationPersonalInjuryMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_lbl" xml:lang="en-US">Workers Compensation/Personal Injury</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OtherRevenueSourceMember" xlink:label="FONR_OtherRevenueSourceMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OtherRevenueSourceMember_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US">Income Statement Location [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="FONR_OperatingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OperatingLeasePaymentsMember" xlink:to="FONR_OperatingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OperatingLeasePaymentsMember_lbl" xml:lang="en-US">Operating Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="FONR_FinancingLeasePaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_FinancingLeasePaymentsMember" xlink:to="FONR_FinancingLeasePaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_FinancingLeasePaymentsMember_lbl" xml:lang="en-US">Financing Lease Payments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_lbl" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="FONR_PatentsAndCopyrightsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatentsAndCopyrightsMember_lbl" xml:lang="en-US">Patents and copyrights</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="us-gaap_NoncompeteAgreementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NoncompeteAgreementsMember" xlink:to="us-gaap_NoncompeteAgreementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NoncompeteAgreementsMember_lbl" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="us-gaap_CustomerRelationshipsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CustomerRelationshipsMember" xlink:to="us-gaap_CustomerRelationshipsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CustomerRelationshipsMember_lbl" xml:lang="en-US">Customer Relationships [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:to="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOperatingActivitiesSegmentAxis_lbl" xml:lang="en-US">Operating Activities [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalEquipmentMember" xlink:label="FONR_MedicalEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalEquipmentMember_lbl" xml:lang="en-US">Medical Equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_lbl" xml:lang="en-US">Management Of Diagnostic Imaging Centers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="us-gaap_SubsequentEventTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTypeAxis" xlink:to="us-gaap_SubsequentEventTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTypeAxis_lbl" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="us-gaap_SubsequentEventMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventMember" xlink:to="us-gaap_SubsequentEventMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventMember_lbl" xml:lang="en-US">Subsequent Event [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US">Current Assets:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US">&#160;Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShortTermInvestments_lbl" xml:lang="en-US">&#160;Short term investments</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="FONR_AccountsReceivableServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_lbl" xml:lang="en-US">&#160;Accounts receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="FONR_AccountReceivableRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountReceivableRelatedParties" xlink:to="FONR_AccountReceivableRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountReceivableRelatedParties_lbl" xml:lang="en-US">&#160;Accounts receivable - related party</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalReceivable" xlink:label="FONR_MedicalReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MedicalReceivable_lbl" xml:lang="en-US">&#160;Medical receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees" xlink:label="FONR_ManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees" xlink:to="FONR_ManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_lbl" xml:lang="en-US">&#160;Management and other fees receivable &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_lbl" xml:lang="en-US">Management and other fees receivable &#8211; related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_lbl" xml:lang="en-US">&#160;Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US">&#160;Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US">&#160;&#160;Total Current Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="FONR_AccountsReceivableNetLongTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetLongTerm" xlink:to="FONR_AccountsReceivableNetLongTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetLongTerm_lbl" xml:lang="en-US">Accounts receivable &#8211; long term</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsDeferredIncome" xlink:to="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsDeferredIncome_lbl" xml:lang="en-US">&#160;Deferred income tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US">&#160;Property and equipment &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; operating lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseRightOfUseAsset_lbl" xml:lang="en-US">&#160;Right-of-use Asset &#8211; financing lease</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US">&#160;Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US">&#160;Other intangible assets &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="us-gaap_OtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssets" xlink:to="us-gaap_OtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssets_lbl" xml:lang="en-US">&#160;Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US">&#160;&#160;Total Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US">Current Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent_lbl" xml:lang="en-US">Current portion of long-term debt and capital leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="us-gaap_DeferredRevenueCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueCurrent" xlink:to="us-gaap_DeferredRevenueCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueCurrent_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:to="FONR_UnearnedRevenueOnServiceContractsRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_UnearnedRevenueOnServiceContractsRelatedParties_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts &#8211; related party</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xml:lang="en-US">&#160;Operating lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityCurrent_lbl" xml:lang="en-US">&#160;Financing lease liability - current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CustomerDeposits" xlink:label="FONR_CustomerDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CustomerDeposits" xlink:to="FONR_CustomerDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CustomerDeposits_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US">Total Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xml:lang="en-US">Long-Term Liabilities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="us-gaap_DeferredRevenueNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenueNoncurrent_lbl" xml:lang="en-US">&#160;Unearned revenue on service contracts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:to="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent_lbl" xml:lang="en-US">&#160;Deferred income tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:to="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableRelatedPartiesNoncurrent_lbl" xml:lang="en-US">&#160;Due to related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">&#160;Operating lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityNoncurrent_lbl" xml:lang="en-US">&#160;Financing lease liability &#8211; net of current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LongTermDebtAndCapitalLeaseObligations_lbl" xml:lang="en-US">&#160;Long-term debt and capital leases, less current portion</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US">&#160;Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="us-gaap_LiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesNoncurrent_lbl" xml:lang="en-US">Total Long-Term Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US">&#160;Total Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US">STOCKHOLDERS' EQUITY:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US">Class A non-voting preferred stock $.0001 par value; 453 shares authorized at September 30, 2022 and June 30, 2022, 313 issued and outstanding at September 30, 2022 and June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US">Preferred stock $.001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, issued and outstanding &#8211; none</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue1" xlink:label="FONR_Commonstockvalue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Commonstockvalue1" xlink:to="FONR_Commonstockvalue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Commonstockvalue1_lbl" xml:lang="en-US">Common Stock $.0001 par value; 8,500 shares authorized at September 30, 2022 and June 30, 2022, 6,566 issued at September 30, 2022 and June 30, 2022, 6,545 and 6,554 outstanding at September 30, 2022 and June 30, 2022, respectively</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue2" xlink:label="FONR_Commonstockvalue2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Commonstockvalue2" xlink:to="FONR_Commonstockvalue2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Commonstockvalue2_lbl" xml:lang="en-US">Class B Common Stock (10 votes per share) $.0001 par value; 227 shares authorized at September 30, 2022 and June 30, 2022; .146 issued and outstanding at September 30, 2022 and June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue3" xlink:label="FONR_Commonstockvalue3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_Commonstockvalue3" xlink:to="FONR_Commonstockvalue3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_Commonstockvalue3_lbl" xml:lang="en-US">&#160;Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, 383 issued and outstanding at September 30, 2022 and June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_AdditionalPaidInCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapital" xlink:to="us-gaap_AdditionalPaidInCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapital_lbl" xml:lang="en-US">&#160;Paid-in capital in excess of par value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US">&#160;Accumulated deficit</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_TreasuryStockValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_TreasuryStockValue_lbl" xml:lang="en-US">Treasury stock, at cost &#8211; 20 shares of common stock at September 30, 2022 and 12 shares of common stock at June 30, 2022</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US">&#160;Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="us-gaap_MinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterest" xlink:to="us-gaap_MinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterest_lbl" xml:lang="en-US">&#160;Noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">&#160;Total Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US">&#160;Total Liabilities and Stockholders' Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_TreasuryStockShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockShares" xlink:to="us-gaap_TreasuryStockShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockShares_lbl" xml:lang="en-US">Treasury Stock, Shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US">REVENUES</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts_lbl" xml:lang="en-US">Patient fee revenue &#8211; net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProductSalesNet" xlink:label="FONR_ProductSalesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProductSalesNet" xlink:to="FONR_ProductSalesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProductSalesNet_lbl" xml:lang="en-US">Product sales &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="FONR_ServiceAndRepairFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesNet" xlink:to="FONR_ServiceAndRepairFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesNet_lbl" xml:lang="en-US">Service and repair fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:to="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ServiceAndRepairFeesRelatedPartiesNet_lbl" xml:lang="en-US">Service and repair fees - related parties &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="FONR_ManagementAndOtherFeesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesNet" xlink:to="FONR_ManagementAndOtherFeesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesNet_lbl" xml:lang="en-US">Management and other fees &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:to="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet_lbl" xml:lang="en-US">Management and other fees - related medical practices &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US">Total Revenues &#8211; Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US">COSTS AND EXPENSES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="us-gaap_OtherCostOfOperatingRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherCostOfOperatingRevenue" xlink:to="us-gaap_OtherCostOfOperatingRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherCostOfOperatingRevenue_lbl" xml:lang="en-US">Costs related to patient fee revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToProductSales" xlink:label="FONR_CostsRelatedToProductSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToProductSales" xlink:to="FONR_CostsRelatedToProductSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToProductSales_lbl" xml:lang="en-US">Costs related to product sales</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="FONR_CostsRelatedToServiceAndRepairFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFees" xlink:to="FONR_CostsRelatedToServiceAndRepairFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFees_lbl" xml:lang="en-US">Costs related to service and repair fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:to="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToServiceAndRepairFeesRelatedParties_lbl" xml:lang="en-US">Costs related to service and repair fees - related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="FONR_CostsRelatedToManagementAndOtherFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFees" xlink:to="FONR_CostsRelatedToManagementAndOtherFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFees_lbl" xml:lang="en-US">Costs related to management and other fees</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:to="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices_lbl" xml:lang="en-US">Costs related to management and other fees &#8211; related medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US">Research and development</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SellingGeneralAndAdministrativeExpense_lbl" xml:lang="en-US">Selling, general and administrative</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US">Total Costs and Expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_lbl" xml:lang="en-US">Income From Operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_OtherNonoperatingIncomeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_OtherNonoperatingIncomeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNonoperatingIncomeExpense_lbl" xml:lang="en-US">Other Income</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InterestExpenses" xlink:label="FONR_InterestExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InterestExpenses" xlink:to="FONR_InterestExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_InterestExpenses_lbl" xml:lang="en-US">Interest Expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="us-gaap_InvestmentIncomeNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeNet" xlink:to="us-gaap_InvestmentIncomeNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentIncomeNet_lbl" xml:lang="en-US">Investment Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_lbl" xml:lang="en-US">Income Before Provision for Income Taxes and Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_IncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Provision for Income Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ProfitLoss_lbl" xml:lang="en-US">Net Income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_lbl" xml:lang="en-US">Net Income - Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income &#8211; Attributable to FONAR</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_EarningsPerShareBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasic" xlink:to="us-gaap_EarningsPerShareBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasic_lbl" xml:lang="en-US">Basic Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_EarningsPerShareDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareDiluted" xlink:to="us-gaap_EarningsPerShareDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareDiluted_lbl" xml:lang="en-US">Diluted Net Income Per Common Share Available to Common Stockholders</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningPerShareBasicAndDiluted" xlink:label="FONR_EarningPerShareBasicAndDiluted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EarningPerShareBasicAndDiluted" xlink:to="FONR_EarningPerShareBasicAndDiluted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EarningPerShareBasicAndDiluted_lbl" xml:lang="en-US">Earning per share basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_lbl" xml:lang="en-US">Weighted average basic and diluted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_lbl" xml:lang="en-US">Weighted Average Diluted Shares Outstanding - Common Stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Balance - June 30, 2021</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_NetIncomeLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_lbl" xml:lang="en-US">Purchase of Treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_lbl" xml:lang="en-US">Distributions - Non controlling</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2_lbl" xml:lang="en-US">Income - Non controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3_lbl" xml:lang="en-US">Balance &#8211; September 30, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Cash Flows from Operating Activities:</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProfitLoss_2_lbl" xml:lang="en-US">&#160;Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="us-gaap_OtherDepreciationAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherDepreciationAndAmortization" xlink:to="us-gaap_OtherDepreciationAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherDepreciationAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_lbl" xml:lang="en-US">Amortization on right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProvisionForBadDebts" xlink:label="FONR_ProvisionForBadDebts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ProvisionForBadDebts" xlink:to="FONR_ProvisionForBadDebts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ProvisionForBadDebts_lbl" xml:lang="en-US">Provision for bad debts</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Deferred income tax &#8211; net</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="FONR_GainOnForgivenessOfPppLoan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_GainOnForgivenessOfPppLoan_lbl" xml:lang="en-US">Gain on forgiveness of PPP loan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingAssetsAbstract_lbl" xml:lang="en-US">(Increase) decrease in operating assets, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_lbl" xml:lang="en-US">Accounts, medical and management fee receivable(s)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="us-gaap_IncreaseDecreaseInReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInReceivables_lbl" xml:lang="en-US">Notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="us-gaap_IncreaseDecreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_lbl" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract_lbl" xml:lang="en-US">Increase (decrease) in operating liabilities, net:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_lbl" xml:lang="en-US">Accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_lbl" xml:lang="en-US">Other current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingLiabilities_lbl" xml:lang="en-US">Operating lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_lbl" xml:lang="en-US">Financing lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_lbl" xml:lang="en-US">Customer deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccruedLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash provided by operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Investing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US">Purchases of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_lbl" xml:lang="en-US">Cost of patents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">&#160;Cash Flows from Financing Activities:</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="us-gaap_RepaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_RepaymentsOfNotesPayable_lbl" xml:lang="en-US">&#160;Repayment of borrowings and capital lease obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_lbl" xml:lang="en-US">Purchase of treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_lbl" xml:lang="en-US">&#160;Distributions to noncontrolling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash used in financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_lbl" xml:lang="en-US">&#160;Net Decrease in Cash and Cash Equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_lbl" xml:lang="en-US">Cash and Cash Equivalents - Beginning of Period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_lbl" xml:lang="en-US">Cash and Cash Equivalents - End of Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_lbl" xml:lang="en-US">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="us-gaap_ReceivablesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReceivablesAbstract" xlink:to="us-gaap_ReceivablesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReceivablesAbstract_lbl" xml:lang="en-US">Receivables [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_lbl" xml:lang="en-US">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:to="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DisclosureOperatingFinancingLeasesAbstract_lbl" xml:lang="en-US">Operating Financing Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xml:lang="en-US">OPERATING &amp; FINANCING LEASES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="us-gaap_InventoryDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureAbstract" xlink:to="us-gaap_InventoryDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureAbstract_lbl" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="us-gaap_InventoryDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryDisclosureTextBlock" xlink:to="us-gaap_InventoryDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryDisclosureTextBlock_lbl" xml:lang="en-US">INVENTORIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US">OTHER INTANGIBLE ASSETS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xml:lang="en-US">OTHER CURRENT LIABILITIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="us-gaap_SegmentReportingAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingAbstract" xlink:to="us-gaap_SegmentReportingAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingAbstract_lbl" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SegmentReportingDisclosureTextBlock_lbl" xml:lang="en-US">SEGMENT AND RELATED INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowSupplementalDisclosuresTextBlock_lbl" xml:lang="en-US">SUPPLEMENTAL CASH FLOW INFORMATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US">INCOME TAXES</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="us-gaap_SubsequentEventsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsAbstract" xlink:to="us-gaap_SubsequentEventsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsAbstract_lbl" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="us-gaap_SubsequentEventsTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventsTextBlock" xlink:to="us-gaap_SubsequentEventsTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventsTextBlock_lbl" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="us-gaap_ConsolidationPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConsolidationPolicyTextBlock" xlink:to="us-gaap_ConsolidationPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ConsolidationPolicyTextBlock_lbl" xml:lang="en-US">Principles of Consolidation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenueRecognitionPolicyTextBlock_lbl" xml:lang="en-US">Revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="us-gaap_BusinessCombinationsPolicy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsPolicy" xlink:to="us-gaap_BusinessCombinationsPolicy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsPolicy_lbl" xml:lang="en-US">BUSINESS COMBINATION</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xml:lang="en-US">Earnings Per Share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US">Recent Accounting Standards</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:to="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock_lbl" xml:lang="en-US">Quarterly Financial Data</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_lbl" xml:lang="en-US">Financing Receivable, Noncurrent, Allowance for Credit Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:to="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_TotalFacilitiesOwnedOrManagedTableTextBlock_lbl" xml:lang="en-US">Schedule of Facilities Owned Or Managed</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:to="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ScheduleOfPatientFeeRevenueTableTextBlock_lbl" xml:lang="en-US">Schedule Of Patient Fee Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:to="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock_lbl" xml:lang="en-US">Lessee Operating Leases Liability Maturity</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfInventoryCurrentTableTextBlock_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US">Other Intangible Assets - Net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_lbl" xml:lang="en-US">Summarized Segment Financial Information</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_lbl" xml:lang="en-US">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_lbl" xml:lang="en-US">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:to="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_OwnershipInterestOfOriginalInvestorsOfHdm_lbl" xml:lang="en-US">The ownership interest of the original investors of HDM</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_DirectPurchaseOfNoncontrollingInterests" xlink:to="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_DirectPurchaseOfNoncontrollingInterests_lbl" xml:lang="en-US">Direct purchase of Noncontrolling Interests</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityMethodInvestmentOwnershipPercentage_lbl" xml:lang="en-US">Direct ownership interest percentage</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="FONR_InvestorsOwnershipInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InvestorsOwnershipInterest" xlink:to="FONR_InvestorsOwnershipInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InvestorsOwnershipInterest_lbl" xml:lang="en-US">Investors ownership interest percentage</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLoss_3_lbl" xml:lang="en-US">Basic Numerator: Net income available to common stockholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2_lbl" xml:lang="en-US">Basic Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningsPerShareBasics" xlink:label="FONR_EarningsPerShareBasics" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EarningsPerShareBasics" xlink:to="FONR_EarningsPerShareBasics_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_EarningsPerShareBasics_lbl" xml:lang="en-US">Basic income per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:to="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_lbl" xml:lang="en-US">Diluted Denominator: Weighted average shares outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ConvertibleClassCStock" xlink:label="FONR_ConvertibleClassCStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ConvertibleClassCStock_lbl" xml:lang="en-US">Convertible Class C Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:to="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock_lbl" xml:lang="en-US">Shares included upon conversion of Class C Common to calculate a diluted EPS</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_lbl" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsNotesAndLoansReceivableLineItems_lbl" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableServiceAndRepairFees" xlink:to="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_AccountsReceivableServiceAndRepairFees_2_lbl" xml:lang="en-US">Accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="FONR_AccountsReceivableNetRelatedParty" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_AccountsReceivableNetRelatedParty_lbl" xml:lang="en-US">Accounts receivable - Related party</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalReceivable" xlink:to="FONR_MedicalReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_MedicalReceivable_2_lbl" xml:lang="en-US">Medical Receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_lbl" xml:lang="en-US">Management and other fees receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:to="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_2_lbl" xml:lang="en-US">Management and other fees receivable from related medical practices ("PC&amp;#39;s")</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueOneToTwoYears" xlink:to="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueOneToTwoYears_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueTwoToThreeYears" xlink:to="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueTwoToThreeYears_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContractReceivableDueThreeToFourYears" xlink:to="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContractReceivableDueThreeToFourYears_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:to="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="us-gaap_DisaggregationOfRevenueTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueTable" xlink:to="us-gaap_DisaggregationOfRevenueTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueTable_lbl" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="us-gaap_DisaggregationOfRevenueLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisaggregationOfRevenueLineItems" xlink:to="us-gaap_DisaggregationOfRevenueLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisaggregationOfRevenueLineItems_lbl" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_lbl" xml:lang="en-US">Patient fee revenue, net of contractual allowances and discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_lbl" xml:lang="en-US">Percentage of net revenue derived from no-fault and personal injury protection claim</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_lbl" xml:lang="en-US">Percentage of consolidated net revenue from management fees charged to related party medical practices</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xml:lang="en-US">2023</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_lbl" xml:lang="en-US">2024</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_lbl" xml:lang="en-US">2025</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_lbl" xml:lang="en-US">2026</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_lbl" xml:lang="en-US">2027</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_lbl" xml:lang="en-US">Thereafter</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscount" xlink:label="FONR_PresentValueDiscount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscount_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="FONR_PresentValueDiscountFinancingLease" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="FONR_PresentValueDiscountFinancingLease_lbl" xml:lang="en-US">Present value discount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="us-gaap_FinanceLeaseLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_FinanceLeaseLiability_lbl" xml:lang="en-US">Total lease liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="us-gaap_OtherInventorySupplies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherInventorySupplies" xlink:to="us-gaap_OtherInventorySupplies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherInventorySupplies_lbl" xml:lang="en-US">Purchased parts, components and supplies</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="us-gaap_InventoryWorkInProcess" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryWorkInProcess" xlink:to="us-gaap_InventoryWorkInProcess_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InventoryWorkInProcess_lbl" xml:lang="en-US">Work-in-process</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:to="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_InventoryFinishedGoodsAndWorkInProcess_2_lbl" xml:lang="en-US">Total Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_lbl" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsLineItems_lbl" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US">Gross other intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US">Less: Accumulated amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_2_lbl" xml:lang="en-US">Other intangible assets-net</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US">Amortization of Intangible Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="us-gaap_AccruedSalariesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedSalariesCurrent" xlink:to="us-gaap_AccruedSalariesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedSalariesCurrent_lbl" xml:lang="en-US">Accrued salaries, commissions and payroll taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SalesAndExciseTaxPayableCurrent" xlink:to="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SalesAndExciseTaxPayableCurrent_lbl" xml:lang="en-US">Sales tax payable</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="FONR_StateIncomeTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_StateIncomeTaxesPayable_lbl" xml:lang="en-US">State income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xml:lang="en-US">Legal and other professional fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent_lbl" xml:lang="en-US">Accounting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="us-gaap_SelfInsuranceReserve" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SelfInsuranceReserve" xlink:to="us-gaap_SelfInsuranceReserve_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SelfInsuranceReserve_lbl" xml:lang="en-US">Self-funded health insurance reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAccruedLiabilitiesNoncurrent_lbl" xml:lang="en-US">Accrued interest and penalty</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherSundryLiabilitiesCurrent_lbl" xml:lang="en-US">Other general &amp; administrative expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_2_lbl" xml:lang="en-US">Other Current Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="FONR_NetRevenuesFromExternalCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_NetRevenuesFromExternalCustomers_lbl" xml:lang="en-US">Net revenues from external customers</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IntersegmentNetRevenues" xlink:label="FONR_IntersegmentNetRevenues" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IntersegmentNetRevenues_lbl" xml:lang="en-US">Inter-segment net revenues</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="us-gaap_IncomeLossFromContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperations" xlink:to="us-gaap_IncomeLossFromContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperations_lbl" xml:lang="en-US">(Loss) Income from operations</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="us-gaap_InterestPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestPaid" xlink:to="us-gaap_InterestPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestPaid_lbl" xml:lang="en-US">Interest paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="us-gaap_IncomeTaxesPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxesPaid" xlink:to="us-gaap_IncomeTaxesPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxesPaid_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchaseProgramAuthorizedAmount1_lbl" xml:lang="en-US">Stock purchase plan</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodShares_lbl" xml:lang="en-US">Number of shares repurchased</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockRepurchasedDuringPeriodValue_2_lbl" xml:lang="en-US">Number of shares repurchased, value</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_lbl" xml:lang="en-US">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:to="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_lbl" xml:lang="en-US">Income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CurrentFederalTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredFederalIncomeTaxExpenseBenefit_lbl" xml:lang="en-US">Income tax component - deferred</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xml:lang="en-US">Deferred tax asset</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:to="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_lbl" xml:lang="en-US">Deferred tax liability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xml:lang="en-US">Operating Loss Carryforwards</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ExciseTax" xlink:label="FONR_ExciseTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ExciseTax" xlink:to="FONR_ExciseTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_ExciseTax_lbl" xml:lang="en-US">Excise tax</link:label>
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CorporateMinimumTax" xlink:label="FONR_CorporateMinimumTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CorporateMinimumTax" xlink:to="FONR_CorporateMinimumTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_CorporateMinimumTax_lbl" xml:lang="en-US">Corporate minimum tax</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="us-gaap_SubsequentEventTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventTable" xlink:to="us-gaap_SubsequentEventTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventTable_lbl" xml:lang="en-US">Subsequent Event [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="us-gaap_SubsequentEventLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsequentEventLineItems" xlink:to="us-gaap_SubsequentEventLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SubsequentEventLineItems_lbl" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US">Cancelled shares</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:to="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DebtInstrumentInterestRateDuringPeriod_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ClassANonVotingPreferredStockMember" xlink:to="FONR_ClassANonVotingPreferredStockMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ClassANonVotingPreferredStockMember_doc" xml:lang="en-US">Class A Non Voting Preferred Stock Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:to="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent_doc" xml:lang="en-US">The percentage of ownership interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:to="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_doc" xml:lang="en-US">The percentage of ownership interest rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_EarningsPerShareBasics" xlink:to="FONR_EarningsPerShareBasics_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_EarningsPerShareBasics_doc" xml:lang="en-US">The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:to="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WeightedAverageNumberOfDilutedSharesOutstandings_doc" xml:lang="en-US">The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ConvertibleClassCStock" xlink:to="FONR_ConvertibleClassCStock_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ConvertibleClassCStock_doc" xml:lang="en-US">The shares of convertible class C stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_AccountsReceivableNetRelatedParty" xlink:to="FONR_AccountsReceivableNetRelatedParty_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_AccountsReceivableNetRelatedParty_doc" xml:lang="en-US">Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementAndOtherFees_NonRelatedParties" xlink:to="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementAndOtherFees_NonRelatedParties_doc" xml:lang="en-US">Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:to="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount_doc" xml:lang="en-US">The amount of Patient fee revenue, net of contractual allowances and discounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicareMedicaidMember" xlink:to="FONR_MedicareMedicaidMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicareMedicaidMember_doc" xml:lang="en-US">Medicare Medicaid</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_CommercialInsuranceManagedCareMember" xlink:to="FONR_CommercialInsuranceManagedCareMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_CommercialInsuranceManagedCareMember_doc" xml:lang="en-US">Commercial Insurance Managed Care Member</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_WorkersCompensationPersonalInjuryMember" xlink:to="FONR_WorkersCompensationPersonalInjuryMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_WorkersCompensationPersonalInjuryMember_doc" xml:lang="en-US">Workers Compensation Personal Injury.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_OtherRevenueSourceMember" xlink:to="FONR_OtherRevenueSourceMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_OtherRevenueSourceMember_doc" xml:lang="en-US">Other Revenue Source</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:to="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfConsolidatedNetRevenueFromManagementFees_doc" xml:lang="en-US">Percentage of consolidated net revenue from management fees.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:to="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_doc" xml:lang="en-US">Percentage of PCs net revenue derived from nofault and personal injury protection claims.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscount" xlink:to="FONR_PresentValueDiscount_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscount_doc" xml:lang="en-US">Present value discount.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PresentValueDiscountFinancingLease_doc" xml:lang="en-US">Present value discount financing lease.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PatentsAndCopyrightsMember" xlink:to="FONR_PatentsAndCopyrightsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_PatentsAndCopyrightsMember_doc" xml:lang="en-US">Patents and copyrights - Member - Custom elements</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_StateIncomeTaxesPayable" xlink:to="FONR_StateIncomeTaxesPayable_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_StateIncomeTaxesPayable_doc" xml:lang="en-US">the value of state income taxes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_NetRevenuesFromExternalCustomers" xlink:to="FONR_NetRevenuesFromExternalCustomers_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_NetRevenuesFromExternalCustomers_doc" xml:lang="en-US">Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MedicalEquipmentMember" xlink:to="FONR_MedicalEquipmentMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MedicalEquipmentMember_doc" xml:lang="en-US">Medical equipment - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IntersegmentNetRevenues" xlink:to="FONR_IntersegmentNetRevenues_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_IntersegmentNetRevenues_doc" xml:lang="en-US">The amount of intersegment net revenues.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_ManagementOfDiagnosticImagingCentersMember" xlink:to="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_ManagementOfDiagnosticImagingCentersMember_doc" xml:lang="en-US">Management of Diagnostic Imaging Centers - Member - Custom element</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:to="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_doc" xml:lang="en-US">The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_2_lbl" xml:lang="en-US">Assets, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_2_lbl" xml:lang="en-US">Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_2_lbl" xml:lang="en-US">Liabilities, Current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenueNoncurrent" xlink:to="us-gaap_DeferredRevenueNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenueNoncurrent_2_lbl" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrent" xlink:to="us-gaap_LiabilitiesNoncurrent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesNoncurrent_2_lbl" xml:lang="en-US">Liabilities, Noncurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_2_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TreasuryStockValue" xlink:to="us-gaap_TreasuryStockValue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TreasuryStockValue_2_lbl" xml:lang="en-US">Treasury Stock, Value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_2_lbl" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4_lbl" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_2_lbl" xml:lang="en-US">Liabilities and Equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_2_lbl" xml:lang="en-US">Revenues [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_2_lbl" xml:lang="en-US">Costs and Expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_InterestExpenses" xlink:to="FONR_InterestExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_InterestExpenses_2_lbl" xml:lang="en-US">InterestExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_lbl" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExpenseBenefit" xlink:to="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxExpenseBenefit_2_lbl" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_lbl" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_GainOnForgivenessOfPppLoan" xlink:to="FONR_GainOnForgivenessOfPppLoan_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_GainOnForgivenessOfPppLoan_2_lbl" xml:lang="en-US">GainOnForgivenessOfPppLoan</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsReceivable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInReceivables" xlink:to="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInReceivables_2_lbl" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInInventories" xlink:to="us-gaap_IncreaseDecreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInInventories_2_lbl" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:to="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidExpense_2_lbl" xml:lang="en-US">Increase (Decrease) in Prepaid Expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayable_2_lbl" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherCurrentLiabilities_2_lbl" xml:lang="en-US">Increase (Decrease) in Other Current Liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInFinancingLiabilities" xlink:to="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInFinancingLiabilities_2_lbl" xml:lang="en-US">IncreaseDecreaseInFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_IncreaseDecreaseInCustomerAdvance" xlink:to="FONR_IncreaseDecreaseInCustomerAdvance_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_IncreaseDecreaseInCustomerAdvance_2_lbl" xml:lang="en-US">IncreaseDecreaseInCustomerAdvance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireIntangibleAssets_2_lbl" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepaymentsOfNotesPayable" xlink:to="us-gaap_RepaymentsOfNotesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepaymentsOfNotesPayable_2_lbl" xml:lang="en-US">Repayments of Notes Payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:to="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock_2_lbl" xml:lang="en-US">Payments for Repurchase of Convertible Preferred Stock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsOfDividendsMinorityInterest_2_lbl" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_2_lbl" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_lbl" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_2_lbl" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FONR_PresentValueDiscountFinancingLease" xlink:to="FONR_PresentValueDiscountFinancingLease_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="FONR_PresentValueDiscountFinancingLease_3_lbl" xml:lang="en-US">PresentValueDiscountFinancingLease</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinanceLeaseLiability" xlink:to="us-gaap_FinanceLeaseLiability_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FinanceLeaseLiability_2_lbl" xml:lang="en-US">Finance Lease, Liability</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_2_lbl" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>fonr-20220930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://fonar.com/role/Cover" xlink:href="fonr-20220930.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:href="fonr-20220930.xsd#CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:href="fonr-20220930.xsd#CondensedConsolidatedStatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories" xlink:href="fonr-20220930.xsd#Inventories" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformation" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingencies" xlink:href="fonr-20220930.xsd#CommitmentsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxes" xlink:href="fonr-20220930.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEvents" xlink:href="fonr-20220930.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:href="fonr-20220930.xsd#OperatingFinancingLeasesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/InventoriesTables" xlink:href="fonr-20220930.xsd#InventoriesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:href="fonr-20220930.xsd#DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="fonr-20220930.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:href="fonr-20220930.xsd#AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:href="fonr-20220930.xsd#OperatingFinancingLeases-LeasePaymentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/Inventories-InventoriesDetails" xlink:href="fonr-20220930.xsd#Inventories-InventoriesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:href="fonr-20220930.xsd#OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:href="fonr-20220930.xsd#OtherIntangibleAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:href="fonr-20220930.xsd#OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:href="fonr-20220930.xsd#SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:href="fonr-20220930.xsd#SupplementalCashFlowInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="fonr-20220930.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:href="fonr-20220930.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:href="fonr-20220930.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheets" xlink:title="00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_us-gaapAssetsCurrentAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAssetsCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapCashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments" xlink:label="loc_us-gaapShortTermInvestments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapShortTermInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountReceivableRelatedParties" xlink:label="loc_FONRAccountReceivableRelatedParties" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountReceivableRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees" xlink:label="loc_FONRManagementAndOtherFees" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetLongTerm" xlink:label="loc_FONRAccountsReceivableNetLongTerm" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_FONRAccountsReceivableNetLongTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsDeferredIncome" xlink:label="loc_us-gaapDeferredTaxAssetsDeferredIncome" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsDeferredIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset" xlink:label="loc_us-gaapFinanceLeaseRightOfUseAsset" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseRightOfUseAsset" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAssetsCurrentAbstract" xlink:to="loc_us-gaapAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_us-gaapLiabilitiesCurrentAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligationsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent" xlink:label="loc_us-gaapDeferredRevenueCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_UnearnedRevenueOnServiceContractsRelatedParties" xlink:label="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesCurrentAbstract" xlink:to="loc_FONRUnearnedRevenueOnServiceContractsRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityCurrent" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CustomerDeposits" xlink:label="loc_FONRCustomerDeposits" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_FONRCustomerDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="loc_us-gaapLiabilitiesNoncurrentAbstract" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent" xlink:label="loc_us-gaapDeferredRevenueNoncurrent" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredRevenueNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxesAndOtherLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesNoncurrent" xlink:label="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapAccountsPayableRelatedPartiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapFinanceLeaseLiabilityNoncurrent" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapFinanceLeaseLiabilityNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLongTermDebtAndCapitalLeaseObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilities" xlink:label="loc_us-gaapOtherLiabilities" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapOtherLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapLiabilitiesNoncurrentAbstract" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="loc_us-gaapStockholdersEquityAbstract" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue1" xlink:label="loc_FONRCommonstockvalue1" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_FONRCommonstockvalue1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue2" xlink:label="loc_FONRCommonstockvalue2" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_FONRCommonstockvalue2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_Commonstockvalue3" xlink:label="loc_FONRCommonstockvalue3" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_FONRCommonstockvalue3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue" xlink:label="loc_us-gaapTreasuryStockValue" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapTreasuryStockValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest" xlink:label="loc_us-gaapMinorityInterest" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapMinorityInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:title="00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_us-gaapStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfFinancialPositionAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ClassANonVotingPreferredStockMember" xlink:label="loc_FONRClassANonVotingPreferredStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_FONRClassANonVotingPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockMember" xlink:label="loc_us-gaapPreferredStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassBMember" xlink:label="loc_us-gaapCommonClassBMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="loc_us-gaapPreferredStockParOrStatedValuePerShare" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="loc_us-gaapPreferredStockSharesAuthorized" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="loc_us-gaapPreferredStockSharesIssued" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="loc_us-gaapPreferredStockSharesOutstanding" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapPreferredStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="loc_us-gaapCommonStockParOrStatedValuePerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockParOrStatedValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="loc_us-gaapCommonStockSharesAuthorized" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesAuthorized" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued" xlink:label="loc_us-gaapCommonStockSharesIssued" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="loc_us-gaapCommonStockSharesOutstanding" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares" xlink:label="loc_us-gaapTreasuryStockShares" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapTreasuryStockShares" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfIncome" xlink:title="00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract" xlink:label="loc_us-gaapIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredClassAMember" xlink:label="loc_us-gaapPreferredClassAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapPreferredClassAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract" xlink:label="loc_us-gaapRevenuesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenuesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProductSalesNet" xlink:label="loc_FONRProductSalesNet" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRProductSalesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesNet" xlink:label="loc_FONRServiceAndRepairFeesNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ServiceAndRepairFeesRelatedPartiesNet" xlink:label="loc_FONRServiceAndRepairFeesRelatedPartiesNet" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRServiceAndRepairFeesRelatedPartiesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesNet" xlink:label="loc_FONRManagementAndOtherFeesNet" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:label="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapRevenuesAbstract" xlink:to="loc_FONRManagementAndOtherFeesRelatedMedicalPracticesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapRevenues" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="loc_us-gaapCostsAndExpensesAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCostsAndExpensesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCostOfOperatingRevenue" xlink:label="loc_us-gaapOtherCostOfOperatingRevenue" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapOtherCostOfOperatingRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToProductSales" xlink:label="loc_FONRCostsRelatedToProductSales" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToProductSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFees" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFees" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToServiceAndRepairFeesRelatedParties" xlink:label="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToServiceAndRepairFeesRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFees" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFees" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:label="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_FONRCostsRelatedToManagementAndOtherFeesRelatedMedicalPractices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense" xlink:label="loc_us-gaapSellingGeneralAndAdministrativeExpense" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapSellingGeneralAndAdministrativeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses" xlink:label="loc_us-gaapCostsAndExpenses" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCostsAndExpensesAbstract" xlink:to="loc_us-gaapCostsAndExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InterestExpenses" xlink:label="loc_FONRInterestExpenses" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInterestExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeNet" xlink:label="loc_us-gaapInvestmentIncomeNet" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapInvestmentIncomeNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic" xlink:label="loc_us-gaapEarningsPerShareBasic" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="loc_us-gaapEarningsPerShareDiluted" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEarningsPerShareDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningPerShareBasicAndDiluted" xlink:label="loc_FONREarningPerShareBasicAndDiluted" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningPerShareBasicAndDiluted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity" xlink:title="00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="loc_us-gaapStatementOfStockholdersEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfStockholdersEquityAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="loc_us-gaapAdditionalPaidInCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapAdditionalPaidInCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccumulatedDeficitMember" xlink:label="loc_FONRAccumulatedDeficitMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_FONRAccumulatedDeficitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember" xlink:label="loc_us-gaapTreasuryStockMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapTreasuryStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:label="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapMinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows" xlink:title="00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_us-gaapStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss" xlink:label="loc_us-gaapProfitLoss" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherDepreciationAndAmortization" xlink:label="loc_us-gaapOtherDepreciationAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOtherDepreciationAndAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ProvisionForBadDebts" xlink:label="loc_FONRProvisionForBadDebts" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRProvisionForBadDebts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredIncomeTaxExpenseBenefit" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_us-gaapDeferredIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_GainOnForgivenessOfPppLoan" xlink:label="loc_FONRGainOnForgivenessOfPppLoan" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="loc_FONRGainOnForgivenessOfPppLoan" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingAssetsAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables" xlink:label="loc_us-gaapIncreaseDecreaseInReceivables" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidExpense" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingAssetsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherCurrentLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOtherCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInOperatingLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInFinancingLiabilities" xlink:label="loc_FONRIncreaseDecreaseInFinancingLiabilities" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IncreaseDecreaseInCustomerAdvance" xlink:label="loc_FONRIncreaseDecreaseInCustomerAdvance" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_FONRIncreaseDecreaseInCustomerAdvance" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncreaseDecreaseInOperatingLiabilitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="loc_us-gaapPaymentsToAcquireIntangibleAssets" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsToAcquireIntangibleAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOfCashFlowsAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable" xlink:label="loc_us-gaapRepaymentsOfNotesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapRepaymentsOfNotesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock" xlink:label="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsForRepurchaseOfConvertiblePreferredStock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsMinorityInterest" xlink:label="loc_us-gaapPaymentsOfDividendsMinorityInterest" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapPaymentsOfDividendsMinorityInterest" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation" xlink:title="00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:label="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_us-gaapSignificantAccountingPoliciesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapSignificantAccountingPoliciesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable" xlink:title="00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:label="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapLoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases" xlink:title="00000010 - Disclosure - OPERATING &amp; FINANCING LEASES">
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="loc_us-gaapLesseeOperatingLeasesTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapLesseeOperatingLeasesTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories" xlink:title="00000011 - Disclosure - INVENTORIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock" xlink:label="loc_us-gaapInventoryDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets" xlink:title="00000012 - Disclosure - OTHER INTANGIBLE ASSETS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:label="loc_us-gaapIntangibleAssetsDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapIntangibleAssetsDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities" xlink:title="00000013 - Disclosure - OTHER CURRENT LIABILITIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation" xlink:title="00000014 - Disclosure - SEGMENT AND RELATED INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_us-gaapSegmentReportingDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapSegmentReportingDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformation" xlink:title="00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapCashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingencies" xlink:title="00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapCommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - INCOME TAXES">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_us-gaapIncomeTaxDisclosureTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxDisclosureTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEvents" xlink:title="00000018 - Disclosure - SUBSEQUENT EVENTS">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock" xlink:label="loc_us-gaapSubsequentEventsTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventsTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock" xlink:label="loc_us-gaapConsolidationPolicyTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapConsolidationPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRecognitionPolicyTextBlock" xlink:label="loc_us-gaapRevenueRecognitionPolicyTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapRevenueRecognitionPolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsPolicy" xlink:label="loc_us-gaapBusinessCombinationsPolicy" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapBusinessCombinationsPolicy" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="loc_us-gaapEarningsPerSharePolicyTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapEarningsPerSharePolicyTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapNewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:label="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapScheduleOfQuarterlyFinancialInformationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables" xlink:title="00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_TotalFacilitiesOwnedOrManagedTableTextBlock" xlink:label="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRTotalFacilitiesOwnedOrManagedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ScheduleOfPatientFeeRevenueTableTextBlock" xlink:label="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRScheduleOfPatientFeeRevenueTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeasesTables" xlink:title="00000022 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:label="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_FONRLesseeOperatingLeasesLiabilityMaturityTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/InventoriesTables" xlink:title="00000023 - Disclosure - INVENTORIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:label="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsTables" xlink:title="00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilitiesTables" xlink:title="00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:label="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformationTables" xlink:title="00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:label="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative" xlink:title="00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="loc_us-gaapStatementEquityComponentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementEquityComponentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain" xlink:label="loc_us-gaapEquityComponentDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementEquityComponentsAxis" xlink:to="loc_us-gaapEquityComponentDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ControllingInterestMember" xlink:label="loc_FONRControllingInterestMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_FONRControllingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember" xlink:label="loc_us-gaapNoncontrollingInterestMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapEquityComponentDomain" xlink:to="loc_us-gaapNoncontrollingInterestMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:label="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRHmcaOwnershipSizeOfImperialManagementServicesPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:label="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OwnershipInterestOfOriginalInvestorsOfHdm" xlink:label="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONROwnershipInterestOfOriginalInvestorsOfHdm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DirectPurchaseOfNoncontrollingInterests" xlink:label="loc_FONRDirectPurchaseOfNoncontrollingInterests" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRDirectPurchaseOfNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:label="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapEquityMethodInvestmentOwnershipPercentage" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_InvestorsOwnershipInterest" xlink:label="loc_FONRInvestorsOwnershipInterest" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRInvestorsOwnershipInterest" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details" xlink:title="00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:label="loc_us-gaapCommonStockMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonClassCMember" xlink:label="loc_us-gaapCommonClassCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_us-gaapCommonClassCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:label="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapWeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_EarningsPerShareBasics" xlink:label="loc_FONREarningsPerShareBasics" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONREarningsPerShareBasics" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WeightedAverageNumberOfDilutedSharesOutstandings" xlink:label="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRWeightedAverageNumberOfDilutedSharesOutstandings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ConvertibleClassCStock" xlink:label="loc_FONRConvertibleClassCStock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRConvertibleClassCStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="loc_us-gaapAccountingPoliciesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:label="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountingPoliciesAbstract" xlink:to="loc_us-gaapIncrementalCommonSharesAttributableToConversionOfPreferredStock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails" xlink:title="00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:label="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:label="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:label="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivableTypeDomain" xlink:label="loc_us-gaapReceivableTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="loc_us-gaapReceivableTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember" xlink:label="loc_us-gaapAccountsReceivableMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapAccountsReceivableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DoubtfulMember" xlink:label="loc_us-gaapDoubtfulMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivableTypeDomain" xlink:to="loc_us-gaapDoubtfulMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableServiceAndRepairFees" xlink:label="loc_FONRAccountsReceivableServiceAndRepairFees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableServiceAndRepairFees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_AccountsReceivableNetRelatedParty" xlink:label="loc_FONRAccountsReceivableNetRelatedParty" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRAccountsReceivableNetRelatedParty" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalReceivable" xlink:label="loc_FONRMedicalReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRMedicalReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementAndOtherFees_NonRelatedParties" xlink:label="loc_FONRManagementAndOtherFees_NonRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagementAndOtherFees_NonRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:label="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAccountsNotesAndLoansReceivableLineItems" xlink:to="loc_FONRManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1" xlink:title="00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueOneToTwoYears" xlink:label="loc_us-gaapContractReceivableDueOneToTwoYears" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueOneToTwoYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueTwoToThreeYears" xlink:label="loc_us-gaapContractReceivableDueTwoToThreeYears" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueTwoToThreeYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractReceivableDueThreeToFourYears" xlink:label="loc_us-gaapContractReceivableDueThreeToFourYears" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapContractReceivableDueThreeToFourYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms" xlink:label="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapAccountsReceivableBilledForLongTermContractsOrPrograms" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails" xlink:title="00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable" xlink:label="loc_us-gaapDisaggregationOfRevenueTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_us-gaapDisaggregationOfRevenueTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems" xlink:label="loc_us-gaapDisaggregationOfRevenueLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapDisaggregationOfRevenueLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesAxis" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueTable" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareOrganizationRevenueSourcesDomain" xlink:label="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesAxis" xlink:to="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CommercialInsuranceManagedCareMember" xlink:label="loc_FONRCommercialInsuranceManagedCareMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRCommercialInsuranceManagedCareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicareMedicaidMember" xlink:label="loc_FONRMedicareMedicaidMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRMedicareMedicaidMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_WorkersCompensationPersonalInjuryMember" xlink:label="loc_FONRWorkersCompensationPersonalInjuryMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONRWorkersCompensationPersonalInjuryMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OtherRevenueSourceMember" xlink:label="loc_FONROtherRevenueSourceMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapHealthCareOrganizationRevenueSourcesDomain" xlink:to="loc_FONROtherRevenueSourceMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:label="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapDisaggregationOfRevenueLineItems" xlink:to="loc_FONRPatientFeeRevenueNetOfContractualAllowancesAndDiscount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative" xlink:title="00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract" xlink:label="loc_us-gaapReceivablesAbstract" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:label="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PercentageOfConsolidatedNetRevenueFromManagementFees" xlink:label="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapReceivablesAbstract" xlink:to="loc_FONRPercentageOfConsolidatedNetRevenueFromManagementFees" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails" xlink:title="00000034 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_DisclosureOperatingFinancingLeasesAbstract" xlink:label="loc_FONRDisclosureOperatingFinancingLeasesAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_FONRDisclosureOperatingFinancingLeasesAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="loc_us-gaapIncomeStatementLocationAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapIncomeStatementLocationAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="loc_us-gaapIncomeStatementLocationDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationAxis" xlink:to="loc_us-gaapIncomeStatementLocationDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_OperatingLeasePaymentsMember" xlink:label="loc_FONROperatingLeasePaymentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONROperatingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_FinancingLeasePaymentsMember" xlink:label="loc_FONRFinancingLeasePaymentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeStatementLocationDomain" xlink:to="loc_FONRFinancingLeasePaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscount" xlink:label="loc_FONRPresentValueDiscount" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PresentValueDiscountFinancingLease" xlink:label="loc_FONRPresentValueDiscountFinancingLease" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRPresentValueDiscountFinancingLease" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapOperatingLeaseLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiability" xlink:label="loc_us-gaapFinanceLeaseLiability" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapFinanceLeaseLiability" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/Inventories-InventoriesDetails" xlink:title="00000035 - Disclosure - INVENTORIES - Inventories (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract" xlink:label="loc_us-gaapInventoryDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherInventorySupplies" xlink:label="loc_us-gaapOtherInventorySupplies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapOtherInventorySupplies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsAndWorkInProcess" xlink:label="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapInventoryDisclosureAbstract" xlink:to="loc_us-gaapInventoryFinishedGoodsAndWorkInProcess" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails" xlink:title="00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:label="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapSoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative" xlink:title="00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:label="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_PatentsAndCopyrightsMember" xlink:label="loc_FONRPatentsAndCopyrightsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_FONRPatentsAndCopyrightsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncompeteAgreementsMember" xlink:label="loc_us-gaapNoncompeteAgreementsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapNoncompeteAgreementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember" xlink:label="loc_us-gaapCustomerRelationshipsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="loc_us-gaapCustomerRelationshipsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapFiniteLivedIntangibleAssetsLineItems" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details" xlink:title="00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="loc_us-gaapPayablesAndAccrualsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedSalariesCurrent" xlink:label="loc_us-gaapAccruedSalariesCurrent" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedSalariesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesAndExciseTaxPayableCurrent" xlink:label="loc_us-gaapSalesAndExciseTaxPayableCurrent" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSalesAndExciseTaxPayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_StateIncomeTaxesPayable" xlink:label="loc_FONRStateIncomeTaxesPayable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_FONRStateIncomeTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrentAndNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherAccruedLiabilitiesNoncurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherSundryLiabilitiesCurrent" xlink:label="loc_us-gaapOtherSundryLiabilitiesCurrent" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherSundryLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="loc_us-gaapOtherLiabilitiesCurrent" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapPayablesAndAccrualsAbstract" xlink:to="loc_us-gaapOtherLiabilitiesCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details" xlink:title="00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract" xlink:label="loc_us-gaapSegmentReportingAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentReportingAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOperatingActivitiesSegmentAxis" xlink:label="loc_us-gaapStatementOperatingActivitiesSegmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementOperatingActivitiesSegmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentOperatingActivitiesDomain" xlink:label="loc_us-gaapSegmentOperatingActivitiesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementOperatingActivitiesSegmentAxis" xlink:to="loc_us-gaapSegmentOperatingActivitiesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MedicalEquipmentMember" xlink:label="loc_FONRMedicalEquipmentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRMedicalEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ManagementOfDiagnosticImagingCentersMember" xlink:label="loc_FONRManagementOfDiagnosticImagingCentersMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSegmentOperatingActivitiesDomain" xlink:to="loc_FONRManagementOfDiagnosticImagingCentersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_NetRevenuesFromExternalCustomers" xlink:label="loc_FONRNetRevenuesFromExternalCustomers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRNetRevenuesFromExternalCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_IntersegmentNetRevenues" xlink:label="loc_FONRIntersegmentNetRevenues" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_FONRIntersegmentNetRevenues" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapCapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative" xlink:title="00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="loc_us-gaapSupplementalCashFlowElementsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaid" xlink:label="loc_us-gaapInterestPaid" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapInterestPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaid" xlink:label="loc_us-gaapIncomeTaxesPaid" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSupplementalCashFlowElementsAbstract" xlink:to="loc_us-gaapIncomeTaxesPaid" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:label="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue" xlink:label="loc_us-gaapStockRepurchasedDuringPeriodValue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapStockRepurchasedDuringPeriodValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:label="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_FONRMaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SelfInsuranceReserve" xlink:label="loc_us-gaapSelfInsuranceReserve" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapCommitmentsAndContingenciesDisclosureAbstract" xlink:to="loc_us-gaapSelfInsuranceReserve" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000042 - Disclosure - INCOME TAXES (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="loc_us-gaapIncomeTaxDisclosureAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:label="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapIncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit" xlink:label="loc_us-gaapCurrentFederalTaxExpenseBenefit" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapCurrentFederalTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:label="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:label="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapDeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="loc_us-gaapOperatingLossCarryforwards" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_us-gaapOperatingLossCarryforwards" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_ExciseTax" xlink:label="loc_FONRExciseTax" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRExciseTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="fonr-20220930.xsd#FONR_CorporateMinimumTax" xlink:label="loc_FONRCorporateMinimumTax" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapIncomeTaxDisclosureAbstract" xlink:to="loc_FONRCorporateMinimumTax" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://fonar.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract" xlink:label="loc_us-gaapSubsequentEventsAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable" xlink:label="loc_us-gaapSubsequentEventTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventsAbstract" xlink:to="loc_us-gaapSubsequentEventTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems" xlink:label="loc_us-gaapSubsequentEventLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis" xlink:label="loc_us-gaapSubsequentEventTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTable" xlink:to="loc_us-gaapSubsequentEventTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain" xlink:label="loc_us-gaapSubsequentEventTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeAxis" xlink:to="loc_us-gaapSubsequentEventTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember" xlink:label="loc_us-gaapSubsequentEventMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventTypeDomain" xlink:to="loc_us-gaapSubsequentEventMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateDuringPeriod" xlink:label="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapSubsequentEventLineItems" xlink:to="loc_us-gaapDebtInstrumentInterestRateDuringPeriod" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782874352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Nov. 07, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--06-30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-10248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">FONAR CORPORATION<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000355019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-2464137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">110 Marcus Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Melville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">11747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(631)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">694-2929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FONR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,538,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">382,513<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055781485472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">&#160;Cash and cash equivalents</a></td>
<td class="nump">$ 48,696<span></span>
</td>
<td class="nump">$ 48,723<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">&#160;Short term investments</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">&#160;Accounts receivable &#8211; net</a></td>
<td class="nump">4,161<span></span>
</td>
<td class="nump">4,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountReceivableRelatedParties', window );">&#160;Accounts receivable - related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">&#160;Medical receivable &#8211; net</a></td>
<td class="nump">19,216<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees', window );">&#160;Management and other fees receivable &#8211; net</a></td>
<td class="nump">34,582<span></span>
</td>
<td class="nump">33,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable &#8211; related medical practices &#8211; net</a></td>
<td class="nump">8,723<span></span>
</td>
<td class="nump">8,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">&#160;Inventories</a></td>
<td class="nump">2,458<span></span>
</td>
<td class="nump">2,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">&#160;Prepaid expenses and other current assets</a></td>
<td class="nump">1,108<span></span>
</td>
<td class="nump">1,104<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">&#160;&#160;Total Current Assets</a></td>
<td class="nump">119,066<span></span>
</td>
<td class="nump">118,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetLongTerm', window );">Accounts receivable &#8211; long term</a></td>
<td class="nump">1,575<span></span>
</td>
<td class="nump">1,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsDeferredIncome', window );">&#160;Deferred income tax asset</a></td>
<td class="nump">11,697<span></span>
</td>
<td class="nump">12,843<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">&#160;Property and equipment &#8211; net</a></td>
<td class="nump">22,207<span></span>
</td>
<td class="nump">22,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; operating lease</a></td>
<td class="nump">34,180<span></span>
</td>
<td class="nump">34,232<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">&#160;Right-of-use Asset &#8211; financing lease</a></td>
<td class="nump">878<span></span>
</td>
<td class="nump">928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">&#160;Goodwill</a></td>
<td class="nump">4,269<span></span>
</td>
<td class="nump">4,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">&#160;Other intangible assets &#8211; net</a></td>
<td class="nump">3,624<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">&#160;Other assets</a></td>
<td class="nump">526<span></span>
</td>
<td class="nump">526<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">&#160;&#160;Total Assets</a></td>
<td class="nump">198,022<span></span>
</td>
<td class="nump">199,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent', window );">Current portion of long-term debt and capital leases</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">773<span></span>
</td>
<td class="nump">1,552<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">5,201<span></span>
</td>
<td class="nump">6,417<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">&#160;Unearned revenue on service contracts</a></td>
<td class="nump">4,123<span></span>
</td>
<td class="nump">4,289<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_UnearnedRevenueOnServiceContractsRelatedParties', window );">&#160;Unearned revenue on service contracts &#8211; related party</a></td>
<td class="nump">82<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">&#160;Operating lease liability - current portion</a></td>
<td class="nump">3,908<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">&#160;Financing lease liability - current portion</a></td>
<td class="nump">212<span></span>
</td>
<td class="nump">210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CustomerDeposits', window );">Customer deposits</a></td>
<td class="nump">532<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">14,873<span></span>
</td>
<td class="nump">16,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-Term Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">&#160;Unearned revenue on service contracts</a></td>
<td class="nump">1,576<span></span>
</td>
<td class="nump">1,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent', window );">&#160;Deferred income tax liability</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent', window );">&#160;Due to related medical practices</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">&#160;Operating lease liability &#8211; net of current portion</a></td>
<td class="nump">33,112<span></span>
</td>
<td class="nump">33,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">&#160;Financing lease liability &#8211; net of current portion</a></td>
<td class="nump">784<span></span>
</td>
<td class="nump">838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">&#160;Long-term debt and capital leases, less current portion</a></td>
<td class="nump">148<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">&#160;Other liabilities</a></td>
<td class="nump">90<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Total Long-Term Liabilities</a></td>
<td class="nump">36,019<span></span>
</td>
<td class="nump">36,357<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">&#160;Total Liabilities</a></td>
<td class="nump">50,892<span></span>
</td>
<td class="nump">53,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>STOCKHOLDERS' EQUITY:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A non-voting preferred stock $.0001 par value; 453 shares authorized at September 30, 2022 and June 30, 2022, 313 issued and outstanding at September 30, 2022 and June 30, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock $.001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, issued and outstanding &#8211; none</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Commonstockvalue1', window );">Common Stock $.0001 par value; 8,500 shares authorized at September 30, 2022 and June 30, 2022, 6,566 issued at September 30, 2022 and June 30, 2022, 6,545 and 6,554 outstanding at September 30, 2022 and June 30, 2022, respectively</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Commonstockvalue2', window );">Class B Common Stock (10 votes per share) $.0001 par value; 227 shares authorized at September 30, 2022 and June 30, 2022; .146 issued and outstanding at September 30, 2022 and June 30, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_Commonstockvalue3', window );">&#160;Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, 383 issued and outstanding at September 30, 2022 and June 30, 2022</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">&#160;Paid-in capital in excess of par value</a></td>
<td class="nump">184,531<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">&#160;Accumulated deficit</a></td>
<td class="num">(31,520)<span></span>
</td>
<td class="num">(33,567)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 20 shares of common stock at September 30, 2022 and 12 shares of common stock at June 30, 2022</a></td>
<td class="num">(797)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">&#160;Total Fonar Corporation&#8217;s Stockholders&#8217; Equity</a></td>
<td class="nump">152,215<span></span>
</td>
<td class="nump">150,290<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">&#160;Noncontrolling interests</a></td>
<td class="num">(5,085)<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">&#160;Total Stockholders' Equity</a></td>
<td class="nump">147,130<span></span>
</td>
<td class="nump">146,236<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">&#160;Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 198,022<span></span>
</td>
<td class="nump">$ 199,342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetLongTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetLongTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Commonstockvalue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Commonstockvalue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Commonstockvalue2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Commonstockvalue2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_Commonstockvalue3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_Commonstockvalue3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CustomerDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CustomerDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_UnearnedRevenueOnServiceContractsRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_UnearnedRevenueOnServiceContractsRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsDeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsDeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055780821024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury Stock, Shares</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember', window );">Class A Non Voting Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">453<span></span>
</td>
<td class="nump">453<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">313<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember', window );">Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">8,500<span></span>
</td>
<td class="nump">8,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">6,566<span></span>
</td>
<td class="nump">6,566<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">227<span></span>
</td>
<td class="nump">227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par or Stated Value Per Share</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">567<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares, Issued</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares, Outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=FONR_ClassANonVotingPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782486544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts', window );">Patient fee revenue &#8211; net of contractual allowances and discounts</a></td>
<td class="nump">$ 6,076<span></span>
</td>
<td class="nump">$ 6,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProductSalesNet', window );">Product sales &#8211; net</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesNet', window );">Service and repair fees &#8211; net</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">1,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ServiceAndRepairFeesRelatedPartiesNet', window );">Service and repair fees - related parties &#8211; net</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesNet', window );">Management and other fees &#8211; net</a></td>
<td class="nump">12,250<span></span>
</td>
<td class="nump">11,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet', window );">Management and other fees - related medical practices &#8211; net</a></td>
<td class="nump">2,987<span></span>
</td>
<td class="nump">2,795<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenues &#8211; Net</a></td>
<td class="nump">23,191<span></span>
</td>
<td class="nump">23,730<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCostOfOperatingRevenue', window );">Costs related to patient fee revenue</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">3,156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToProductSales', window );">Costs related to product sales</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFees', window );">Costs related to service and repair fees</a></td>
<td class="nump">718<span></span>
</td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties', window );">Costs related to service and repair fees - related parties</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFees', window );">Costs related to management and other fees</a></td>
<td class="nump">6,501<span></span>
</td>
<td class="nump">6,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices', window );">Costs related to management and other fees &#8211; related medical practices</a></td>
<td class="nump">1,398<span></span>
</td>
<td class="nump">1,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">349<span></span>
</td>
<td class="nump">386<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">6,334<span></span>
</td>
<td class="nump">5,090<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Costs and Expenses</a></td>
<td class="nump">19,280<span></span>
</td>
<td class="nump">17,989<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet', window );">Income From Operations</a></td>
<td class="nump">3,911<span></span>
</td>
<td class="nump">5,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other Income</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InterestExpenses', window );">Interest Expense</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeNet', window );">Investment Income</a></td>
<td class="nump">151<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income Before Provision for Income Taxes and Noncontrolling Interests</a></td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">6,598<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for Income Taxes</a></td>
<td class="num">(1,409)<span></span>
</td>
<td class="num">(1,416)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net Income</a></td>
<td class="nump">2,650<span></span>
</td>
<td class="nump">5,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net Income - Noncontrolling Interests</a></td>
<td class="num">(603)<span></span>
</td>
<td class="num">(1,295)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 2,047<span></span>
</td>
<td class="nump">$ 3,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted Net Income Per Common Share Available to Common Stockholders</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic and diluted</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted Average Diluted Shares Outstanding - Common Stockholders</a></td>
<td class="nump">6,673<span></span>
</td>
<td class="nump">6,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 1,923<span></span>
</td>
<td class="nump">$ 3,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic and diluted</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember', window );">Preferred Class A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 92<span></span>
</td>
<td class="nump">$ 175<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>COSTS AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income &#8211; Attributable to FONAR</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningPerShareBasicAndDiluted', window );">Earning per share basic and diluted</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average basic and diluted</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToProductSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToProductSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CostsRelatedToServiceAndRepairFeesRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CostsRelatedToServiceAndRepairFeesRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EarningPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EarningPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InterestExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InterestExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProductSalesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProductSalesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ServiceAndRepairFeesRelatedPartiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ServiceAndRepairFeesRelatedPartiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCostOfOperatingRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other costs incurred during the reporting period related to other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCostOfOperatingRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_PreferredClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055780826400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Common Stock [Member]</div></th>
<th class="th"><div>Additional Paid-in Capital [Member]</div></th>
<th class="th"><div>Accumulated Deficit [Member]</div></th>
<th class="th"><div>Treasury Stock [Member]</div></th>
<th class="th"><div>Noncontrolling Interest [Member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance - June 30, 2021 at Jun. 30, 2021</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 185,101<span></span>
</td>
<td class="num">$ (46,008)<span></span>
</td>
<td class="num">$ (675)<span></span>
</td>
<td class="num">$ (3,049)<span></span>
</td>
<td class="nump">$ 135,370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,887<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">3,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,295<span></span>
</td>
<td class="nump">1,295<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; September 30, 2021 at Sep. 30, 2021</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">185,101<span></span>
</td>
<td class="num">(42,121)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(2,834)<span></span>
</td>
<td class="nump">139,472<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance - June 30, 2021 at Jun. 30, 2022</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">184,531<span></span>
</td>
<td class="num">(33,567)<span></span>
</td>
<td class="num">(675)<span></span>
</td>
<td class="num">(4,054)<span></span>
</td>
<td class="nump">146,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,047<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">2,047<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Purchase of Treasury stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(122)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions - Non controlling</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
<td class="num">(1,634)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Income - Non controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">603<span></span>
</td>
<td class="nump">603<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance &#8211; September 30, 2021 at Sep. 30, 2022</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 184,531<span></span>
</td>
<td class="num">$ (31,520)<span></span>
</td>
<td class="nump">$ 797<span></span>
</td>
<td class="num">$ (5,085)<span></span>
</td>
<td class="nump">$ 147,130<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055781594352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">&#160;Net income</a></td>
<td class="nump">$ 2,650<span></span>
</td>
<td class="nump">$ 5,182<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>&#160;Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization on right-of-use assets</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ProvisionForBadDebts', window );">Provision for bad debts</a></td>
<td class="nump">1,398<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax &#8211; net</a></td>
<td class="nump">1,146<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_GainOnForgivenessOfPppLoan', window );">Gain on forgiveness of PPP loan</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(701)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract', window );"><strong>(Increase) decrease in operating assets, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts, medical and management fee receivable(s)</a></td>
<td class="num">(1,407)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Notes receivable</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidExpense', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract', window );"><strong>Increase (decrease) in operating liabilities, net:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(779)<span></span>
</td>
<td class="num">(733)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities', window );">Other current liabilities</a></td>
<td class="num">(1,580)<span></span>
</td>
<td class="num">(3,383)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(912)<span></span>
</td>
<td class="num">(547)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInFinancingLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(52)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IncreaseDecreaseInCustomerAdvance', window );">Customer deposits</a></td>
<td class="nump">171<span></span>
</td>
<td class="nump">58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Other liabilities</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(939)<span></span>
</td>
<td class="num">(1,180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost of patents</a></td>
<td class="num">(24)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(963)<span></span>
</td>
<td class="num">(1,209)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>&#160;Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">&#160;Repayment of borrowings and capital lease obligations</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock', window );">Purchase of treasury stock</a></td>
<td class="num">(122)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">&#160;Distributions to noncontrolling interests</a></td>
<td class="num">(1,634)<span></span>
</td>
<td class="num">(1,080)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(1,761)<span></span>
</td>
<td class="num">(1,087)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect', window );">&#160;Net Decrease in Cash and Cash Equivalents</a></td>
<td class="num">(27)<span></span>
</td>
<td class="num">(1,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - Beginning of Period</a></td>
<td class="nump">48,723<span></span>
</td>
<td class="nump">44,460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash Equivalents - End of Period</a></td>
<td class="nump">$ 48,696<span></span>
</td>
<td class="nump">$ 43,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_GainOnForgivenessOfPppLoan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_GainOnForgivenessOfPppLoan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInCustomerAdvance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInCustomerAdvance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IncreaseDecreaseInFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IncreaseDecreaseInFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ProvisionForBadDebts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ProvisionForBadDebts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055783872000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</a></td>
<td class="text"><p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zomOqPW1rqB1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
1 &#8211; <span id="xdx_827_zPqSR7Go8Qm2">DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Description
of Business</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
<span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zrsMEisrp1J9" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM">24.2</span>% interest in HDM. Health Management Corporation of America retained a direct ownership interest of <span id="xdx_902_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zDgomMJcHnkk" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM">45.8</span>% in HDM, and the original
investors in HDM retained a <span id="xdx_90A_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zQDwIm3QPn86" title="The ownership interest of the original investors of HDM">30.0</span>% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $<span id="xdx_909_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuJuHI9L2Zf" title="Direct purchase of Noncontrolling Interests">546,000</span>. Currently the Company has a direct ownership interest
of <span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zmA0wFNtJOSb" title="Direct ownership interest percentage">70.8</span>% and the investors&#8217; have a <span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zKKMnnawY0P7" title="Investors ownership interest percentage">29.2</span>% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#8220;Health Management Company of America&#8221;.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basis
of Presentation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Since
March 2020, the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and
economies which has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations.
Generally, COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel
to travel for marketing purposes or to service our customers. At the end of fiscal year ending June 30, 2020, the Company was able to
enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#8220;PPP&#8221;) and Medicare
advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant disruption of the
business and the volume has recently risen back almost to pre- COVID-19 levels. Although we are unable to predict if there will be additional
consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with positive cash flows, low debt
and cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784578272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text"><p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zFA2y6FveWza" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
2 - <span id="xdx_82F_z7J3XfelRr75">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zZqUeLbjL8t7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86A_zSPe9ftYLH11">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zFkfmYW1UJi9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zNojIKhqRfIg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zzUJtloDScG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86F_zrwc8kbaWza5">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zHDs3gVpTrv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_860_zYu9CAZVtc7d">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2022 and 2021.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2022 and 2021, diluted EPS for
common shareholders includes <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zMeJg2SsDwA8" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zIHYhF8BivT9" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">128</span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_zwi3vROioEQc" style="display: none">Quarterly Financial Data</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2021</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,887</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,652</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">60</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.31</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.59</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,673</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze1UxGim4le9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_865_zdcJBeT4Mjni">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2022 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055783879840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</a></td>
<td class="text"><p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zDCr5x8keM76" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
3 &#8211; <span id="xdx_822_zh1GUBKJDNEh">ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Receivables,
net is comprised of the following at September 30, 2022, and June 30, 2022:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_ziCJYFNmkl63" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z6ZWc9zPwJw" style="display: none">Financing Receivable, Noncurrent, Allowance for Credit Loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,366</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--AccountsReceivableServiceAndRepairFees_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,161</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zTXKTzGHM9Bj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0702">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--AccountsReceivableNetRelatedParty_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--MedicalReceivable_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,216</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--MedicalReceivable_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zxa2sY00ZPU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,216</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">52,331</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">17,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34,582</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,964</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,723</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,541</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,336</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrRRrCsSt7Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">50,047</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,628</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">33,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,603</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p id="xdx_8A5_zeJlMWJylyA9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's customers are concentrated in the healthcare industry.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Credit
risk with respect to the Company&#8217;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Long
Term Accounts Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of September 30, 2022 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zJ0KtngUHJRg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_8B3_zhaSgGVkFlI6" style="display: none">Schedule of Facilities Owned Or Managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20220930_zZPzI6vIxtc3" style="width: 43%; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,072</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: top"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20220930_zaYSJvS3eRf4" style="text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">420</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20220930_zfH1gz10n0Tj" style="border-bottom: Black 1pt solid; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">84</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
Receivables</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#8217;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#8217;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
and Other Fees Receivable</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Payment
of the management fee receivables from the PC&#8217;s may be impaired by the inability of the PC&#8217;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately <span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_z8PCvEocf2R2" title="Percentage of net revenue derived from no-fault and personal injury protection claim">69.0</span>%
and <span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20210930_zzzRpMovET18" title="Percentage of net revenue derived from no-fault and personal injury protection claim">66.7</span>% of the PCs&#8217; net revenues for the three months ended September 30, 2022 and 2021, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
revenues from management and other fees charged to the related PCs accounted for approximately <span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zvFge6A6WCm7" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">12.9</span>% and <span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20210930_zux8MPqExS13" title="Percentage of consolidated net revenue from management fees charged to related party medical practices">11.8</span>% of the consolidated net
revenues for the three months ended September 30, 2022 and 2021, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>


























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company&#8217;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2022 and 2021
are summarized in the following table.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_z2tkiblHGlN3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zR9cdlyJcHC8" style="display: none">Schedule Of Patient Fee Revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br/>September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">911</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,086</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">238</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,235</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,124</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">692</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,392</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,076</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,851</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784596544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">OPERATING &amp; FINANCING LEASES</a></td>
<td class="text"><p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_z4j6oEUwcyC5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
4 &#8211; <span id="xdx_829_zVV6uuVeGdXj">OPERATING &amp; FINANCING LEASES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#8216;ASC&#8217;) 842 &#8211;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#8220;IBR&#8221;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2022 is as follows:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zyejPdOLEzYa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zog7zBJRno9i" style="display: none">Lessee Operating Leases Liability Maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br/>September 30,</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br/>Payments</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziAGgjiTK0fb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,525</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zyvFhxggZQ49" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpZyzCY2Zctb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,427</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPFs9veGRgue" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z23RFqEzpaw3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,315</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1V2ER8AzFw9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z0qMvSx2KM2j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,865</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z9dznTsIHu7e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z5b4OCb1ctrb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,596</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zVl2duC35pta" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">102</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zw02DQKtnjVf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">22,380</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPhHZgo8jPJc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0845">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscount_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zY05KY6enTG4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(10,088</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z0IMDRR3sxc4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(82</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zuTaBmrgh9C6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">37,020</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zwtvaw3NTf9g" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">996</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055786611968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORIES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbPk0WSrY913" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
5 - <span id="xdx_821_zx1CEjtXnos5">INVENTORIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zqJyUDhbf3w7" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B1_zUksbCVW7Fjc" style="display: none">Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49D_20220930_zBCjcu8QBAW7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49E_20220630_z71Hl6dbyoP3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzXq3_zmWhz94fYS86" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,182</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,126</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzXq3_zdUg9SpQYl1i" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">276</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">234</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzXq3_zFYtMcUyAZK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,458</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,360</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055786611968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">OTHER INTANGIBLE ASSETS</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zNFFoptuVnLf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
6 &#8211; <span id="xdx_82B_zlvXSdqXm3ll">OTHER INTANGIBLE ASSETS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zueSOH2CKYbb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B1_zhuUt2gjsOL6" style="display: none">Other Intangible Assets - Net</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,357</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,333</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,412</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,388</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220930_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,788</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,684</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220930_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,624</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,704</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
























<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of patents and copyrights for the three months ended September 30, 2022 and 2021 amounted to $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets">54</span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zrGt20WSdSYj" title="Amortization of Intangible Assets">47</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of non-compete for the three months ended September 30, 2022, and 2021 amounted to $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets">0</span> and $<span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets">13</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Amortization
of customer relationships for the three months ended September 30, 2022 and 2021 amounted to $<span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets">50</span> and $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets">50</span>, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055785189568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">OTHER CURRENT LIABILITIES</a></td>
<td class="text"><p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ze5VfT95XDQg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
7 &#8211; <span id="xdx_82F_zmhjWTTOfQKk">OTHER CURRENT LIABILITIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjFwUZswbog9" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span id="xdx_8BF_zD8fGA9u2bTc" style="display: none">Other Current Liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20220930_zjAkICBldQSf" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_497_20220630_zkQqr8E7jfij" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzmgj_zNG0R4wOkjvj" style="vertical-align: bottom">
    <td style="width: 60%; padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,037</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,653</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzmgj_zPaB4XnAbnDl" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">269</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzmgj_zYKiOHmy7Bp8" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">250</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">382</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzmgj_z9kzlYBj2Zm3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzmgj_z0Z8gYPzrn2h" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">76</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">120</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzmgj_zxOjt87ohX3e" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">45</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">79</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzmgj_zIBxQtkJnXZ3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzmgj_zpN8ssEOoDYi" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general &amp; administrative expenses</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,445</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">854</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzmgj_zcpzZhxKAhY7" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,201</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,417</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055785194592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT AND RELATED INFORMATION</a></td>
<td class="text"><p id="xdx_807_eus-gaap--SegmentReportingDisclosureTextBlock_z7CzVQaD6pNc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
8 - <span id="xdx_829_z8uwefxGfBjc">SEGMENT AND RELATED INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#8217;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Summarized
financial information concerning the Company's reportable segments is shown in the following table:</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_znf9HDYDKO" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B5_zX2kODdwcrFb" style="display: none">Summarized Segment Financial Information</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/>
    Equipment</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/>
    of Diagnostic <br/>
    Imaging <br/>
    Centers</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 49%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,878</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,313</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,191</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(802</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,713</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,911</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,046</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,118</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">24</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_988_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">939</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">963</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2021</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,112</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,618</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,730</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">236</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1004">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_983_ecustom--IntersegmentNetRevenues_c20210701__20210930_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">236</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(490</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,231</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,741</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">67</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,102</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,169</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">121</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,088</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,209</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784625984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW INFORMATION</a></td>
<td class="text"><p id="xdx_80A_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zVXAouvO9FY2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
9 &#8211; <span id="xdx_829_zIEBWX59BQwg">SUPPLEMENTAL CASH FLOW INFORMATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $<span id="xdx_90D_eus-gaap--InterestPaid_c20220701__20220930_pn3n3" title="Interest paid">15</span> and $<span id="xdx_90F_eus-gaap--InterestPaid_c20210701__20210930_pn3n3" title="Interest paid">189</span> for interest, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $<span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20220701__20220930_pn3n3" title="Income taxes paid">395</span> and $<span id="xdx_90F_eus-gaap--IncomeTaxesPaid_c20210701__20210930_pn3n3" title="Income taxes paid">221</span> for income taxes, respectively.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI https://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055785097216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text"><p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRohQSYjQOa8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
10 &#8211; <span id="xdx_828_zxmdJ2Fv0L3">COMMITMENTS AND CONTINGENCIES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Litigation</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
Matters</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $<span id="xdx_90F_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zW1EScCi9NYa" title="Stock purchase plan">9</span> million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the quarter ended September 30, 2022, the Company
repurchased <span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_z3hiwXMF6yJ9" title="Number of shares repurchased">9</span> shares at a cost of $<span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zYwIyA4Aiac1" title="Number of shares repurchased, value">122</span>.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $<span id="xdx_903_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20220930_pn3n3" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances">150</span> per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2022 and June 30, 2022, the Company had approximately $<span id="xdx_907_eus-gaap--SelfInsuranceReserve_c20220930_pn3n3" title="Self-funded health insurance reserve">45</span> and $<span id="xdx_908_eus-gaap--SelfInsuranceReserve_c20220630_pn3n3" title="Self-funded health insurance reserve">79</span>, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#8220;Other current liabilities&#8221; in the
condensed consolidated balance sheets.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#8217; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784625984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text"><p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zsNBjRNsWMqg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
11 - <span id="xdx_82F_zR1F6waqtpQl">INCOME TAXES</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC 740-270, Income Taxes &#8211; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2022 and 2021, the Company recorded income tax expense of $<span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20220930_pn3n3" title="Income tax expense">1,409</span> in 2022 as compared
to $<span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20210930_pn3n3" title="Income tax expense">1,416</span> in 2021. The 2022 provision is comprised of a current income tax component of $<span id="xdx_901_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - current">263</span> and a deferred income tax component of $<span id="xdx_905_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - deferred">1,146</span>.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#8217;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.</span></p>






















<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#8220;Interest expense, net&#8221;. Penalties if incurred would be recognized as a component of &#8220;Selling,
general and administrative&#8221; expenses.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company recorded a deferred tax asset of $<span id="xdx_90B_eus-gaap--DeferredTaxAssetsNet_c20220930_pn3n3" title="Deferred tax asset">11,697</span> and a deferred tax liability of $<span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220930_pn3n3" title="Deferred tax liability">216</span> as of September 30, 2022, primarily relating to
net operating loss carryforwards of approximately $<span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_c20220930_pn3n3" title="Operating Loss Carryforwards">15,640</span> available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2022, no such changes in ownership have occurred.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><b style="font-style: normal; font-weight: normal">The Inflation Reduction Act (&#8220;IRA&#8221;)
was enacted on August 16, 2022. The IRA includes provisions imposing a <span id="xdx_909_ecustom--ExciseTax_dp_c20220701__20220930_zfYObwtVb5Ae" title="Excise tax">1</span>% excise tax on share repurchases that occur after December 31,
2022 and introduces a <span id="xdx_903_ecustom--CorporateMinimumTax_dp_c20220701__20220930_zyezC1XKpQc3" title="Corporate minimum tax">15</span>% corporate alternative minimum tax (&#8220;CAMT&#8221;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting the IRA to have a material impact to
the Company&#8217;s financial statements.</b></p>
<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055786587888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text"><p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zEB9mukrQ6bl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">NOTE
12 &#8211; <span id="xdx_824_zJ0erQNyFbE3">SUBSEQUENT EVENTS</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
Company has evaluated events that occurred subsequent to September 30, 2022 and through the date the condensed consolidated financial
statements were issued.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
October 2022, the Company cancelled <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pn3n3_c20221001__20221031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYmITS4nJtq9" title="Cancelled shares">16</span> shares of common stock which were held as treasury stock at September 30, 2022.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">During
October 2022, the Company amended the revolving credit agreement. The agreement was extended to January 6, 2023. The interest rate on
borrowings is at the current prime rate of <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230101__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zns5dnap3emd" title="Interest rate">6.25</span>% along with certain financial covenants.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782981936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zZqUeLbjL8t7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86A_zSPe9ftYLH11">Principles
of Consolidation</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#8220;Company&#8221;). All significant intercompany accounts and transactions have been eliminated
in consolidation.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenues</a></td>
<td class="text"><p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zFkfmYW1UJi9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_864_zNojIKhqRfIg">Revenues</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#8217;s revenue recognition policies and significant judgements employed in
the determination of revenue.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text"><p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zzUJtloDScG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_86F_zrwc8kbaWza5">BUSINESS
COMBINATION</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>






















<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zHDs3gVpTrv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_860_zYu9CAZVtc7d">Earnings
Per Share</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
earnings per share (&#8220;EPS&#8221;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#8220;Participating Securities and the Two-Class method&#8221;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2022 and 2021.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2022 and 2021, diluted EPS for
common shareholders includes <span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zMeJg2SsDwA8" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"><span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zIHYhF8BivT9" title="Shares included upon conversion of Class C Common to calculate a diluted EPS">128</span></span> shares upon conversion of Class C Common.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Earnings
Per Share</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_zwi3vROioEQc" style="display: none">Quarterly Financial Data</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2021</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,887</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,652</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">60</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.31</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.59</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,673</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze1UxGim4le9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_865_zdcJBeT4Mjni">Recent
Accounting Standards</span></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2022 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>



















<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055785206112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock', window );">Quarterly Financial Data</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_zwi3vROioEQc" style="display: none">Quarterly Financial Data</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Three
    months ended <br/> September 30, 2021</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Common
    Stock</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Class
    C Common <br/> Stock</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Numerator:&#160;
    <br/> Net income available to common stockholders</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,047</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,923</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">32</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,887</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,652</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">60</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Weighted
    average shares outstanding</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Basic
    income per common share</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.31</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.59</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.56</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Denominator:
    <br/> Weighted average shares outstanding</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,545</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,554</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Convertible
    Class C Stock</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0674">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">128</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0678">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Denominator for diluted earnings per share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,673</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,682</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">383</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Diluted
    income per common share</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.29</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.08</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.55</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">0.16</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126900988&amp;loc=d3e1280-108306<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055785081200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock', window );">Financing Receivable, Noncurrent, Allowance for Credit Loss</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_ziCJYFNmkl63" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"><span id="xdx_8BE_z6ZWc9zPwJw" style="display: none">Financing Receivable, Noncurrent, Allowance for Credit Loss</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,366</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_986_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98F_ecustom--AccountsReceivableServiceAndRepairFees_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,161</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable - related party</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zTXKTzGHM9Bj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0702">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--AccountsReceivableNetRelatedParty_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">90</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_989_ecustom--MedicalReceivable_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,216</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--MedicalReceivable_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zxa2sY00ZPU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0708">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_987_ecustom--MedicalReceivable_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">19,216</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">52,331</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">17,749</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_981_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">34,582</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,964</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,723</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, 2022</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 11pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Receivable</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Allowance
    for doubtful accounts</span></td><td style="padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounts
    receivable</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,541</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">205</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 5%; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,336</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrRRrCsSt7Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0732">&#8212;</span>&#160;&#160;</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,109</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">50,047</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98E_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,628</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">33,419</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    and other fees receivable from related medical practices ("PC&#8217;s")</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">13,290</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,687</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&quot;PC's&quot;)"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">8,603</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock', window );">Schedule of Facilities Owned Or Managed</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zJ0KtngUHJRg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span id="xdx_8B3_zhaSgGVkFlI6" style="display: none">Schedule of Facilities Owned Or Managed</span></td><td style="text-align: left">&#160;</td><td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 43%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="width: 10%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20220930_zZPzI6vIxtc3" style="width: 43%; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,072</span></td><td style="width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: center; vertical-align: top"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20220930_zaYSJvS3eRf4" style="text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">420</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20220930_zfH1gz10n0Tj" style="border-bottom: Black 1pt solid; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">84</span></td><td style="text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock', window );">Schedule Of Patient Fee Revenue</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_z2tkiblHGlN3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span id="xdx_8BE_zR9cdlyJcHC8" style="display: none">Schedule Of Patient Fee Revenue</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the Three Months Ended <br/>September 30,</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2021</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Commercial
    Insurance/ Managed Care</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">911</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,086</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medicare/Medicaid</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">238</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Workers'
    Compensation/Personal Injury</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,235</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,124</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">692</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,392</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patient
    Fee Revenue, net of contractual allowances and discounts</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,076</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,851</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ScheduleOfPatientFeeRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ScheduleOfPatientFeeRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_TotalFacilitiesOwnedOrManagedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_TotalFacilitiesOwnedOrManagedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784625984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DisclosureOperatingFinancingLeasesAbstract', window );"><strong>Operating Financing Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock', window );">Lessee Operating Leases Liability Maturity</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zyejPdOLEzYa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span id="xdx_8B9_zog7zBJRno9i" style="display: none">Lessee Operating Leases Liability Maturity</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Twelve
    Months Ending <br/>September 30,</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Operating
    Lease <br/>Payments</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Financing
    Lease Payments</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2023</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziAGgjiTK0fb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,525</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zyvFhxggZQ49" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2024</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpZyzCY2Zctb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,427</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPFs9veGRgue" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2025</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z23RFqEzpaw3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,315</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1V2ER8AzFw9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2026</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z0qMvSx2KM2j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,865</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z9dznTsIHu7e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">244</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2027</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z5b4OCb1ctrb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,596</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zVl2duC35pta" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">102</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Thereafter</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zw02DQKtnjVf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">22,380</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPhHZgo8jPJc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0845">&#8212;</span>&#160;&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Present
                                            value discount</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_981_ecustom--PresentValueDiscount_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zY05KY6enTG4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(10,088</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td id="xdx_988_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z0IMDRR3sxc4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(82</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
                                            lease liability</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zuTaBmrgh9C6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">37,020</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td id="xdx_984_eus-gaap--FinanceLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zwtvaw3NTf9g" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">996</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DisclosureOperatingFinancingLeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DisclosureOperatingFinancingLeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784560320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventories</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zqJyUDhbf3w7" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"><span id="xdx_8B1_zUksbCVW7Fjc" style="display: none">Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49D_20220930_zBCjcu8QBAW7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td><td id="xdx_49E_20220630_z71Hl6dbyoP3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right">&#160;</td><td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30, <br/>2022</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30, <br/>2022</span></td></tr>
  <tr id="xdx_40D_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzXq3_zmWhz94fYS86" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Purchased
    parts, components and supplies</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,182</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,126</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzXq3_zdUg9SpQYl1i" style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Work-in-process</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">276</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">234</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzXq3_zFYtMcUyAZK2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Total
    Inventories</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,458</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td><td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,360</span></td><td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055871208640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Other Intangible Assets - Net</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zueSOH2CKYbb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B1_zhuUt2gjsOL6" style="display: none">Other Intangible Assets - Net</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 58%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capitalized
    software development costs</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 8%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">7,005</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Patents
    and copyrights</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,357</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,333</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Non-compete</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,150</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Customer
    relationships</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,900</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Gross
    Other intangible assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,412</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="text-align: right" title="Gross other intangible assets"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20,388</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Less:
    Accumulated amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220930_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,788</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">16,684</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Intangible Assets</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220930_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,624</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,704</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784581536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjFwUZswbog9" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span id="xdx_8BF_zD8fGA9u2bTc" style="display: none">Other Current Liabilities</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_49D_20220930_zjAkICBldQSf" style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td id="xdx_497_20220630_zkQqr8E7jfij" style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">September
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">June
    30,</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2022</span></p></td></tr>
  <tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzmgj_zNG0R4wOkjvj" style="vertical-align: bottom">
    <td style="width: 60%; padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    salaries, commissions and payroll taxes</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,037</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 7%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="width: 11%; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,653</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzmgj_zPaB4XnAbnDl" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Sales
    tax payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">269</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">249</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzmgj_zYKiOHmy7Bp8" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">State
    income taxes payable</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">250</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">382</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzmgj_z9kzlYBj2Zm3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Legal
    and other professional fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">20</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzmgj_z0Z8gYPzrn2h" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accounting
    fees</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">76</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">120</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzmgj_zxOjt87ohX3e" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Self-funded
    health insurance reserve</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">45</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">79</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzmgj_zIBxQtkJnXZ3" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Accrued
    interest and penalty</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">59</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzmgj_zpN8ssEOoDYi" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    general &amp; administrative expenses</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,445</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">854</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzmgj_zcpzZhxKAhY7" style="vertical-align: bottom">
    <td style="padding-left: 9pt; text-indent: -9pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Other
    Current Liabilities</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,201</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 2.25pt double"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,417</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784560320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summarized Segment Financial Information</a></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_znf9HDYDKO" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)">
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span id="xdx_8B5_zX2kODdwcrFb" style="display: none">Summarized Segment Financial Information</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Medical
    <br/>
    Equipment</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Management
    <br/>
    of Diagnostic <br/>
    Imaging <br/>
    Centers</span></td>
    <td style="text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: black 1pt solid; text-align: center"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Totals</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></p>
    <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2022</span></p></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 49%; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,878</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,313</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 4%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,191</span></td>
    <td style="width: 1%"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_984_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl0974">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">245</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(802</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">4,713</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">3,911</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">72</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,046</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,118</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_985_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">24</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_988_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">939</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">963</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">For
    the three months ended September 30, 2021</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Net
    revenues from external customers</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">2,112</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">21,618</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="text-align: right" title="Net revenues from external customers"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">23,730</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Inter-segment
    net revenues</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">236</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif"><span style="-sec-ix-hidden: xdx2ixbrl1004">&#8212;</span>&#160;&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_983_ecustom--IntersegmentNetRevenues_c20210701__20210930_pn3n3" style="text-align: right" title="Inter-segment net revenues"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">236</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(Loss)
    Income from operations</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">(490</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">)</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">6,231</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">5,741</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Depreciation
    and amortization</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">67</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,102</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,169</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 5.4pt"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">Capital
    expenditures</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">121</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,088</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">$</span></td>
    <td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">1,209</span></td>
    <td><span style="font: normal 10pt Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782362656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember', window );">Controlling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent', window );">The ownership interest of Imperial Management Services after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent', window );">The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_DirectPurchaseOfNoncontrollingInterests', window );">Direct purchase of Noncontrolling Interests</a></td>
<td class="nump">$ 546,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Direct ownership interest percentage</a></td>
<td class="nump">70.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm', window );">The ownership interest of the original investors of HDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_InvestorsOwnershipInterest', window );">Investors ownership interest percentage</a></td>
<td class="nump">29.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_DirectPurchaseOfNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_DirectPurchaseOfNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_InvestorsOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_InvestorsOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership interest rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_OwnershipInterestOfOriginalInvestorsOfHdm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_OwnershipInterestOfOriginalInvestorsOfHdm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=FONR_ControllingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055776220800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 2,047<span></span>
</td>
<td class="nump">$ 3,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 1,923<span></span>
</td>
<td class="nump">$ 3,652<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">6,545<span></span>
</td>
<td class="nump">6,554<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember', window );">Common Class C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Basic Numerator: Net income available to common stockholders</a></td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_EarningsPerShareBasics', window );">Basic income per common share</a></td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings', window );">Diluted Denominator: Weighted average shares outstanding</a></td>
<td class="nump">383<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ConvertibleClassCStock', window );">Convertible Class C Stock</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ConvertibleClassCStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The shares of convertible class C stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ConvertibleClassCStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_EarningsPerShareBasics">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_EarningsPerShareBasics</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_WeightedAverageNumberOfDilutedSharesOutstandings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_WeightedAverageNumberOfDilutedSharesOutstandings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784591072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock', window );">Shares included upon conversion of Class C Common to calculate a diluted EPS</a></td>
<td class="nump">128<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e2029-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055776186848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">$ 4,161<span></span>
</td>
<td class="nump">$ 4,336<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">19,216<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">34,582<span></span>
</td>
<td class="nump">33,419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC&amp;#39;s")</a></td>
<td class="nump">8,723<span></span>
</td>
<td class="nump">8,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">4,366<span></span>
</td>
<td class="nump">4,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="nump">19,216<span></span>
</td>
<td class="nump">20,109<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">52,331<span></span>
</td>
<td class="nump">50,047<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC&amp;#39;s")</a></td>
<td class="nump">13,687<span></span>
</td>
<td class="nump">13,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember', window );">Doubtful [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableServiceAndRepairFees', window );">Accounts receivable</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">205<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_AccountsReceivableNetRelatedParty', window );">Accounts receivable - Related party</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MedicalReceivable', window );">Medical Receivables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagementAndOtherFees_NonRelatedParties', window );">Management and other fees receivable</a></td>
<td class="nump">17,749<span></span>
</td>
<td class="nump">16,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances', window );">Management and other fees receivable from related medical practices ("PC&amp;#39;s")</a></td>
<td class="nump">$ 4,964<span></span>
</td>
<td class="nump">$ 4,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableNetRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableNetRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_AccountsReceivableServiceAndRepairFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_AccountsReceivableServiceAndRepairFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagementAndOtherFees_NonRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagementAndOtherFees_NonRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MedicalReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MedicalReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_DoubtfulMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055784934576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueOneToTwoYears', window );">2024</a></td>
<td class="nump">$ 1,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueTwoToThreeYears', window );">2025</a></td>
<td class="nump">420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractReceivableDueThreeToFourYears', window );">2026</a></td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms', window );">Total</a></td>
<td class="nump">$ 1,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueOneToTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueOneToTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueThreeToFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueThreeToFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractReceivableDueTwoToThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 910<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126937589&amp;loc=SL119991595-234733<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractReceivableDueTwoToThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782576160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 6,076<span></span>
</td>
<td class="nump">$ 6,851<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember', window );">Commercial Insurance / Managed Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">911<span></span>
</td>
<td class="nump">1,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember', window );">Medicare/Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">238<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember', window );">Workers Compensation/Personal Injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">4,235<span></span>
</td>
<td class="nump">4,124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount', window );">Patient fee revenue, net of contractual allowances and discounts</a></td>
<td class="nump">$ 692<span></span>
</td>
<td class="nump">$ 1,392<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of Patient fee revenue, net of contractual allowances and discounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_CommercialInsuranceManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_MedicareMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_WorkersCompensationPersonalInjuryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HealthCareOrganizationRevenueSourcesAxis=FONR_OtherRevenueSourceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782548592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims', window );">Percentage of net revenue derived from no-fault and personal injury protection claim</a></td>
<td class="nump">69.00%<span></span>
</td>
<td class="nump">66.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees', window );">Percentage of consolidated net revenue from management fees charged to related party medical practices</a></td>
<td class="nump">12.90%<span></span>
</td>
<td class="nump">11.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfConsolidatedNetRevenueFromManagementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of consolidated net revenue from management fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfConsolidatedNetRevenueFromManagementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of PCs net revenue derived from nofault and personal injury protection claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782917904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember', window );">Operating Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 5,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">5,427<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">5,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">4,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">3,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">22,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscount', window );">Present value discount</a></td>
<td class="num">(10,088)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">37,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember', window );">Financing Lease Payments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">244<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_PresentValueDiscountFinancingLease', window );">Present value discount</a></td>
<td class="num">(82)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total lease liability</a></td>
<td class="nump">$ 996<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_PresentValueDiscountFinancingLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value discount financing lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_PresentValueDiscountFinancingLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_OperatingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=FONR_FinancingLeasePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782943648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORIES - Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventorySupplies', window );">Purchased parts, components and supplies</a></td>
<td class="nump">$ 2,182<span></span>
</td>
<td class="nump">$ 2,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work-in-process</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess', window );">Total Inventories</a></td>
<td class="nump">$ 2,458<span></span>
</td>
<td class="nump">$ 2,360<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsAndWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsAndWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventorySupplies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventorySupplies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055783158144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 20,412<span></span>
</td>
<td class="nump">$ 20,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: Accumulated amortization</a></td>
<td class="nump">16,788<span></span>
</td>
<td class="nump">16,684<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets-net</a></td>
<td class="nump">3,624<span></span>
</td>
<td class="nump">3,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">5,357<span></span>
</td>
<td class="nump">5,333<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">4,150<span></span>
</td>
<td class="nump">4,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross other intangible assets</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055781712576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember', window );">Patents and copyrights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">$ 47<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer Relationships [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">$ 50<span></span>
</td>
<td class="nump">$ 50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=FONR_PatentsAndCopyrightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782931120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued salaries, commissions and payroll taxes</a></td>
<td class="nump">$ 3,037<span></span>
</td>
<td class="nump">$ 4,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesAndExciseTaxPayableCurrent', window );">Sales tax payable</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_StateIncomeTaxesPayable', window );">State income taxes payable</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Legal and other professional fees</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent', window );">Accounting fees</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesNoncurrent', window );">Accrued interest and penalty</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other general &amp; administrative expenses</a></td>
<td class="nump">1,445<span></span>
</td>
<td class="nump">854<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other Current Liabilities</a></td>
<td class="nump">$ 5,201<span></span>
</td>
<td class="nump">$ 6,417<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_StateIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>the value of state income taxes payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_StateIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesAndExciseTaxPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesAndExciseTaxPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055781509824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">$ 23,191<span></span>
</td>
<td class="nump">$ 23,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">3,911<span></span>
</td>
<td class="nump">5,741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,118<span></span>
</td>
<td class="nump">1,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">963<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">1,878<span></span>
</td>
<td class="nump">2,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="nump">245<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="num">(802)<span></span>
</td>
<td class="num">(490)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">24<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember', window );">Management Of Diagnostic Imaging Centers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_NetRevenuesFromExternalCustomers', window );">Net revenues from external customers</a></td>
<td class="nump">21,313<span></span>
</td>
<td class="nump">21,618<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_IntersegmentNetRevenues', window );">Inter-segment net revenues</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperations', window );">(Loss) Income from operations</a></td>
<td class="nump">4,713<span></span>
</td>
<td class="nump">6,231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,046<span></span>
</td>
<td class="nump">1,102<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures</a></td>
<td class="nump">$ 939<span></span>
</td>
<td class="nump">$ 1,088<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_IntersegmentNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intersegment net revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_IntersegmentNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_NetRevenuesFromExternalCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_NetRevenuesFromExternalCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613673-111683<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.13)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOperatingActivitiesSegmentAxis=FONR_ManagementOfDiagnosticImagingCentersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055781682560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 189<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">$ 395<span></span>
</td>
<td class="nump">$ 221<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055776172080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Number of shares repurchased</a></td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Number of shares repurchased, value</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance', window );">Maximum limit for individual claims under stop-loss umbrella policy for health insurances</a></td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-funded health insurance reserve</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782372752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability', window );">Income tax expense</a></td>
<td class="nump">$ 1,409<span></span>
</td>
<td class="nump">$ 1,416<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Income tax component - current</a></td>
<td class="nump">263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Income tax component - deferred</a></td>
<td class="nump">1,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax asset</a></td>
<td class="nump">11,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus', window );">Deferred tax liability</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating Loss Carryforwards</a></td>
<td class="nump">$ 15,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_ExciseTax', window );">Excise tax</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_FONR_CorporateMinimumTax', window );">Corporate minimum tax</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_CorporateMinimumTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_CorporateMinimumTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_FONR_ExciseTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">FONR_ExciseTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>FONR_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6487024&amp;loc=d3e29054-158556<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140055782548720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 06, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Cancelled shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateDuringPeriod', window );">Interest rate</a></td>
<td class="nump">6.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>fonar_10q_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:FONR="http://fonar.com/20220930"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="fonr-20220930.xsd" xlink:type="simple"/>
    <context id="From2022-07-01to2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-11-07_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="AsOf2022-11-07_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="AsOf2022-11-07_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="AsOf2022-11-07_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-07</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">FONR:ClassANonVotingPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_PreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2021-07-012021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_PreferredClassAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:PreferredClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonClassCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CommonStockMember266973265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CommonStockMember266973296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_custom_AccumulatedDeficitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:AccumulatedDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_TreasuryStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2021-09-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="From2021-07-012022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_ControllingInterestMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">FONR:ControllingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_AccountsReceivableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_DoubtfulMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:DoubtfulMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:CommercialInsuranceManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MedicareMedicaidMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:MedicareMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:WorkersCompensationPersonalInjuryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_OtherRevenueSourceMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HealthCareOrganizationRevenueSourcesAxis">FONR:OtherRevenueSourceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_OperatingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:OperatingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_FinancingLeasePaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">FONR:FinancingLeasePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="AsOf2022-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">FONR:PatentsAndCopyrightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_MedicalEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementOperatingActivitiesSegmentAxis">FONR:ManagementOfDiagnosticImagingCentersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="AsOf2022-09-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
        </entity>
        <period>
            <instant>2022-09-26</instant>
        </period>
    </context>
    <context id="From2022-10-012022-10-31_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-01-06_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000355019</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-07-01to2022-09-30">0000355019</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-07-01to2022-09-30">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-07-01to2022-09-30">--06-30</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2022-07-01to2022-09-30">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="From2022-07-01to2022-09-30">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCurrentReportingStatus contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0032">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2022-07-01to2022-09-30" id="xdx2ixbrl0034">Yes</dei:EntityInteractiveDataCurrent>
    <FONR:AccountReceivableRelatedParties
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0065"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParties
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0128"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-09-30"
      id="xdx2ixbrl0175"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0176"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-09-30"
      id="xdx2ixbrl0194"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0195"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:Commonstockvalue2
      contextRef="AsOf2022-09-30"
      id="xdx2ixbrl0232"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:Commonstockvalue2
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0233"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:Commonstockvalue3
      contextRef="AsOf2022-09-30"
      id="xdx2ixbrl0251"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:Commonstockvalue3
      contextRef="AsOf2022-06-30"
      id="xdx2ixbrl0252"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0411"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0413"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0414"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265"
      id="xdx2ixbrl0417"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0418"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0421"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265"
      id="xdx2ixbrl0424"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember"
      id="xdx2ixbrl0426"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0427"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember266973265"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0432"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember"
      id="xdx2ixbrl0433"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281"
      id="xdx2ixbrl0452"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0453"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0455"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      id="xdx2ixbrl0456"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281"
      id="xdx2ixbrl0459"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0460"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0462"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember266973281"
      id="xdx2ixbrl0466"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0467"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember"
      id="xdx2ixbrl0468"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_TreasuryStockMember"
      id="xdx2ixbrl0469"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2022-07-01to2022-09-30"
      id="xdx2ixbrl0501"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2022-07-01to2022-09-30"
      id="xdx2ixbrl0519"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2021-07-012021-09-30"
      id="xdx2ixbrl0565"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0674"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      id="xdx2ixbrl0678"
      unitRef="Shares"
      xsi:nil="true"/>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0702"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0708"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      id="xdx2ixbrl0732"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      id="xdx2ixbrl0845"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl0974"
      unitRef="USD"
      xsi:nil="true"/>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      id="xdx2ixbrl1004"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2022-07-01to2022-09-30">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="From2022-07-01to2022-09-30">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="From2022-07-01to2022-09-30">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:EntityFileNumber contextRef="From2022-07-01to2022-09-30">0-10248</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2022-07-01to2022-09-30">FONAR CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-07-01to2022-09-30">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-07-01to2022-09-30">11-2464137</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-07-01to2022-09-30">110 Marcus Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-07-01to2022-09-30">Melville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-07-01to2022-09-30">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-07-01to2022-09-30">11747</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-07-01to2022-09-30">(631)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-07-01to2022-09-30">694-2929</dei:LocalPhoneNumber>
    <dei:EntityFilerCategory contextRef="From2022-07-01to2022-09-30">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2022-07-01to2022-09-30">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-07-01to2022-09-30">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="From2022-07-01to2022-09-30">false</dei:EntityShellCompany>
    <dei:Security12bTitle contextRef="From2022-07-01to2022-09-30">Common     Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-07-01to2022-09-30">FONR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-07-01to2022-09-30">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-11-07_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6538148000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-11-07_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-11-07_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">382513000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2022-11-07_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313438000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">48696000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48723000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">32000</us-gaap:ShortTermInvestments>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">4161000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4336000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountReceivableRelatedParties contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">90000</FONR:AccountReceivableRelatedParties>
    <FONR:MedicalReceivable contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">19216000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">34582000</FONR:ManagementAndOtherFees>
    <FONR:ManagementAndOtherFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33419000</FONR:ManagementAndOtherFees>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">8723000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">8603000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">2458000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2360000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1108000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1104000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">119066000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">118686000</us-gaap:AssetsCurrent>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1575000</FONR:AccountsReceivableNetLongTerm>
    <FONR:AccountsReceivableNetLongTerm contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1872000</FONR:AccountsReceivableNetLongTerm>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">11697000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:DeferredTaxAssetsDeferredIncome contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">12843000</us-gaap:DeferredTaxAssetsDeferredIncome>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">22207000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">22282000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">34180000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">34232000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">878000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">928000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4269000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">3624000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OtherAssets contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">526000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">526000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">198022000</us-gaap:Assets>
    <us-gaap:Assets contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">199342000</us-gaap:Assets>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">42000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">40000</us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">773000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1552000</us-gaap:AccountsPayableCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">5201000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6417000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">4123000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4289000</us-gaap:DeferredRevenueCurrent>
    <FONR:UnearnedRevenueOnServiceContractsRelatedParties contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">82000</FONR:UnearnedRevenueOnServiceContractsRelatedParties>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">3908000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3880000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">212000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">210000</us-gaap:FinanceLeaseLiabilityCurrent>
    <FONR:CustomerDeposits contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">532000</FONR:CustomerDeposits>
    <FONR:CustomerDeposits contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">361000</FONR:CustomerDeposits>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">14873000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">16749000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1576000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1857000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">216000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">216000</us-gaap:DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">93000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">93000</us-gaap:AccountsPayableRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">33112000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33091000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">784000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">838000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">148000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">155000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OtherLiabilities contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">90000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">107000</us-gaap:OtherLiabilities>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">36019000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">36357000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">50892000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">53106000</us-gaap:Liabilities>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">453000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-09-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_custom_ClassANonVotingPreferredStockMember"
      decimals="-3"
      unitRef="Shares">313000</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="INF"
      unitRef="USDPShares">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_PreferredStockMember"
      decimals="-3"
      unitRef="Shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">8500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6566000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6566000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:CommonStockSharesOutstanding>
    <FONR:Commonstockvalue1 contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1000</FONR:Commonstockvalue1>
    <FONR:Commonstockvalue1 contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">1000</FONR:Commonstockvalue1>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">227000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassBMember"
      decimals="-3"
      unitRef="Shares">146000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">567000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2022-06-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">184531000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">184531000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">-31520000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-33567000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares contextRef="AsOf2022-09-30" decimals="-3" unitRef="Shares">20000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares contextRef="AsOf2022-06-30" decimals="-3" unitRef="Shares">12000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">797000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">675000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">152215000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">150290000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">-5085000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">-4054000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">147130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">146236000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">198022000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">199342000</us-gaap:LiabilitiesAndStockholdersEquity>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">6076000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">6851000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts>
    <FONR:ProductSalesNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">30000</FONR:ProductSalesNet>
    <FONR:ProductSalesNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">148000</FONR:ProductSalesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1820000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1936000</FONR:ServiceAndRepairFeesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ServiceAndRepairFeesRelatedPartiesNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">28000</FONR:ServiceAndRepairFeesRelatedPartiesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">12250000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">11972000</FONR:ManagementAndOtherFeesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2987000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">2795000</FONR:ManagementAndOtherFeesRelatedMedicalPracticesNet>
    <us-gaap:Revenues
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">23191000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">23730000</us-gaap:Revenues>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">3800000</us-gaap:OtherCostOfOperatingRevenue>
    <us-gaap:OtherCostOfOperatingRevenue
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">3156000</us-gaap:OtherCostOfOperatingRevenue>
    <FONR:CostsRelatedToProductSales
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">169000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToProductSales
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">109000</FONR:CostsRelatedToProductSales>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">718000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFees
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">724000</FONR:CostsRelatedToServiceAndRepairFees>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">11000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToServiceAndRepairFeesRelatedParties
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">10000</FONR:CostsRelatedToServiceAndRepairFeesRelatedParties>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">6501000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFees
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">6877000</FONR:CostsRelatedToManagementAndOtherFees>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1398000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1637000</FONR:CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">349000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">386000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">6334000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">5090000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">19280000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">17989000</us-gaap:CostsAndExpenses>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">3911000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">5741000</us-gaap:IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">11000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">811000</us-gaap:OtherNonoperatingIncomeExpense>
    <FONR:InterestExpenses
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">14000</FONR:InterestExpenses>
    <FONR:InterestExpenses
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">17000</FONR:InterestExpenses>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">151000</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">63000</us-gaap:InvestmentIncomeNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">4059000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">6598000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1409000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1416000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">5182000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1923000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3652000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">92000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_PreferredClassAMember"
      decimals="-3"
      unitRef="USD">175000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">60000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="USDPShares">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.55</us-gaap:EarningsPerShareDiluted>
    <FONR:EarningPerShareBasicAndDiluted
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</FONR:EarningPerShareBasicAndDiluted>
    <FONR:EarningPerShareBasicAndDiluted
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</FONR:EarningPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="Shares">6673000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="Shares">6682000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_CommonStockMember266973265"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">-33567000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-4054000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">146236000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-012022-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-012022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">603000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_CommonStockMember266973296"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">184531000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">-31520000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">797000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2022-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-5085000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">147130000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">185101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">-46008000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-3049000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">135370000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1295000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_AdditionalPaidInCapitalMember"
      decimals="-3"
      unitRef="USD">185101000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_custom_AccumulatedDeficitMember"
      decimals="-3"
      unitRef="USD">-42121000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_TreasuryStockMember"
      decimals="-3"
      unitRef="USD">-675000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2021-09-30_us-gaap_NoncontrollingInterestMember"
      decimals="-3"
      unitRef="USD">-2834000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">139472000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2650000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">5182000</us-gaap:ProfitLoss>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OtherDepreciationAndAmortization
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1169000</us-gaap:OtherDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1061000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">648000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <FONR:ProvisionForBadDebts
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1398000</FONR:ProvisionForBadDebts>
    <FONR:ProvisionForBadDebts
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">502000</FONR:ProvisionForBadDebts>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1146000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1195000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <FONR:GainOnForgivenessOfPppLoan
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">701000</FONR:GainOnForgivenessOfPppLoan>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1407000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1730000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-11000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-11000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">98000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">172000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">14000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">188000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">4000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-779000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-733000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-1580000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherCurrentLiabilities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-3383000</us-gaap:IncreaseDecreaseInOtherCurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-912000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOperatingLiabilities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-547000</us-gaap:IncreaseDecreaseInOperatingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">52000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInFinancingLiabilities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">50000</FONR:IncreaseDecreaseInFinancingLiabilities>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">171000</FONR:IncreaseDecreaseInCustomerAdvance>
    <FONR:IncreaseDecreaseInCustomerAdvance
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">58000</FONR:IncreaseDecreaseInCustomerAdvance>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-16000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-16000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2697000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1241000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">939000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1180000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">24000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">29000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-963000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-1209000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">5000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">7000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:PaymentsForRepurchaseOfConvertiblePreferredStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1634000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1080000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-1761000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-1087000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">-27000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">-1055000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">48723000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-06-30" decimals="-3" unitRef="USD">44460000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">48696000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="AsOf2021-09-30" decimals="-3" unitRef="USD">43405000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_801_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zomOqPW1rqB1" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
1 &#x2013; &lt;span id="xdx_827_zPqSR7Go8Qm2"&gt;DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Description
of Business&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Effective
July 1, 2015, the Company restructured the corporate organization of the management of diagnostic imaging centers segment of our business.
The reorganization was structured to more completely integrate the operations of Health Management Corporation of America and HDM. Imperial
contributed all of its assets (which were utilized in the business of Health Management Corporation of America) to HDM and received a
&lt;span id="xdx_902_ecustom--HmcaOwnershipSizeOfImperialManagementServicesPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zrsMEisrp1J9" title="The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"&gt;24.2&lt;/span&gt;% interest in HDM. Health Management Corporation of America retained a direct ownership interest of &lt;span id="xdx_902_ecustom--OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zDgomMJcHnkk" title="The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"&gt;45.8&lt;/span&gt;% in HDM, and the original
investors in HDM retained a &lt;span id="xdx_90A_ecustom--OwnershipInterestOfOriginalInvestorsOfHdm_iI_pip0_dp_c20150701__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zQDwIm3QPn86" title="The ownership interest of the original investors of HDM"&gt;30.0&lt;/span&gt;% ownership interest in the newly expanded HDM. During the fiscal year ended June 30, 2022, the Company
purchased non-controlling interests from the minority shareholders for $&lt;span id="xdx_909_ecustom--DirectPurchaseOfNoncontrollingInterests_pn3n3_c20210701__20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_ziuJuHI9L2Zf" title="Direct purchase of Noncontrolling Interests"&gt;546,000&lt;/span&gt;. Currently the Company has a direct ownership interest
of &lt;span id="xdx_909_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__custom--ControllingInterestMember_zmA0wFNtJOSb" title="Direct ownership interest percentage"&gt;70.8&lt;/span&gt;% and the investors&#x2019; have a &lt;span id="xdx_90A_ecustom--InvestorsOwnershipInterest_iI_pip0_dp_c20220630__us-gaap--StatementEquityComponentsAxis__us-gaap--NoncontrollingInterestMember_zKKMnnawY0P7" title="Investors ownership interest percentage"&gt;29.2&lt;/span&gt;% ownership interest. The entire management of diagnostic imaging centers business segment
is now being conducted by HDM, operating under the name &#x201c;Health Management Company of America&#x201d;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basis
of Presentation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they
do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered
necessary for a fair presentation have been included. Operating results for the three months ended September 30, 2022, are not necessarily
indicative of the results that may be expected for the fiscal year ending June 30, 2023. For further information, refer to the consolidated
financial statements and footnotes thereto included in the Company's Annual Report on Form 10-K filed on September 28, 2022 for the fiscal
year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Since
March 2020, the global pandemic of COVID-19 has caused turbulence and uncertainty in the United States and international markets and
economies which has adversely affected our workforce, liquidity, financial conditions, revenues, profitability and business operations.
Generally, COVID-19 had caused us to require that much of our workforce work from home and has restricted the ability of our personnel
to travel for marketing purposes or to service our customers. At the end of fiscal year ending June 30, 2020, the Company was able to
enact certain decisions to allow the Company to survive during the global pandemic and from further losses or additional decreases in
scan volume. The Company also received some government stimulus funds from the Paycheck Protection Program (&#x201c;PPP&#x201d;) and Medicare
advances/stimulus payments. The Company has been able to navigate through these challenges and avoid any significant disruption of the
business and the volume has recently risen back almost to pre- COVID-19 levels. Although we are unable to predict if there will be additional
consequences on our operations from the continuing global pandemic of COVID-19, the Company believes with positive cash flows, low debt
and cash on hand, it will be able to maintain operations to pre COVID-19 levels going forward.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


















</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.242</FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent>
    <FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent
      contextRef="AsOf2015-07-01_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.458</FONR:OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent>
    <FONR:OwnershipInterestOfOriginalInvestorsOfHdm
      contextRef="AsOf2015-07-01_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.300</FONR:OwnershipInterestOfOriginalInvestorsOfHdm>
    <FONR:DirectPurchaseOfNoncontrollingInterests
      contextRef="From2021-07-012022-06-30_custom_ControllingInterestMember"
      decimals="-3"
      unitRef="USD">546000000</FONR:DirectPurchaseOfNoncontrollingInterests>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="AsOf2022-06-30_custom_ControllingInterestMember"
      decimals="INF"
      unitRef="Pure">0.708</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <FONR:InvestorsOwnershipInterest
      contextRef="AsOf2022-06-30_us-gaap_NoncontrollingInterestMember"
      decimals="INF"
      unitRef="Pure">0.292</FONR:InvestorsOwnershipInterest>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_803_eus-gaap--SignificantAccountingPoliciesTextBlock_zFA2y6FveWza" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
2 - &lt;span id="xdx_82F_z7J3XfelRr75"&gt;SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zZqUeLbjL8t7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86A_zSPe9ftYLH11"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zFkfmYW1UJi9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_864_zNojIKhqRfIg"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zzUJtloDScG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86F_zrwc8kbaWza5"&gt;BUSINESS
COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zHDs3gVpTrv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_860_zYu9CAZVtc7d"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2022 and 2021, diluted EPS for
common shareholders includes &lt;span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zMeJg2SsDwA8" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zIHYhF8BivT9" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;128&lt;/span&gt;&lt;/span&gt; shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BF_zwi3vROioEQc" style="display: none"&gt;Quarterly Financial Data&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,673&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze1UxGim4le9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_865_zdcJBeT4Mjni"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2022 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_845_eus-gaap--ConsolidationPolicyTextBlock_zZqUeLbjL8t7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86A_zSPe9ftYLH11"&gt;Principles
of Consolidation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
unaudited condensed consolidated financial statements include the accounts of FONAR Corporation, its majority and wholly-owned subsidiaries
and partnerships (collectively the &#x201c;Company&#x201d;). All significant intercompany accounts and transactions have been eliminated
in consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:RevenueRecognitionPolicyTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_84E_eus-gaap--RevenueRecognitionPolicyTextBlock_zFkfmYW1UJi9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_864_zNojIKhqRfIg"&gt;Revenues&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined
in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard
also requires expanded disclosures regarding the Company&#x2019;s revenue recognition policies and significant judgements employed in
the determination of revenue.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Our
revenues generally relate to net patient fees&#160;received from various payers and patients themselves under contracts in which our
performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to
provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period
of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payer (Medicare, Medicaid,
managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the
transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed
care health plans and commercial insurance companies) the third-party payers. The payment arrangements with third-party payers for the
services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide
for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews
the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care
contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:BusinessCombinationsPolicy contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_84C_eus-gaap--BusinessCombinationsPolicy_zzUJtloDScG7" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_86F_zrwc8kbaWza5"&gt;BUSINESS
COMBINATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;When
the qualifications for business combination accounting treatment are met, it requires the Company to recognize separately from goodwill
the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured
as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities
assumed. While the Company uses their best estimates and assumptions to accurately value assets acquired and liabilities assumed at the
acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which
may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding
offset to goodwill. Upon the conclusion of the measurement period of final determination of the values of assets acquired or liabilities
assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zHDs3gVpTrv" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_860_zYu9CAZVtc7d"&gt;Earnings
Per Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
earnings per share (&#x201c;EPS&#x201d;) is computed based upon the weighted average number of shares of common stock and stock equivalents
outstanding, net of common stock. In accordance with ASC topic 260-10, &#x201c;Participating Securities and the Two-Class method&#x201d;,
the Company used the Two-Class method for calculating basic income per share and applied the if converted method in calculating diluted
income per share for the three months ended September 30, 2022 and 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.5in"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS reflects the potential dilution from the exercise or conversion of all dilutive securities into common stock based on the average
market price of common shares outstanding during the period. For the three months ended September 30, 2022 and 2021, diluted EPS for
common shareholders includes &lt;span id="xdx_902_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20220701__20220930_zMeJg2SsDwA8" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;&lt;span id="xdx_904_eus-gaap--IncrementalCommonSharesAttributableToConversionOfPreferredStock_pn3n3_c20210701__20210930_zIHYhF8BivT9" title="Shares included upon conversion of Class C Common to calculate a diluted EPS"&gt;128&lt;/span&gt;&lt;/span&gt; shares upon conversion of Class C Common.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Earnings
Per Share&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BF_zwi3vROioEQc" style="display: none"&gt;Quarterly Financial Data&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,673&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="Shares">128000</us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock>
    <us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfQuarterlyFinancialInformationTableTextBlock_z6g3NERSnexd" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BF_zwi3vROioEQc" style="display: none"&gt;Quarterly Financial Data&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Three
    months ended &lt;br/&gt; September 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Common
    Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Class
    C Common &lt;br/&gt; Stock&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 40%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Numerator:&#160;
    &lt;br/&gt; Net income available to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,047&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,923&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;32&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,887&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,652&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--NetIncomeLoss_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; width: 6%; text-align: right" title="Basic Numerator: Net income available to common stockholders"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Weighted
    average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930_zZAlvJUTSTx2" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z5oV2RR4x1ah" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zgijZGkzGJXf" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930_zifpoYQArv9i" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYJFjA5vGEo9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zNx0nnqplZ57" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Basic
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930_z9htDDmF7gn9" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.31&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_znFKnuCaNiO6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--EarningsPerShareBasics_pip0_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zrbkvqQxbbX8" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930_z2XoEoWMR7Vh" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.59&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_z3Gnm688ExOe" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.56&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--EarningsPerShareBasics_pip0_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zICmwzbZyh49" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Basic income per common share"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Denominator:
    &lt;br/&gt; Weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zYkTxFFktk8j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,545&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zL4ww1DDxp05" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zgtyHejSkjE4" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,554&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--WeightedAverageNumberOfDilutedSharesOutstandings_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_zCJjUdqtz9sl" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Diluted Denominator: Weighted average shares outstanding"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 1pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Convertible
    Class C Stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zww6fApVlkGj" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ConvertibleClassCStock_pn3n3_c20220701__20220930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z58845wwzhgb" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0674"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonStockMember_zsAkomkjUWm" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;128&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ConvertibleClassCStock_pn3n3_c20210701__20210930__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassCMember_z7YSpMxySIP7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Convertible Class C Stock"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0678"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Denominator for diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,673&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,682&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;383&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-indent: -8.85pt; padding-left: 8.85pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Diluted
    income per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.29&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.08&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.55&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">2047000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">1923000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">32000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">3887000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="USD">3652000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="USD">60000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="USDPShares">0.31</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.29</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.08</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="USDPShares">0.59</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="INF"
      unitRef="USDPShares">0.56</FONR:EarningsPerShareBasics>
    <FONR:EarningsPerShareBasics
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="INF"
      unitRef="USDPShares">0.16</FONR:EarningsPerShareBasics>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6545000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2022-07-012022-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">6554000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:WeightedAverageNumberOfDilutedSharesOutstandings
      contextRef="From2021-07-012021-09-30_us-gaap_CommonClassCMember"
      decimals="-3"
      unitRef="Shares">383000</FONR:WeightedAverageNumberOfDilutedSharesOutstandings>
    <FONR:ConvertibleClassCStock
      contextRef="From2022-07-012022-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <FONR:ConvertibleClassCStock
      contextRef="From2021-07-012021-09-30_us-gaap_CommonStockMember"
      decimals="-3"
      unitRef="Shares">128000</FONR:ConvertibleClassCStock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_842_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ze1UxGim4le9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_865_zdcJBeT4Mjni"&gt;Recent
Accounting Standards&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;FASB,
the Emerging Issues Task Force and the SEC have issued certain other accounting standards, updates, and regulations as of September 30,
2022 that will become effective in subsequent periods; however, management does not believe that any of those updates would have significantly
affected our financial accounting measures or disclosures had they been in effect during 2022 or 2021, and it does not believe that any
of those standards will have a significant impact on our consolidated condensed financial statements at the time they become effective.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;



















</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_801_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zDCr5x8keM76" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
3 &#x2013; &lt;span id="xdx_822_zh1GUBKJDNEh"&gt;ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Receivables,
net is comprised of the following at September 30, 2022, and June 30, 2022:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_ziCJYFNmkl63" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span id="xdx_8BE_z6ZWc9zPwJw" style="display: none"&gt;Financing Receivable, Noncurrent, Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,366&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccountsReceivableServiceAndRepairFees_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,161&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zTXKTzGHM9Bj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0702"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccountsReceivableNetRelatedParty_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--MedicalReceivable_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--MedicalReceivable_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zxa2sY00ZPU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--MedicalReceivable_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;52,331&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;17,749&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;34,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,336&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrRRrCsSt7Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0732"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;50,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;33,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A5_zeJlMWJylyA9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company's customers are concentrated in the healthcare industry.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Credit
risk with respect to the Company&#x2019;s accounts receivable related to product sales and service and repair fees is limited due to the
customer advances received prior to the commencement of work performed and the billing of amounts to customers as sub-assemblies are
completed. Service and repair fees are billed on a monthly or quarterly basis and the Company does not continue providing these services
if accounts receivable become past due. The Company controls credit risk with respect to accounts receivable from service and repair
fees through its credit evaluation process, credit limits, monitoring procedures and reasonably short collection terms. The Company performs
ongoing credit authorizations before a product sales contract is entered into or service and repair fees are provided.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Long
Term Accounts Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company will generate revenue from long-term, non-cancellable contracts to provide service and repair services. Future revenue to be
recognized over the following three years as of September 30, 2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zJ0KtngUHJRg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_8B3_zhaSgGVkFlI6" style="display: none"&gt;Schedule of Facilities Owned Or Managed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20220930_zZPzI6vIxtc3" style="width: 43%; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,072&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20220930_zaYSJvS3eRf4" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;420&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20220930_zfH1gz10n0Tj" style="border-bottom: Black 1pt solid; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
Receivables&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
receivables are due under fee-for-service contracts from third party payors, such as hospitals, government sponsored healthcare programs,
patient&#x2019;s legal counsel and directly from patients. Substantially all the revenue relates to patients residing in Florida. The
carrying amount of the medical receivable is reduced by an allowance that reflects management&#x2019;s best estimate of the amounts that
will not be collected. The Company determines allowances for contractual adjustments and uncollectible accounts based on specific agings,
specific payor collection issues that have been identified and based on payor classifications and historical experience at each site.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
and Other Fees Receivable&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company's receivables from the related and non-related professional corporations (PC's) substantially consist of fees outstanding under
management agreements. Payment of the outstanding fees is dependent on collection by the PC's of fees from third party medical reimbursement
organizations, principally insurance companies and health management organizations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Payment
of the management fee receivables from the PC&#x2019;s may be impaired by the inability of the PC&#x2019;s to collect in a timely manner
their medical fees from the third party payors, particularly insurance carriers covering automobile no-fault and workers compensation
claims due to longer payment cycles and rigorous informational requirements and certain other disallowed claims. Approximately &lt;span id="xdx_904_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20220701__20220930_z8PCvEocf2R2" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;69.0&lt;/span&gt;%
and &lt;span id="xdx_901_ecustom--PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims_pip0_dp_c20210701__20210930_zzzRpMovET18" title="Percentage of net revenue derived from no-fault and personal injury protection claim"&gt;66.7&lt;/span&gt;% of the PCs&#x2019; net revenues for the three months ended September 30, 2022 and 2021, respectively, were derived from no-fault
and personal injury protection claims. The Company considers the aging of its accounts receivable in determining the amount of allowance
for doubtful accounts. The Company generally takes all legally available steps to collect its receivables. Credit losses associated with
the receivables are provided for in the condensed consolidated financial statements and have historically been within management's expectations.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
revenues from management and other fees charged to the related PCs accounted for approximately &lt;span id="xdx_901_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20220701__20220930_zvFge6A6WCm7" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;12.9&lt;/span&gt;% and &lt;span id="xdx_909_ecustom--PercentageOfConsolidatedNetRevenueFromManagementFees_pip0_dp_c20210701__20210930_zux8MPqExS13" title="Percentage of consolidated net revenue from management fees charged to related party medical practices"&gt;11.8&lt;/span&gt;% of the consolidated net
revenues for the three months ended September 30, 2022 and 2021, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Tallahassee
Magnetic Resonance Imaging, PA, Stand Up MRI of Boca Raton, PA and Stand Up MRI &amp;amp; Diagnostic Center, PA (all related medical practices)
entered into a guaranty agreement, pursuant to which they cross guaranteed all management fees which are payable to the Company, which
have arisen under each individual management agreement. Additional Company managed entities also operate under a guaranty agreement,
pursuant to which management fees are payable to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s patient fee revenue, net of contractual allowances and discounts for the three months ended September 30, 2022 and 2021
are summarized in the following table.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_z2tkiblHGlN3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BE_zR9cdlyJcHC8" style="display: none"&gt;Schedule Of Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,086&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,235&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,124&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;692&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,392&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,851&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_899_eus-gaap--ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock_ziCJYFNmkl63" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span id="xdx_8BE_z6ZWc9zPwJw" style="display: none"&gt;Financing Receivable, Noncurrent, Allowance for Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,366&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_986_ecustom--AccountsReceivableServiceAndRepairFees_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98F_ecustom--AccountsReceivableServiceAndRepairFees_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,161&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable - related party&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_ecustom--AccountsReceivableNetRelatedParty_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableNetRelatedParty_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zTXKTzGHM9Bj" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0702"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--AccountsReceivableNetRelatedParty_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts receivable - Related party"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;90&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--MedicalReceivable_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--MedicalReceivable_iI_pn3n3_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zxa2sY00ZPU7" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0708"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--MedicalReceivable_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;19,216&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;52,331&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;17,749&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;34,582&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,964&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,723&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-size: 11pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 46%; text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounts
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_985_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,541&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;205&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5%; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--AccountsReceivableServiceAndRepairFees_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; width: 11%; text-align: right" title="Accounts receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,336&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--MedicalReceivable_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--MedicalReceivable_iI_pn3n3_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_zrRRrCsSt7Jg" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0732"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--MedicalReceivable_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Medical Receivables"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,109&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;50,047&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,628&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--ManagementAndOtherFees__NonRelatedParties_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;33,419&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt; text-indent: -17.1pt; padding-left: 17.1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    and other fees receivable from related medical practices ("PC&#x2019;s")&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--AccountsReceivableMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;13,290&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630__us-gaap--AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis__us-gaap--DoubtfulMember_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,687&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98B_ecustom--ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances_c20220630_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Management and other fees receivable from related medical practices (&amp;quot;PC's&amp;quot;)"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;8,603&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4366000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">205000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">4161000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableNetRelatedParty
      contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">90000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:AccountsReceivableNetRelatedParty contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">90000</FONR:AccountsReceivableNetRelatedParty>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">19216000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">19216000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">52331000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">17749000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">34582000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-09-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">13687000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-09-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4964000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">8723000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">4541000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">205000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:AccountsReceivableServiceAndRepairFees contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4336000</FONR:AccountsReceivableServiceAndRepairFees>
    <FONR:MedicalReceivable
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:MedicalReceivable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20109000</FONR:MedicalReceivable>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">50047000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">16628000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagementAndOtherFees_NonRelatedParties contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">33419000</FONR:ManagementAndOtherFees_NonRelatedParties>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-06-30_us-gaap_AccountsReceivableMember"
      decimals="-3"
      unitRef="USD">13290000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances
      contextRef="AsOf2022-06-30_us-gaap_DoubtfulMember"
      decimals="-3"
      unitRef="USD">4687000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">8603000</FONR:ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances>
    <FONR:TotalFacilitiesOwnedOrManagedTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_ecustom--TotalFacilitiesOwnedOrManagedTableTextBlock_zJ0KtngUHJRg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span id="xdx_8B3_zhaSgGVkFlI6" style="display: none"&gt;Schedule of Facilities Owned Or Managed&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 43%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 10%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--ContractReceivableDueOneToTwoYears_iI_pn3n3_c20220930_zZPzI6vIxtc3" style="width: 43%; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,072&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: center; vertical-align: top"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--ContractReceivableDueTwoToThreeYears_iI_pn3n3_c20220930_zaYSJvS3eRf4" style="text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;420&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--ContractReceivableDueThreeToFourYears_iI_pn3n3_c20220930_zfH1gz10n0Tj" style="border-bottom: Black 1pt solid; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;84&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--AccountsReceivableBilledForLongTermContractsOrPrograms_c20220930_pn3n3" style="border-bottom: Black 2.5pt double; text-align: right" title="Total"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,576&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:TotalFacilitiesOwnedOrManagedTableTextBlock>
    <us-gaap:ContractReceivableDueOneToTwoYears contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1072000</us-gaap:ContractReceivableDueOneToTwoYears>
    <us-gaap:ContractReceivableDueTwoToThreeYears contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">420000</us-gaap:ContractReceivableDueTwoToThreeYears>
    <us-gaap:ContractReceivableDueThreeToFourYears contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">84000</us-gaap:ContractReceivableDueThreeToFourYears>
    <us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1576000</us-gaap:AccountsReceivableBilledForLongTermContractsOrPrograms>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="Pure">0.690</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Pure">0.667</FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="Pure">0.129</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:PercentageOfConsolidatedNetRevenueFromManagementFees
      contextRef="From2021-07-012021-09-30"
      decimals="INF"
      unitRef="Pure">0.118</FONR:PercentageOfConsolidatedNetRevenueFromManagementFees>
    <FONR:ScheduleOfPatientFeeRevenueTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--ScheduleOfPatientFeeRevenueTableTextBlock_z2tkiblHGlN3" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span id="xdx_8BE_zR9cdlyJcHC8" style="display: none"&gt;Schedule Of Patient Fee Revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the Three Months Ended &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Commercial
    Insurance/ Managed Care&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;911&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--CommercialInsuranceManagedCareMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,086&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medicare/Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;238&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--MedicareMedicaidMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Workers'
    Compensation/Personal Injury&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_987_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,235&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--WorkersCompensationPersonalInjuryMember_pn3n3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,124&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;692&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930__us-gaap--HealthCareOrganizationRevenueSourcesAxis__custom--OtherRevenueSourceMember_pn3n3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,392&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; text-indent: -12.6pt; padding-left: 12.6pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patient
    Fee Revenue, net of contractual allowances and discounts&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20220701__20220930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,076&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_ecustom--PatientFeeRevenueNetOfContractualAllowancesAndDiscount_c20210701__20210930_pn3n3" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Patient fee revenue, net of contractual allowances and discounts"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,851&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:ScheduleOfPatientFeeRevenueTableTextBlock>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">911000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_CommercialInsuranceManagedCareMember"
      decimals="-3"
      unitRef="USD">1086000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">238000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_MedicareMedicaidMember"
      decimals="-3"
      unitRef="USD">249000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">4235000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_WorkersCompensationPersonalInjuryMember"
      decimals="-3"
      unitRef="USD">4124000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-012022-09-30_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">692000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30_custom_OtherRevenueSourceMember"
      decimals="-3"
      unitRef="USD">1392000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">6076000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">6851000</FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_807_eus-gaap--LesseeOperatingLeasesTextBlock_z4j6oEUwcyC5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
4 &#x2013; &lt;span id="xdx_829_zVV6uuVeGdXj"&gt;OPERATING &amp;amp; FINANCING LEASES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
July 2019, the Company adopted ASU 2016-02, Leases (Topic 842). This standard requires lessees to apply a dual approach, classifying
leases as either finance or operating leases based upon the principle of whether or not the lease is effectively a financed purchase
by the lessee. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not
apply the standard to the comparative periods presented in the consolidated financial statements. We have also elected the transition
package of the practical expedients permitted within the standard which eliminates the requirements to reassess prior conclusions about
lease identification, lease classification and indirect costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company accounts for its various operating leases in accordance with Accounting Standards Codification (&#x2018;ASC&#x2019;) 842 &#x2013;
Lease, as updated by ASU 2016-02. At the inception of a lease, the Company recognizes right-of-use lease assets and related lease liabilities
measured at present value of future lease payments on its balance sheet. Lease expense is recognized on a straight-line basis over the
term of the lease. Our most common initial term varies in length from 2 to 10 years. Including renewal options negotiated with the landlord,
we have a total span of 2 to 16 years at the facilities we lease. The Company reviewed its contracts with vendors and customers, determining
that its right-to-use lease assets consisted of only office space operating leases. In determining the right-to-use lease assets and
liabilities, the Company did recognize lease extension options which the Company feels would be reasonably exercised. Our incremental
borrowing rate (&#x201c;IBR&#x201d;) used to discount the stream of operating lease payments is closely related to the interest rates available
to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;A
reconciliation of operating and financing lease payments undiscounted cash flows to lease liabilities recognized as of September 30,
2022 is as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zyejPdOLEzYa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_8B9_zog7zBJRno9i" style="display: none"&gt;Lessee Operating Leases Liability Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Twelve
    Months Ending &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease &lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziAGgjiTK0fb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zyvFhxggZQ49" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpZyzCY2Zctb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPFs9veGRgue" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z23RFqEzpaw3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1V2ER8AzFw9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z0qMvSx2KM2j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,865&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z9dznTsIHu7e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z5b4OCb1ctrb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,596&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zVl2duC35pta" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zw02DQKtnjVf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;22,380&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPhHZgo8jPJc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0845"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscount_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zY05KY6enTG4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(10,088&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z0IMDRR3sxc4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(82&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zuTaBmrgh9C6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;37,020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zwtvaw3NTf9g" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;996&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:LesseeOperatingLeasesTextBlock>
    <FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_884_ecustom--LesseeOperatingLeasesLiabilityMaturityTableTextBlock_zyejPdOLEzYa" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - OPERATING &amp;amp; FINANCING LEASES - Lease Payments (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span id="xdx_8B9_zog7zBJRno9i" style="display: none"&gt;Lessee Operating Leases Liability Maturity&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Twelve
    Months Ending &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Operating
    Lease &lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Financing
    Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_ziAGgjiTK0fb" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,525&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98D_eus-gaap--FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zyvFhxggZQ49" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 26%; text-align: right" title="2023"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zpZyzCY2Zctb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,427&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearTwo_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPFs9veGRgue" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2024"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z23RFqEzpaw3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,315&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_982_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearThree_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z1V2ER8AzFw9" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2025"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z0qMvSx2KM2j" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,865&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_98E_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFour_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z9dznTsIHu7e" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2026"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;244&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_z5b4OCb1ctrb" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,596&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_989_eus-gaap--FinanceLeaseLiabilityPaymentsDueYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zVl2duC35pta" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="2027"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;102&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zw02DQKtnjVf" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;22,380&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--FinanceLeaseLiabilityPaymentsDueAfterYearFive_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zPhHZgo8jPJc" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Thereafter"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0845"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Present
                                            value discount&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_981_ecustom--PresentValueDiscount_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zY05KY6enTG4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(10,088&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_988_ecustom--PresentValueDiscountFinancingLease_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_z0IMDRR3sxc4" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Present value discount"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(82&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
                                            lease liability&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_983_eus-gaap--OperatingLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--OperatingLeasePaymentsMember_zuTaBmrgh9C6" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;37,020&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--FinanceLeaseLiability_iI_pn3n3_c20220930__us-gaap--IncomeStatementLocationAxis__custom--FinancingLeasePaymentsMember_zwtvaw3NTf9g" style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right" title="Total lease liability"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;996&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5525000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5427000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">5315000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">4865000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">244000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">3596000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">102000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">22380000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <FONR:PresentValueDiscount
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-10088000</FONR:PresentValueDiscount>
    <FONR:PresentValueDiscountFinancingLease
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">-82000</FONR:PresentValueDiscountFinancingLease>
    <us-gaap:OperatingLeaseLiability
      contextRef="AsOf2022-09-30_custom_OperatingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">37020000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="AsOf2022-09-30_custom_FinancingLeasePaymentsMember"
      decimals="-3"
      unitRef="USD">996000</us-gaap:FinanceLeaseLiability>
    <us-gaap:InventoryDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_80E_eus-gaap--InventoryDisclosureTextBlock_zbPk0WSrY913" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
5 - &lt;span id="xdx_821_zx1CEjtXnos5"&gt;INVENTORIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inventories
included in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zqJyUDhbf3w7" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zUksbCVW7Fjc" style="display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20220930_zBCjcu8QBAW7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220630_z71Hl6dbyoP3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzXq3_zmWhz94fYS86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,182&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,126&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzXq3_zdUg9SpQYl1i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;276&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;234&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzXq3_zFYtMcUyAZK2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,458&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zqJyUDhbf3w7" style="font: 11pt Calibri, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INVENTORIES - Inventories (Details)"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zUksbCVW7Fjc" style="display: none"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20220930_zBCjcu8QBAW7" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49E_20220630_z71Hl6dbyoP3" style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30, &lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eus-gaap--OtherInventorySupplies_iI_pn3n3_maIFGAWzXq3_zmWhz94fYS86" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 56%; text-align: left; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Purchased
    parts, components and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,182&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 12%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,126&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--InventoryWorkInProcess_iI_pn3n3_maIFGAWzXq3_zdUg9SpQYl1i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;276&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;234&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--InventoryFinishedGoodsAndWorkInProcess_iTI_pn3n3_mtIFGAWzXq3_zFYtMcUyAZK2" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left; padding-bottom: 2.5pt; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Total
    Inventories&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,458&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; font: 10pt Arial, Helvetica, Sans-Serif; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,360&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Arial, Helvetica, Sans-Serif; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">2182000</us-gaap:OtherInventorySupplies>
    <us-gaap:OtherInventorySupplies contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2126000</us-gaap:OtherInventorySupplies>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">276000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">234000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">2458000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:InventoryFinishedGoodsAndWorkInProcess contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">2360000</us-gaap:InventoryFinishedGoodsAndWorkInProcess>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_80C_eus-gaap--IntangibleAssetsDisclosureTextBlock_zNFFoptuVnLf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
6 &#x2013; &lt;span id="xdx_82B_zlvXSdqXm3ll"&gt;OTHER INTANGIBLE ASSETS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets, net of accumulated amortization, in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zueSOH2CKYbb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zhuUt2gjsOL6" style="display: none"&gt;Other Intangible Assets - Net&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 58%; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,357&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,333&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,412&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,388&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220930_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,788&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220930_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,624&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,704&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
























&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of patents and copyrights for the three months ended September 30, 2022 and 2021 amounted to $&lt;span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" title="Amortization of Intangible Assets"&gt;54&lt;/span&gt; and $&lt;span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pn3n3_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_zrGt20WSdSYj" title="Amortization of Intangible Assets"&gt;47&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of non-compete for the three months ended September 30, 2022, and 2021 amounted to $&lt;span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" title="Amortization of Intangible Assets"&gt;13&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Amortization
of customer relationships for the three months ended September 30, 2022 and 2021 amounted to $&lt;span id="xdx_908_eus-gaap--AmortizationOfIntangibleAssets_c20220701__20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt; and $&lt;span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20210701__20210930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" title="Amortization of Intangible Assets"&gt;50&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_88B_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zueSOH2CKYbb" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B1_zhuUt2gjsOL6" style="display: none"&gt;Other Intangible Assets - Net&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 58%; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capitalized
    software development costs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 8%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--SoftwareAndSoftwareDevelopmentCostsMember_pn3n3" style="width: 11%; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;7,005&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Patents
    and copyrights&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,357&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndCopyrightsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,333&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Non-compete&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,150&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Customer
    relationships&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,900&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Gross
    Other intangible assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220930_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,412&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsGross_c20220630_pn3n3" style="text-align: right" title="Gross other intangible assets"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20,388&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Less:
    Accumulated amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220930_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,788&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_c20220630_pn3n3" style="border-bottom: black 1pt solid; text-align: right" title="Less: Accumulated amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Intangible Assets&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220930_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,624&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--IntangibleAssetsNetExcludingGoodwill_c20220630_pn3n3" style="border-bottom: black 2.25pt double; text-align: right" title="Other intangible assets-net"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,704&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-09-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"
      decimals="-3"
      unitRef="USD">7005000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5357000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">5333000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">4150000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="AsOf2022-06-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">3900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">20412000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">20388000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">16788000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">16684000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">3624000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">3704000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">54000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_custom_PatentsAndCopyrightsMember"
      decimals="-3"
      unitRef="USD">47000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012022-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_us-gaap_NoncompeteAgreementsMember"
      decimals="-3"
      unitRef="USD">13000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2022-07-012022-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="From2021-07-012021-09-30_us-gaap_CustomerRelationshipsMember"
      decimals="-3"
      unitRef="USD">50000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_80C_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_ze5VfT95XDQg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
7 &#x2013; &lt;span id="xdx_82F_zmhjWTTOfQKk"&gt;OTHER CURRENT LIABILITIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
current liabilities in the accompanying condensed consolidated balance sheets consist of the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjFwUZswbog9" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span id="xdx_8BF_zD8fGA9u2bTc" style="display: none"&gt;Other Current Liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20220930_zjAkICBldQSf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20220630_zkQqr8E7jfij" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzmgj_zNG0R4wOkjvj" style="vertical-align: bottom"&gt;
    &lt;td style="width: 60%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,037&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,653&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzmgj_zPaB4XnAbnDl" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;269&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzmgj_zYKiOHmy7Bp8" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;250&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;382&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzmgj_z9kzlYBj2Zm3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzmgj_z0Z8gYPzrn2h" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;120&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzmgj_zxOjt87ohX3e" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzmgj_zIBxQtkJnXZ3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzmgj_zpN8ssEOoDYi" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    general &amp;amp; administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,445&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;854&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzmgj_zcpzZhxKAhY7" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,417&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zjFwUZswbog9" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span id="xdx_8BF_zD8fGA9u2bTc" style="display: none"&gt;Other Current Liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_49D_20220930_zjAkICBldQSf" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_497_20220630_zkQqr8E7jfij" style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;September
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;June
    30,&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_pn3n3_maOLCzmgj_zNG0R4wOkjvj" style="vertical-align: bottom"&gt;
    &lt;td style="width: 60%; padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    salaries, commissions and payroll taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,037&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 7%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,653&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_pn3n3_maOLCzmgj_zPaB4XnAbnDl" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Sales
    tax payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;269&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;249&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--StateIncomeTaxesPayable_iI_pn3n3_maOLCzmgj_zYKiOHmy7Bp8" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;State
    income taxes payable&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;250&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;382&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pn3n3_maOLCzmgj_z9kzlYBj2Zm3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Legal
    and other professional fees&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;20&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eus-gaap--AccruedProfessionalFeesCurrentAndNoncurrent_iI_pn3n3_maOLCzmgj_z0Z8gYPzrn2h" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accounting
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;120&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eus-gaap--SelfInsuranceReserve_iI_pn3n3_maOLCzmgj_zxOjt87ohX3e" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Self-funded
    health insurance reserve&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;45&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;79&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eus-gaap--OtherAccruedLiabilitiesNoncurrent_iI_pn3n3_maOLCzmgj_zIBxQtkJnXZ3" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Accrued
    interest and penalty&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;59&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_pn3n3_maOLCzmgj_zpN8ssEOoDYi" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    general &amp;amp; administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,445&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;854&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--OtherLiabilitiesCurrent_iTI_pn3n3_mtOLCzmgj_zcpzZhxKAhY7" style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 9pt; text-indent: -9pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
    Current Liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,201&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,417&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">3037000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">4653000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">269000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <us-gaap:SalesAndExciseTaxPayableCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">249000</us-gaap:SalesAndExciseTaxPayableCurrent>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">250000</FONR:StateIncomeTaxesPayable>
    <FONR:StateIncomeTaxesPayable contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">382000</FONR:StateIncomeTaxesPayable>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">20000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">21000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">76000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">120000</us-gaap:AccruedProfessionalFeesCurrentAndNoncurrent>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">45000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">79000</us-gaap:SelfInsuranceReserve>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">59000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesNoncurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">59000</us-gaap:OtherAccruedLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">1445000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">854000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">5201000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">6417000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_807_eus-gaap--SegmentReportingDisclosureTextBlock_z7CzVQaD6pNc" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
8 - &lt;span id="xdx_829_z8uwefxGfBjc"&gt;SEGMENT AND RELATED INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 20pt; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging
centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies as
disclosed in the Company&#x2019;s 10-K as of June 30, 2022. All inter-segment sales are market-based. The Company evaluates performance
based on income or loss from operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Summarized
financial information concerning the Company's reportable segments is shown in the following table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_znf9HDYDKO" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zX2kODdwcrFb" style="display: none"&gt;Summarized Segment Financial Information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt;
    Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt;
    of Diagnostic &lt;br/&gt;
    Imaging &lt;br/&gt;
    Centers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 49%; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,878&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,313&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(802&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,713&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,911&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,046&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;24&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;939&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,112&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,618&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,730&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;236&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1004"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_c20210701__20210930_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;236&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(490&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,231&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,741&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;67&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,102&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,169&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;121&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,088&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,209&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2022-07-01to2022-09-30">&lt;table cellpadding="0" cellspacing="0" id="xdx_889_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_znf9HDYDKO" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span id="xdx_8B5_zX2kODdwcrFb" style="display: none"&gt;Summarized Segment Financial Information&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Medical
    &lt;br/&gt;
    Equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Management
    &lt;br/&gt;
    of Diagnostic &lt;br/&gt;
    Imaging &lt;br/&gt;
    Centers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-left: 5.4pt"&gt;&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 49%; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,878&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,313&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20220701__20220930_pn3n3" style="width: 11%; text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IntersegmentNetRevenues_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0974"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IntersegmentNetRevenues_c20220701__20220930_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;245&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(802&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;4,713&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperations_c20220701__20220930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;3,911&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;72&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,046&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eus-gaap--DepreciationDepletionAndAmortization_c20220701__20220930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,118&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;24&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;939&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20220701__20220930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;963&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;For
    the three months ended September 30, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Net
    revenues from external customers&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;2,112&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;21,618&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenuesFromExternalCustomers_c20210701__20210930_pn3n3" style="text-align: right" title="Net revenues from external customers"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;23,730&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Inter-segment
    net revenues&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;236&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IntersegmentNetRevenues_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pdn3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1004"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IntersegmentNetRevenues_c20210701__20210930_pn3n3" style="text-align: right" title="Inter-segment net revenues"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;236&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(Loss)
    Income from operations&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;(490&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;)&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;6,231&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eus-gaap--IncomeLossFromContinuingOperations_c20210701__20210930_pn3n3" style="text-align: right" title="(Loss) Income from operations"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;5,741&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;67&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,102&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eus-gaap--DepreciationDepletionAndAmortization_c20210701__20210930_pn3n3" style="text-align: right" title="Depreciation and amortization"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,169&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-left: 5.4pt"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Capital
    expenditures&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--MedicalEquipmentMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;121&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930__us-gaap--StatementOperatingActivitiesSegmentAxis__custom--ManagementOfDiagnosticImagingCentersMember_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,088&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--CapitalExpendituresIncurredButNotYetPaid_c20210701__20210930_pn3n3" style="text-align: right" title="Capital expenditures"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;1,209&lt;/span&gt;&lt;/td&gt;
    &lt;td&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">1878000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">21313000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">23191000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">245000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-802000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">4713000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">3911000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">72000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1046000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1118000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-012022-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">24000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-012022-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">939000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">963000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">2112000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">21618000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:NetRevenuesFromExternalCustomers
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">23730000</FONR:NetRevenuesFromExternalCustomers>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">236000</FONR:IntersegmentNetRevenues>
    <FONR:IntersegmentNetRevenues
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">236000</FONR:IntersegmentNetRevenues>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">-490000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">6231000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">5741000</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">67000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1102000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1169000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012021-09-30_custom_MedicalEquipmentMember"
      decimals="-3"
      unitRef="USD">121000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012021-09-30_custom_ManagementOfDiagnosticImagingCentersMember"
      decimals="-3"
      unitRef="USD">1088000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1209000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_80A_eus-gaap--CashFlowSupplementalDisclosuresTextBlock_zVXAouvO9FY2" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
9 &#x2013; &lt;span id="xdx_829_zIEBWX59BQwg"&gt;SUPPLEMENTAL CASH FLOW INFORMATION&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $&lt;span id="xdx_90D_eus-gaap--InterestPaid_c20220701__20220930_pn3n3" title="Interest paid"&gt;15&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--InterestPaid_c20210701__20210930_pn3n3" title="Interest paid"&gt;189&lt;/span&gt; for interest, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
the three months ended September 30, 2022 and September 30, 2021, the Company paid $&lt;span id="xdx_909_eus-gaap--IncomeTaxesPaid_c20220701__20220930_pn3n3" title="Income taxes paid"&gt;395&lt;/span&gt; and $&lt;span id="xdx_90F_eus-gaap--IncomeTaxesPaid_c20210701__20210930_pn3n3" title="Income taxes paid"&gt;221&lt;/span&gt; for income taxes, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:InterestPaid
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">15000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">189000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">395000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">221000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_806_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zRohQSYjQOa8" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
10 &#x2013; &lt;span id="xdx_828_zxmdJ2Fv0L3"&gt;COMMITMENTS AND CONTINGENCIES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Litigation&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company is subject to legal proceedings and claims arising from the ordinary course of its business, including personal injury, customer
contract and employment claims. In the opinion of management, the aggregate liability, if any, with respect to such actions, will not
have a material adverse effect on the consolidated financial position or results of operations of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;There
were no material changes in litigation from that reported in our Form 10-K for the fiscal year ended June 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Other
Matters&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;On
September 13, 2022, the Company adopted a stock repurchase plan. The plan has no expiration date and cannot determine the number of shares
which will be repurchased. On September 26, 2022, the Board of Directors has approved up to $&lt;span id="xdx_90F_eus-gaap--StockRepurchaseProgramAuthorizedAmount1_iI_pn3n3_dm_c20220926_zW1EScCi9NYa" title="Stock purchase plan"&gt;9&lt;/span&gt; million to be repurchased under the plan
which will be purchased on the publicly traded open market at prevailing prices. During the quarter ended September 30, 2022, the Company
repurchased &lt;span id="xdx_909_eus-gaap--StockRepurchasedDuringPeriodShares_pn3n3_c20220701__20220930_z3hiwXMF6yJ9" title="Number of shares repurchased"&gt;9&lt;/span&gt; shares at a cost of $&lt;span id="xdx_90B_eus-gaap--StockRepurchasedDuringPeriodValue_pn3n3_c20220701__20220930_zYwIyA4Aiac1" title="Number of shares repurchased, value"&gt;122&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum
potential liability for individual claims to $&lt;span id="xdx_903_ecustom--MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance_c20220930_pn3n3" title="Maximum limit for individual claims under stop-loss umbrella policy for health insurances"&gt;150&lt;/span&gt; per person and for a maximum potential claim liability based on member enrollment.
With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance
program liability and related expense. As of September 30, 2022 and June 30, 2022, the Company had approximately $&lt;span id="xdx_907_eus-gaap--SelfInsuranceReserve_c20220930_pn3n3" title="Self-funded health insurance reserve"&gt;45&lt;/span&gt; and $&lt;span id="xdx_908_eus-gaap--SelfInsuranceReserve_c20220630_pn3n3" title="Self-funded health insurance reserve"&gt;79&lt;/span&gt;, respectively,
in reserve for its self-funded health insurance programs. The reserves are included in &#x201c;Other current liabilities&#x201d; in the
condensed consolidated balance sheets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company regularly analyzes its reserves for incurred but not reported claims, and for reported but not paid claims related to its reinsurance
and self-funded insurance programs. The Company believes its reserves are adequate. However, significant judgment is involved in assessing
these reserves such as assessing historical paid claims, average lags between the claims&#x2019; incurred date, reported dates and paid
dates, and the frequency and severity of claims. There may be differences between actual settlement amounts and recorded reserves and
any resulting adjustments are included in expense once a probable amount is known. There were no significant adjustments recorded in
the periods covered by this report.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="AsOf2022-09-26" decimals="-3" unitRef="USD">9000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="Shares">9000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">122000</us-gaap:StockRepurchasedDuringPeriodValue>
    <FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">150000</FONR:MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">45000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="AsOf2022-06-30" decimals="-3" unitRef="USD">79000</us-gaap:SelfInsuranceReserve>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zsNBjRNsWMqg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
11 - &lt;span id="xdx_82F_zR1F6waqtpQl"&gt;INCOME TAXES&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC 740-270, Income Taxes &#x2013; Interim Reporting, the Company is required at the end of each interim period to determine
the best estimate of its annual effective tax rate and apply that rate to year-to-date ordinary income or loss. The resulting tax expense
(or benefit) is adjusted for the tax effect of specific events, if any, required to be discretely recognized in the interim period as
they occur. For the three months ended September 30, 2022 and 2021, the Company recorded income tax expense of $&lt;span id="xdx_907_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20220701__20220930_pn3n3" title="Income tax expense"&gt;1,409&lt;/span&gt; in 2022 as compared
to $&lt;span id="xdx_905_eus-gaap--IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability_c20210701__20210930_pn3n3" title="Income tax expense"&gt;1,416&lt;/span&gt; in 2021. The 2022 provision is comprised of a current income tax component of $&lt;span id="xdx_901_eus-gaap--CurrentFederalTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - current"&gt;263&lt;/span&gt; and a deferred income tax component of $&lt;span id="xdx_905_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20220701__20220930_pn3n3" title="Income tax component - deferred"&gt;1,146&lt;/span&gt;.
Obligations for any liability associated with the current income tax provision, has been reduced, primarily resulting from the benefits
and utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;ASC
topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax
positions taken or expected to be taken in a corporate tax return. For those benefits to be recognized, a tax position must be more-likely-than-not
to be sustained upon examination by taxing authorities. Differences between tax positions taken or expected to be taken in a tax return
and the benefit recognized and measured pursuant to the interpretation are referred to as unrecognized benefits. A liability is recognized
(or amount of net operating loss carryforward or amount of tax refundable is reduced) for an unrecognized tax benefit because it represents
an enterprise&#x2019;s potential future obligation to the taxing authority for a tax position that was not recognized as a result of applying
the provisions of ASC topic 740. The Company believes there are no uncertain tax positions in prior years tax filings and therefore it
has not recorded a liability for unrecognized tax benefits.&lt;/span&gt;&lt;/p&gt;






















&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;In
accordance with ASC topic 740, interest costs related to unrecognized tax benefits are required to be calculated (if applicable) and
would be classified as &#x201c;Interest expense, net&#x201d;. Penalties if incurred would be recognized as a component of &#x201c;Selling,
general and administrative&#x201d; expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company files corporate income tax returns in the United States (federal) and in various state and local jurisdictions. In most instances,
the Company is no longer subject to federal, state and local income tax examinations by tax authorities for years prior to 2017.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company recorded a deferred tax asset of $&lt;span id="xdx_90B_eus-gaap--DeferredTaxAssetsNet_c20220930_pn3n3" title="Deferred tax asset"&gt;11,697&lt;/span&gt; and a deferred tax liability of $&lt;span id="xdx_90B_eus-gaap--DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus_c20220930_pn3n3" title="Deferred tax liability"&gt;216&lt;/span&gt; as of September 30, 2022, primarily relating to
net operating loss carryforwards of approximately $&lt;span id="xdx_90D_eus-gaap--OperatingLossCarryforwards_c20220930_pn3n3" title="Operating Loss Carryforwards"&gt;15,640&lt;/span&gt; available to offset future taxable income through 2032. The net operating losses
begin to expire in 2023 for federal tax and state income tax purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;Future
ownership changes as determined under Section 382 of the Internal Revenue code could further limit the utilization of net operating loss
carryforwards. As of September, 2022, no such changes in ownership have occurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"/&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;b style="font-style: normal; font-weight: normal"&gt;The Inflation Reduction Act (&#x201c;IRA&#x201d;)
was enacted on August 16, 2022. The IRA includes provisions imposing a &lt;span id="xdx_909_ecustom--ExciseTax_dp_c20220701__20220930_zfYObwtVb5Ae" title="Excise tax"&gt;1&lt;/span&gt;% excise tax on share repurchases that occur after December 31,
2022 and introduces a &lt;span id="xdx_903_ecustom--CorporateMinimumTax_dp_c20220701__20220930_zyezC1XKpQc3" title="Corporate minimum tax"&gt;15&lt;/span&gt;% corporate alternative minimum tax (&#x201c;CAMT&#x201d;) on adjusted financial statement income. The CAMT will
be effective for tax years beginning after December 31, 2022. Currently, the Company is expecting the IRA to have a material impact to
the Company&#x2019;s financial statements.&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
ultimate realization of deferred tax assets is dependent on the generation of future taxable income during the periods in which those
temporary differences become deductible or when such net operating losses can be utilized. The Company considers projected future taxable
income, the regulatory environment of the industry and tax planning strategies in making this assessment. At present, the Company believes
that it is more likely than not that the benefits from certain deferred tax asset carryforwards, will not all be fully realized. In recognition
of this inherent risk, a valuation allowance was established for the partial value of the deferred tax asset, which principally related
to research and development tax credits. A valuation allowance will be maintained until sufficient positive evidence exists to support
the reversal of the remainder of the valuation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1409000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
      contextRef="From2021-07-012021-09-30"
      decimals="-3"
      unitRef="USD">1416000</us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">263000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="From2022-07-01to2022-09-30"
      decimals="-3"
      unitRef="USD">1146000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredTaxAssetsNet contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">11697000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">216000</us-gaap:DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus>
    <us-gaap:OperatingLossCarryforwards contextRef="AsOf2022-09-30" decimals="-3" unitRef="USD">15640000</us-gaap:OperatingLossCarryforwards>
    <FONR:ExciseTax
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="Pure">0.01</FONR:ExciseTax>
    <FONR:CorporateMinimumTax
      contextRef="From2022-07-01to2022-09-30"
      decimals="INF"
      unitRef="Pure">0.15</FONR:CorporateMinimumTax>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2022-07-01to2022-09-30">&lt;p id="xdx_806_eus-gaap--SubsequentEventsTextBlock_zEB9mukrQ6bl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;NOTE
12 &#x2013; &lt;span id="xdx_824_zJ0erQNyFbE3"&gt;SUBSEQUENT EVENTS&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;The
Company has evaluated events that occurred subsequent to September 30, 2022 and through the date the condensed consolidated financial
statements were issued.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
October 2022, the Company cancelled &lt;span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_pn3n3_c20221001__20221031__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYmITS4nJtq9" title="Cancelled shares"&gt;16&lt;/span&gt; shares of common stock which were held as treasury stock at September 30, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font: normal 10pt Arial, Helvetica, Sans-Serif"&gt;During
October 2022, the Company amended the revolving credit agreement. The agreement was extended to January 6, 2023. The interest rate on
borrowings is at the current prime rate of &lt;span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pip0_dp_c20230101__20230106__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zns5dnap3emd" title="Interest rate"&gt;6.25&lt;/span&gt;% along with certain financial covenants.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="From2022-10-012022-10-31_us-gaap_SubsequentEventMember"
      decimals="-3"
      unitRef="Shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:DebtInstrumentInterestRateDuringPeriod
      contextRef="From2023-01-012023-01-06_us-gaap_SubsequentEventMember"
      decimals="INF"
      unitRef="Pure">0.0625</us-gaap:DebtInstrumentInterestRateDuringPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>54
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M]OZA!*_ W$8%GXGT/\E"KDX&X0 M^#+:IO*+>/C(=X!\W5\LTJ+\BQYVMMX
MQ=M"BO6NL?)@G6359_1]-Q![#3!S-""[!N2Q#>BN 2V!5IZ5L,XB&4V/<_&
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M!NKWI5"\O+O11_WK?^V8_A]02P,$%     @ NHEN5>_GC!]3!   ^Q8  !@
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MG'0#ACTP,AT+E42/HIWNWX_ZL"B+%).TSD,LR9=7YY"7]US2/']F_%N^H52
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M25Q>[C *<%H V/,M(?2M49Q,UJ?ILW\!4$L#!!0    ( +J);E7_FZ81\P8
M *@>   8    >&PO=V]R:W-H965T<R]S:&5E=#8N>&ULK5G_;]HZ$/]7+#9-
MK31&[(0 78M$H7VKM+5HM&\_FV# ;R%FL>F7]]>_LP,))([;[2%5)0GGXW-W
MOOO<.>=/(OTIEXPI]+R*$WG16"JU/FNU9+1D*RH_B35+X)NY2%=4P6VZ:,EU
MRNC,+%K%+>)Y86M%>=+HGYMGX[1_+C8JY@D;ITAN5BN:OERR6#Q=-'!C]^ [
M7RR5?M#JGZ_I@DV8>EB/4[AKY5IF?,42R46"4C:_: SPV= /]0(C\3=G3W+O
M&FE3ID+\U#<WLXN&IQ&QF$5*JZ#P\<B&+(ZU)L#Q:ZNTD?^F7KA_O=-^;8P'
M8Z94LJ&(?_"96EXTN@TT8W.ZB=5W\?2%;0UJ:WV1B*7YCYZVLEX#11NIQ&J[
M&!"L>))]TN>M(_86@![[ K)=0,H+@IH%_G:!;PS-D!FS1E31_GDJGE"JI4&;
MOC"^,:O!&I[H,$Y4"M]R6*?ZP[O;T=7MY&J$X&IR]_5F-+B'F\D]?'R[NKV?
MH+MK-!Q,OJ#KKW<_)NCDX7;P,+H!F5/41 ^3$3IY?XK>(YZ@^Z782)K,Y'E+
M 3*MOQ5M45QF*$@-"A]]$XE:2G25S-CL<'T++,K-(CNS+HE3X82M/R'?^XB(
M1X@%S_#MR[$#CI][V3?ZVG5>IG*)KB%E))JG8H7NUBREBB<+--#;F"O.Y)G-
M;9E:WZY6I_B97-.(730@AR5+'UFC_^$=#KW/-IN/I.S  T'N@>!/M=]"L>))
M)%;,YH%,;6C4ZIKTV"=AVSMO/>Y;5A5JXR[)A0X0MW/$;5?,7(@'LW\@,Z&8
M*8F4@&H6B23B,4-);HI^KN\B'?EU*AXY;&PT?4$B#SUUA[Y]S- ?2=F!(\/<
MD:%+>W_$0&G$:5:VDQFB*Y$J_J]Y8+,\4Q?L11-CW"V%W"84]NPA[^1(.TZD
M@SU@2-.4YH"FF#<WDB$J)5/6VM:I0O%"7,);%0J#KAUN-X?;=<(=ZVUE^!3H
M',AL!OPUM4/L5B'ZO;)+JT)MKR:)>CG$WBNQG[,TA9V_RPKZC#Z\ZQ*,/^OT
ML$'M60(;A"6H-J%>VXX5>P47>DZT?T';@S)W+J"Y2)B42,S1>#Q&L:#6O>K6
M:,\L9,O0K:)]DYH=#]>8M$?OV,D\)S=)!.V=9*>P.;(KS=5[5<ALZX\Z&M8R
MM-5_I#IT+&V'WB"%-X@[P:-(;!)M[HK->$1C4X]6-(&.59=S-&=,EW/&'^DT
M9B?RU.H24@T5#KQ.:8]:Q3J^5Q/2HI? 3J+NWPK%Y!Y**T3?DB!E?$Z90W %
MS6,GS_=O$L@;)5)@-2NNH.J32AVR">%.327"!9]C)\M!N61KRF>(/<,,),&%
M.O9"+5D*C384*0A_?8W?ZB[%O S<)M2MJ?*XX$_L)M [@]&!S;G\=VI0E52;
M00WZ@E-QQUF!=@4(G>P*T.EA!8HYG?+8-$*.,N1D[M\N0T?2=NB2@K>QF[AW
M90BMZ4MM!E?9N-GI],H[SB;E^S4Q*U@;NVG[[B K]@)D15HEXR9N=\L]NDW,
M][LU6$E!VL1-VL4L%9MM]@I:8N'9'B8EL#:I=M"IP5JP,7'R6_^:)Q0FA3=C
MQ184%:@VH1J2(053$C=3#LW1 VR"&5L+R>V%AU09#G?*-&,1:M>41%)P('%S
M8+9!7W-?E>":N-Q)OB)TB*^@0>*FP=NWCGY6W%7^(V&OW%Y8I# ):@B<%"Q)
M_GCL+9]B:*Z7;SG%($>=98^E[=!!!1L3-QN/-VFTI+I_@-$ P@M!52^FEV"_
M-GRMVTBK#RS<VO/+]=PF!;-O73H7)$S<D^U02&7P4J5/+:P JQ-JDY0['*M0
MS=1-"CXD;C[,LP7F;#TJPM]N9[V2*1;ZZX5^&;1%"A.O#G;!DJ1WK%0I"O]K
MJ>(DYM].E2-I.SST+*C9_X/I-]/_'7KQ%S-RP:Z<BA1T@W>RGCRB:ZY@-LLX
M4DQCOC!',M8MX-N8NK0!;#(U7.X77.Z[N7Q7![0!2O>UF_0% 6E&/ZTP+2R-
M29G+W3_YID[^T)J"[WTGW[M"->)2I7RZ,2$PYYHBB42B4A''>D?S1#%88J\J
MOFT(#OUR7;&*>75US]\[=W]E5BY7EGF>B.[*XMO:@D[E5,\JYG7K-E?1/_C_
MZ[A\M'>48TJ-3AMS<04<]$CCNB+O6T9K4NXL;$+8:]<<K_E%:^&[!_!:I*B)
M+MF")XF.BSYP8RD7,RO^ZH0==#ND7/%M8D$0UFVG@OM]-_>[++C2IPE.[&'E
M+470#7OEAM0FY@=>V?NMO7=^T*<OS*M0B<Q@F;TGRY_FKUL'YB5CZ?DE/AMF
M+TT+-=D[W&\TA:!(J,-S4.E]ZH!7T^RU:':CQ-J\69P*!<."N5PR.F.I%H#O
MYT*HW8W^@?SE=/\_4$L#!!0    ( +J);E4\\26[2 <  "80   8    >&PO
M=V]R:W-H965T<R]S:&5E=#<N>&ULK5AK;QNW$OV^OX)0@38!'+ULIVYB&Y ?
MO7$O;*M6TGN!B_N!VIV5V'#)+<F5HO[ZGB%W);E07!3H%VN72\Z<>9T9^GQM
MW6>_) KB2Z6-O^@M0ZC?#08^7U(E?=_69/"EM*Z2 :]N,?"U(UG$0Y4>C(?#
MMX-**M.[/(]K4W=Y;IN@E:&I$[ZI*NDV5Z3M^J(WZG4+3VJQ#+PPN#ROY8)F
M%#[54X>WP59*H2HR7EDC')47O<GHW=4)[X\;?E&T]GO/@BV96_N97^Z*B]Z0
M 9&F/+ $B9\579/6+ @P?FME]K8J^>#^<R?]QV@[;)E+3]=6_T<587G1.^N)
M@DK9Z/!DUQ^HM>>4Y>56^_A7K-/>TV%/Y(T/MFH/ T&E3/J57UH_[!TX^]J!
M<7M@''$G11'EC0SR\MS9M7"\&]+X(9H:3P.<,AR467#XJG N7-[<SJZ?[J8?
M[QX?Q../XNK3[.[A=C83DX<;<369W<UX=?IT.[M]^#CA7>># +5\>)"W*JZ2
MBO%75!R+>VO"THM;4U#Q_/P <+>8QQWFJ_&+ F=4]\7Q\$B,A^/Q"_*.MSXX
MCO).OR)ODN>V,4&9A9A:K7)%7OQO,O?!(6?^?\C@)._XL#RNHW>^ECE=]% H
MGMR*>I???C-Z.WS_ MJ3+=J3EZ3_,Q%[4<5A QX>/]YF(_'M-V?CT>B]^-LP
MQ WYW*F:BS&SI;AJ/-1ZI$594JS-[*=&;\2(XSHZ/1)A2>+:5K4T&Y0_HM'D
MH7%4Q ^Y=;5U,I  (4FC?I>QR"&7OU;2@%' '8%7"B47QOJ@<J$JN> XY_A$
MS@M/BVZ7;5#?+:9^]A%2'#V3O9;8OX?"BLHZ1E+5F@(!NH+0103%($"<+I[T
M+/X#21V6XGZ'[+HUH<4]J<BI7 II"O'AYKXO[BH(4%)G.<K'J7D3H%5JS9M5
M\$)Z3_AYM5ZJ?"G6!"Q-4%K]CFW*1 B=/7\'P&NV#  B$$<Y(3+0FXU/^F-Q
M<MH_0^GUA^+TY.W1<#@4WP^Q,OX!WZZD5YXC.^6<,2$)AB,SF><ICNSZQLBF
M4&P+["I [^G)H_(*R<NE,M+D,!S>Q@)#]6(I5S"'R AD9"U=LI$%NP*[";0)
MXQ9DX'.-4. +U=%AV^+.:J<@%\'R MTL1LNI:D^?,JG+Q78!ZZ-,]J,R*? Q
MF' /-P0Q&K[Y.6Z;.*26)BRP&Y]HT>@D8_;FOWTQB1BA7V]B3F^RP@IC X3F
MNBFH"VG2\QQ :6W 5@!V]%NCV.KY9L\DL6?2 =O;+/ADHKMG[$V_%^F,O="E
M[T&W(PE-F\O*M&FRJZVC"%T6OZ)-I2B]XD J'Z%AJV%C-"=1XQRO 9EKI/:O
M8\15@9PM,H,<\QX308R*%*543M3[.;0+?NNSHB\>4W5!*':B!:>8,M:P= 0*
M2#V'N.>(&?NCFI/;M@U@1[UP&#KU2F\R90KXA;FHBT@G/"QE@.D;P!#TI09A
M<::V&DOE<]BY(>E8(8/ZJ3'4*3ON<\*(LG'8[/:#?,1S#9:04HG4=F60'2R#
MYTG!X@AG.Z]T 6]9\SLO)L; W\A)%#I8SFPS]]\ K7&"LW3KG/%9<LZ?#,LZ
MP[!_WZYQ7\R@FK)[Z<! 6!DFUEYH.X=68"BH NO"E]>/O]S=O!G]@%AZD<N&
MJQX\.F\T<?6R70T>7, <&3:',Y<WQ:(UT7G0@#GR,R6W9 3OV8I[=R)$5B2+
M%5B>J5G&)L,&@^9Y4(2).1T)K5!7H"/4YL[A3$PJ%CL':$6F(3S5SI8JR#DH
M%@@9S(Y>MU3?S_[5U>'1OM%%9W03":0MYS:M&L!M.] 66GP2I;.56-HJ>8A-
MBIU015/80QV<]CAP>&L,Z8Q3RJ%N= QF<E1DC :D[YD'8MIQ<U?0QH?3N D)
M(*T0I2/F+/DO\GOXO%=SGY1S\&&P&1F,4**-*Z;E7/F.0^$B##[[!QE. SBH
MOJ*)?'$HF6()L%NZ>M+6M_;((H4-VZ$*=Q1>5R8#>B-65C<5];DA;36"BNRN
MQWGV\\(B94SLC^"QJM$(6-F8PB>EC&@J-[@;Y9_1Z%"&Z7:!1W3^2KSB^6@\
M?#^=3N/3Z/WKB/B>F%D<>F&QXG[E!UOIM=RT9+L/C6,=*:]UI3!RI19IMG"V
M6<3&Y,$92SB2S**M#[FR"G\AP*N%4264PI)">=?4>Q-2MDU=/L1&)?>T*<;C
M$8K&*7 P+CTP5>H*$Q3C #._V66V1GEH3AC,%A'5FB*SHLNWN+$?IJ/=E8FO
MT%71-4"CNVCQA.-1$4P%GBF)LW%O?-IZGB<A91I.C1<XYGDZSDDK@/2IFR/W
M5>3W7/JE*)&"J&Q.Q(+F(6-GQ ^QZ9CB"(/6#F]K$%]U8SKO(4QV_MDM2":&
MB@)<2X>>=6CZ'^S=W5![BWA#!45RAT_7N.WJ]A(\27>_W?9T@P8-8[CU4%[B
MZ+#_/2X\+MU*TTNP=;P)SFU H<?')2[RY'@#OG-GZ5Y8P?9? Y=_ %!+ P04
M    " "ZB6Y5XO<&XG *  "H&0  &    'AL+W=O<FMS:&5E=',O<VAE970X
M+GAM;*59;6_;.!+^KE]!>!>+%G <QT[<;),&2-RD9^#R<G5ZQ>%P'VB)MME*
MHDI*=GV__IX94K*<.-G%WI=8;YR79V:>&3+G:V._NZ52I?B9I;G[T%F69?'^
M\-#%2Y5)US.%RO%F;FPF2]S:Q:$KK)()+\K2PT&_/SK,I,X[%^?\[,%>G)NJ
M3'6N'JQP599)N[E2J5E_Z!QUZ@>?]6)9TH/#B_-"+M14E5^*!XN[PT9*HC.5
M.VUR8=7\0^?RZ/W5,7W/'_Q3J[5K70OR9&;,=[J9)!\Z?3)(I2HN28+$STJ-
M59J2()CQ(\CL-"II8?NZEG[#OL.7F71J;-*O.BF7'SJG'9&HN:S2\K-9_TT%
M?TY(7FQ2QW_%VG][/.R(N'*ER<)B6)#IW/_*GP&'UH+3_@L+!F'!@.WVBMC*
MC[*4%^?6K(6EKR&-+MA57@WC=$Y!F986;S76E1?3+[>WEY__)>YOQ'3RZ6YR
M,QE?WCV*R_'X_LO=X^3NDWBX__MD/+F>GA^6T$>K#N,@^\K+'KP@>RAN35XN
MG;C.$Y7LKC^$G8VQ@]K8J\&K J>JZ(EAORL&_<'@%7G#QODARSMY0=YE')LJ
M+W6^$ \FU;%63OS[<N9*BV3YSSZ'O;SA?GE40.]=(6/UH8,*<<JN5.?BMU^.
M1OVS5ZP];JP]?DWZ_QFJ5V7OM_SN_O$Z&H@#\><UBP>K\U@7J7*1F8NQR1V
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M22I=5P465Z,*G+MA)E6:P,B:#1'@Y68WJ#JS)E#%6I&Y^B!>66C+OYT;!L!
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M(H,[T >FV.0NPYWH<$_+C54=U;<5F6?@64.")8[Q3&!Z0A)DI4@A1=6L$Q9
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MZ>?&\G8XAW0+*]^[5A$A ]W:'H8W<C5G3Y.#UFBPCQ5,N%I"*D+!LD?!T'@
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M$%=%&L89RTFYCAY/#>3B^>6O'W[[\DE]N_CWI^O3681&7I_EG?3[)+U\1OI
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MTUYE;I#!/0#.[ED7LR0=L 7]#W:T#23H3@/36J17]ZR-,:9;G.RADP"_CP8
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MG[Y7I!MT</E&L'(QNEHN-Z1A*V_ \])A9NIN^(#AH]'Y_P!02P,$%     @
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MX&3<$]9_4/(WZ /X(\[<5)7)^3)5$MQ. _!^85#OP@TI:+_JG?T/4$L#!!0
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M?==7#+3%H@7<2-;%3K*V 3M-L2ZRNX&=;1^*/M#2V"*6(K4DM4[^OD-*5E/
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MW(,"5Z1A^E9L/V.GY]3RY8(I]X5M%QMXD#=*BZH#FPPJRMN5/'9UV ,8GL.
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MN'_7_W,T'MT]9L,OCY]'$W0]&E6=T1_HED7/Z!%XB/J>QY:12- $//!?Z#0
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MJJ]1%"9!GV\X5R^!&>WF8@[_ %!+ P04    " "ZB6Y5H__%>-<#   ^$0
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M=,W-3&XOH/+C!*:2:_=/ME5MX)%TK8W,*S JR)DHK_2IZD,#@#SM@+ "A/N
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M0*TD7FX8RX%D>;%)FS"IMGS%Z4)ML@G7#ZC[,\;DVT#O^ZIM>_0'4$L#!!0
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MP-=@=3Y_JC2<;X=$E@26DUS+)-<,>OV(Y!M"B82S.U4I/AI2B>F2S$- 72%
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M"&#,F4HE#%B"R3[>U69J1_[64<]_EW"&Q2D$WB?P/=]OT-/_=WCK'3E!7>#
M\K4/\:V*(D-][A7)H$]D"D-]<V!0QB1\[\ZE$OHT_VBJ7<D=-'.;&WXE"Q)C
MQ]%76*)8HQ-]_- Z][XV&?]/9'ME.*O+</8>>S1B"C6K@H+0I,EI"3^W<--Z
MUE&K';KK7?T-*1>7=<Z>K'8MJ_T763'/$11Y07E06OO-OL'E:VUO<WQS?/:T
MN3O7-$>QM-U+0LQ73)7GNX[6#;)K^\*K>$\WSK+/_:$IN^Z8B"5E$C)<:$KO
M](O6)<I.5DX4+VPSF'.E6XL=IKKYHS )>GW!N=I.S ;U[R3Z#5!+ P04
M" "ZB6Y5I?Q4;V8#  "-"P  &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX
M;6RMEF]OVS80QK_*02N&%D@B6?[;S!:0V-F6 G:#.MU>#'M!2[1%A!15DK+3
M;[^C)*M6+ OUX#>V*/%YCO<C=;KQ3JH7'5-JX%7P1$^<V)CTUG5U&%-!](U,
M:8)/UE()8G"H-JY.%251+A+<]3UOX K"$B<8Y_>>5#"6F>$LH4\*="8$4=_O
M*9>[B=-Q]C>^L$UL[ TW&*=D0Y?4?$V?%([<RB5B@B::R00474^<N\[M;&3G
MYQ/^8G2G#Z[!9K*2\L4.'J.)X]D%44Y#8QT(_FWIE')NC7 9WTI/IPIIA8?7
M>_??\]PQEQ71="KYWRPR\<09.1#1-<FX^2)W?](RG[[U"R77^2_LRKF> V&F
MC12E&%<@6%+\D]>2PX$ ?9H%?BGPWPIZ)P3=4M#]64&O%/1R,D4J.8<9,208
M*[D#96>CF[W(8>9J3)\E=MN71N%3ACH33#_/YX_/\X?%\Q+N%C.8?EX\/R[^
M>%A,'Q^6\'Y&#6%<PX(H1>P.?8!K^+J<P?MW'T#'1%$-+('G6&::))&^@G>U
M\=@UN$@;R@W+!=T7"_)/+*@+<YF86,-#$M&HKG<QN2I#?Y_AO=]JN*3I#72]
M*_ ]WV]8S_0GY/[@I'S6+O^4):>BU[+I5OO5S?WZI_9+"L$,OG=& P*&*<)B
MR88F(<.MF#$=<JDS1>&?NY4V"E^K?YOVH C2;0YB2\VM3DE()P[6$DW5ECK!
MK[]T!MYO30 O:3:[D%D-;J^"VVMS#Y9&AB^09BJ,L91 RDG2!*_5Y%QXA=D@
M-[,U>AM\]#QO[&X/H5PH8@U*OX+2;X6RR,2**I#K_?NNZ)Y0U$2G<.L=)E3/
M9MH:[]SS<B&S&II!A6;PO]%<P9;PC#81&AQM><?6AAJCUL#G,KJ068W1L&(T
M;&4T)Z],9 (XP[H%V*?@]R%B6Q9EA$/("1,:,BSUV(H8F5YC]<*Q6"GL! BD
MDK/P>ZZ**>$F1C%6-Y*$M/'3,CPZ>YW^FW=IVKK<<\E>R*Q&=E21';57*\K7
MUVO++CJB V6X)DBCH^/7Z[]AU!KX7$;'\88_*D*1N7O0P BJ-GDCJ"&466**
M7J:Z6_6:=WF+Y?Z87C2J<Z(VB $X7:/4NQEB@5!%\U<,\)3E[=!*&FRN\DND
MAP?03L#G:RG-?F #5!UX\!]02P,$%     @ NHEN53$$\2$_ P  1 L  !D
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M.@,  $X3   -    >&PO<W1Y;&5S+GAM;.U8;6_:,!#^*Y&[3JTT-4#6E*R
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M%     @ NHEN59>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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MR2&W^([E0JC&Q"B/?A\R02KQG;MDSO"O6_,G8I-C!F"0/GS'_@ E-QC3^)!
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M2P$"% ,4    " "ZB6Y5,5'F$NX    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " "ZB6Y5F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( +J);E6L27^6.08  'DC   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " "ZB6Y54&Z6ND<)  #F,0
M&               @(%\#@  >&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L!
M A0#%     @ NHEN5>_GC!]3!   ^Q8  !@              ("!^1<  'AL
M+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( +J);E6@R$VLA <
M .<D   8              " @8(<  !X;"]W;W)K<VAE971S+W-H965T-"YX
M;6Q02P$"% ,4    " "ZB6Y5JKS)^9L$  !9%P  &               @($\
M)   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ NHEN5?^;
MIA'S!@  J!X  !@              ("!#2D  'AL+W=O<FMS:&5E=',O<VAE
M970V+GAM;%!+ 0(4 Q0    ( +J);E4\\26[2 <  "80   8
M  " @38P  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4    " "Z
MB6Y5XO<&XG *  "H&0  &               @(&T-P  >&PO=V]R:W-H965T
M<R]S:&5E=#@N>&UL4$L! A0#%     @ NHEN53&?,J:O"0  O1<  !@
M         ("!6D(  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0
M   ( +J);E5CIY"M408  .L-   9              " @3],  !X;"]W;W)K
M<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ NHEN56_[Z_"? @  K 4
M !D              ("!QU(  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q0
M2P$"% ,4    " "ZB6Y51MEDIW8#   :"   &0              @(&=50
M>&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( +J);E755NTI
M2P,  /$&   9              " @4I9  !X;"]W;W)K<VAE971S+W-H965T
M,3,N>&UL4$L! A0#%     @ NHEN56XY4CA'!   N0D  !D
M ("!S%P  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4    " "Z
MB6Y5E>&P+FP"  #*!0  &0              @(%*80  >&PO=V]R:W-H965T
M<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( +J);E4+=ITH=04  *$+   9
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M970R,"YX;6Q02P$"% ,4    " "ZB6Y5"&_<B$($  #E"@  &0
M    @(%1@P  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    (
M +J);E51ROX[M (  .X%   9              " @<J'  !X;"]W;W)K<VAE
M971S+W-H965T,C(N>&UL4$L! A0#%     @ NHEN53V1 )EG @  -P4  !D
M             ("!M8H  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q02P$"
M% ,4    " "ZB6Y5_F(.1^,"   I!@  &0              @(%3C0  >&PO
M=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( +J);E4&-UH4"P,
M &,&   9              " @6V0  !X;"]W;W)K<VAE971S+W-H965T,C4N
M>&UL4$L! A0#%     @ NHEN5=43Y7X] P  <P<  !D              ("!
MKY,  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " "ZB6Y5
M\*[GUG\#  #7"P  &0              @($CEP  >&PO=V]R:W-H965T<R]S
M:&5E=#(W+GAM;%!+ 0(4 Q0    ( +J);E5T:C#:]0,  "@0   9
M      " @=F:  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#%
M  @ NHEN51M=OC66 @  _@4  !D              ("!!9\  'AL+W=O<FMS
M:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "ZB6Y5"@C@9E,$  "0%
M&0              @('2H0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+
M 0(4 Q0    ( +J);E5)24I";0(  *0%   9              " @5RF  !X
M;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ NHEN5:/_Q7C7
M P  /A$  !D              ("! *D  'AL+W=O<FMS:&5E=',O<VAE970S
M,BYX;6Q02P$"% ,4    " "ZB6Y55;R_[^D"   1!P  &0
M@($.K0  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( +J)
M;E49^)/V.P,  ,(+   9              " @2ZP  !X;"]W;W)K<VAE971S
M+W-H965T,S0N>&UL4$L! A0#%     @ NHEN53!7R:E] @  4@8  !D
M         ("!H+,  'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"% ,4
M    " "ZB6Y5Z]_L:M,#  !^$0  &0              @(%4M@  >&PO=V]R
M:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( +J);E5)U"RK) ,  !T,
M   9              " @5ZZ  !X;"]W;W)K<VAE971S+W-H965T,S<N>&UL
M4$L! A0#%     @ NHEN5>K9XE)X P  ? H  !D              ("!N;T
M 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4    " "ZB6Y5H0&5
M2A\$  !J$   &0              @(%HP0  >&PO=V]R:W-H965T<R]S:&5E
M=#,Y+GAM;%!+ 0(4 Q0    ( +J);E4+;_"KE (  %H&   9
M  " @;[%  !X;"]W;W)K<VAE971S+W-H965T-# N>&UL4$L! A0#%     @
MNHEN5:7\5&]F P  C0L  !D              ("!B<@  'AL+W=O<FMS:&5E
M=',O<VAE970T,2YX;6Q02P$"% ,4    " "ZB6Y5,03Q(3\#  !$"P  &0
M            @($FS   >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4
M Q0    ( +J);E4^[A),A (  )D&   9              " @9S/  !X;"]W
M;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ NHEN56!W/S,Z P
M3A,   T              ( !5](  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M" "ZB6Y5EXJ[',     3 @  "P              @ &\U0  7W)E;',O+G)E
M;'-02P$"% ,4    " "ZB6Y57-4Q+_0#   Q'0  #P              @ &E
MU@  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ NHEN5>Y)W?^> 0  "!H
M !H              ( !QMH  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ NHEN5:C*A]FK 0  01H  !,              ( !G-P
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     #, ,P#<#0  >-X

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>95</ContextCount>
  <ElementCount>238</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>27</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfIncome</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - OPERATING &amp; FINANCING LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - INVENTORIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories</Role>
      <ShortName>INVENTORIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets</Role>
      <ShortName>OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - OTHER CURRENT LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities</Role>
      <ShortName>OTHER CURRENT LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - SEGMENT AND RELATED INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformation</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingencies</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxes</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEvents</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - OPERATING &amp; FINANCING LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeasesTables</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OperatingFinancingLeases</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - INVENTORIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/InventoriesTables</Role>
      <ShortName>INVENTORIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/Inventories</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsTables</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilitiesTables</Role>
      <ShortName>OTHER CURRENT LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherCurrentLiabilities</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformationTables</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://fonar.com/role/SegmentAndRelatedInformation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative</Role>
      <ShortName>DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative</Role>
      <ShortName>ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails</Role>
      <ShortName>OPERATING &amp; FINANCING LEASES - Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - INVENTORIES - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/Inventories-InventoriesDetails</Role>
      <ShortName>INVENTORIES - Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails</Role>
      <ShortName>OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative</Role>
      <ShortName>OTHER INTANGIBLE ASSETS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/OtherIntangibleAssetsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details</Role>
      <ShortName>OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details</Role>
      <ShortName>SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SupplementalCashFlowInformation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/CommitmentsAndContingencies</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - INCOME TAXES (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/IncomeTaxes</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="fonar_10q.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://fonar.com/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://fonar.com/role/SubsequentEvents</ParentRole>
      <Position>43</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0549-DocumentTransitionReport-false] In submission type 10-Q, DocumentTransitionReport value should have false in the Required Context. fonar_10q.htm </Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="fonar_10q.htm">fonar_10q.htm</File>
    <File>fonar_exhibit-31.htm</File>
    <File>fonar_exhibit-32.htm</File>
    <File>fonr-20220930.xsd</File>
    <File>fonr-20220930_cal.xml</File>
    <File>fonr-20220930_def.xml</File>
    <File>fonr-20220930_lab.xml</File>
    <File>fonr-20220930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>fonar-logo.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="408">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>60
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fonar_10q.htm": {
   "axisCustom": 0,
   "axisStandard": 8,
   "contextCount": 95,
   "dts": {
    "calculationLink": {
     "local": [
      "fonr-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fonr-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "fonar_10q.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fonr-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fonr-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "fonr-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 348,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 35,
    "http://fonar.com/20220930": 14,
    "http://xbrl.sec.gov/dei/2022": 7,
    "total": 56
   },
   "keyCustom": 52,
   "keyStandard": 186,
   "memberCustom": 12,
   "memberStandard": 14,
   "nsprefix": "FONR",
   "nsuri": "http://fonar.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://fonar.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - OPERATING & FINANCING LEASES",
     "role": "http://fonar.com/role/OperatingFinancingLeases",
     "shortName": "OPERATING & FINANCING LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - INVENTORIES",
     "role": "http://fonar.com/role/Inventories",
     "shortName": "INVENTORIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - OTHER INTANGIBLE ASSETS",
     "role": "http://fonar.com/role/OtherIntangibleAssets",
     "shortName": "OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - OTHER CURRENT LIABILITIES",
     "role": "http://fonar.com/role/OtherCurrentLiabilities",
     "shortName": "OTHER CURRENT LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - SEGMENT AND RELATED INFORMATION",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation",
     "shortName": "SEGMENT AND RELATED INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION",
     "role": "http://fonar.com/role/SupplementalCashFlowInformation",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://fonar.com/role/CommitmentsAndContingencies",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - INCOME TAXES",
     "role": "http://fonar.com/role/IncomeTaxes",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://fonar.com/role/SubsequentEvents",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - OPERATING & FINANCING LEASES (Tables)",
     "role": "http://fonar.com/role/OperatingFinancingLeasesTables",
     "shortName": "OPERATING & FINANCING LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - INVENTORIES (Tables)",
     "role": "http://fonar.com/role/InventoriesTables",
     "shortName": "INVENTORIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://fonar.com/role/OtherIntangibleAssetsTables",
     "shortName": "OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - OTHER CURRENT LIABILITIES (Tables)",
     "role": "http://fonar.com/role/OtherCurrentLiabilitiesTables",
     "shortName": "OTHER CURRENT LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - SEGMENT AND RELATED INFORMATION (Tables)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformationTables",
     "shortName": "SEGMENT AND RELATED INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2015-07-01_custom_ControllingInterestMember",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:HmcaOwnershipSizeOfImperialManagementServicesPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Earnings Per Share - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "INF",
      "lang": null,
      "name": "FONR:EarningsPerShareBasics",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USDPShares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "span",
       "p",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncrementalCommonSharesAttributableToConversionOfPreferredStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "role": "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:TreasuryStockShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:AccountsReceivableServiceAndRepairFees",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "FONR:AccountsReceivableNetRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE - Long Term Accounts Receivable (Details 1)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:TotalFacilitiesOwnedOrManagedTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ContractReceivableDueOneToTwoYears",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:ScheduleOfPatientFeeRevenueTableTextBlock",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "FONR:PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30_custom_OperatingLeasePaymentsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "role": "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
     "shortName": "OPERATING & FINANCING LEASES - Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "FONR:LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30_custom_OperatingLeasePaymentsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - INVENTORIES - Inventories (Details)",
     "role": "http://fonar.com/role/Inventories-InventoriesDetails",
     "shortName": "INVENTORIES - Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "us-gaap:InventoryDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OtherInventorySupplies",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "role": "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
     "shortName": "OTHER INTANGIBLE ASSETS - Other Intagible Assets Net of Amoritization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - OTHER INTANGIBLE ASSETS (Details Narrative)",
     "role": "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative",
     "shortName": "OTHER INTANGIBLE ASSETS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IntangibleAssetsDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-012022-09-30_custom_PatentsAndCopyrightsMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "role": "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details",
     "shortName": "OTHER CURRENT LIABILITIES - Other Current Liabilities - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "role": "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
     "shortName": "SEGMENT AND RELATED INFORMATION - Sumarized Segments - (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "us-gaap:SegmentReportingDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:NetRevenuesFromExternalCustomers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "FONR:PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "role": "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative",
     "shortName": "SUPPLEMENTAL CASH FLOW INFORMATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:InterestPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-26",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "role": "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2022-09-26",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - INCOME TAXES (Details Narrative)",
     "role": "http://fonar.com/role/IncomeTaxesDetailsNarrative",
     "shortName": "INCOME TAXES (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-10-012022-10-31_us-gaap_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://fonar.com/role/SubsequentEventsDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-10-012022-10-31_us-gaap_SubsequentEventMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "role": "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:OtherDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "USD",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "role": "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation",
     "shortName": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://fonar.com/role/SummaryOfSignificantAccountingPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "role": "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable",
     "shortName": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "fonar_10q.htm",
      "contextRef": "From2022-07-01to2022-09-30",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 27,
   "tag": {
    "FONR_AccountReceivableRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable - related party"
       }
      }
     },
     "localname": "AccountReceivableRelatedParties",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetLongTerm": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 long term"
       }
      }
     },
     "localname": "AccountsReceivableNetLongTerm",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableNetRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts receivable from service and repair fees of Related Party MRI scanner customers; net of allowances for doubtful accounts",
        "label": "Accounts receivable - Related party"
       }
      }
     },
     "localname": "AccountsReceivableNetRelatedParty",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccountsReceivableServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts receivable \u2013 net",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableServiceAndRepairFees",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_AccumulatedDeficitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated Deficit [Member]"
       }
      }
     },
     "localname": "AccumulatedDeficitMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ClassANonVotingPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Non Voting Preferred Stock Member",
        "label": "Class A Non Voting Preferred Stock [Member]"
       }
      }
     },
     "localname": "ClassANonVotingPreferredStockMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_CommercialInsuranceManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance Managed Care Member",
        "label": "Commercial Insurance / Managed Care"
       }
      }
     },
     "localname": "CommercialInsuranceManagedCareMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_Commonstockvalue1": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock $.0001 par value; 8,500 shares authorized at September 30, 2022 and June 30, 2022, 6,566 issued at September 30, 2022 and June 30, 2022, 6,545 and 6,554 outstanding at September 30, 2022 and June 30, 2022, respectively"
       }
      }
     },
     "localname": "Commonstockvalue1",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_Commonstockvalue2": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Common Stock (10 votes per share) $.0001 par value; 227 shares authorized at September 30, 2022 and June 30, 2022; .146 issued and outstanding at September 30, 2022 and June 30, 2022"
       }
      }
     },
     "localname": "Commonstockvalue2",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_Commonstockvalue3": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Class C Common Stock (25 votes per share) $.0001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, 383 issued and outstanding at September 30, 2022 and June 30, 2022"
       }
      }
     },
     "localname": "Commonstockvalue3",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ControllingInterestMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Controlling Interest [Member]"
       }
      }
     },
     "localname": "ControllingInterestMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ConvertibleClassCStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The shares of convertible class C stock.",
        "label": "Convertible Class C Stock"
       }
      }
     },
     "localname": "ConvertibleClassCStock",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_CorporateMinimumTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate minimum tax"
       }
      }
     },
     "localname": "CorporateMinimumTax",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFees",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to management and other fees \u2013 related medical practices"
       }
      }
     },
     "localname": "CostsRelatedToManagementAndOtherFeesRelatedMedicalPractices",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToProductSales": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to product sales"
       }
      }
     },
     "localname": "CostsRelatedToProductSales",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFees",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CostsRelatedToServiceAndRepairFeesRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs related to service and repair fees - related parties"
       }
      }
     },
     "localname": "CostsRelatedToServiceAndRepairFeesRelatedParties",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_CustomerDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer deposits"
       }
      }
     },
     "localname": "CustomerDeposits",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DirectPurchaseOfNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Direct purchase of Noncontrolling Interests"
       }
      }
     },
     "localname": "DirectPurchaseOfNoncontrollingInterests",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_DisclosureOperatingFinancingLeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Financing Leases"
       }
      }
     },
     "localname": "DisclosureOperatingFinancingLeasesAbstract",
     "nsuri": "http://fonar.com/20220930",
     "xbrltype": "stringItemType"
    },
    "FONR_EarningPerShareBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earning per share basic and diluted"
       }
      }
     },
     "localname": "EarningPerShareBasicAndDiluted",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "FONR_EarningsPerShareBasics": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic income per common share"
       }
      }
     },
     "localname": "EarningsPerShareBasics",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "perShareItemType"
    },
    "FONR_ExciseTax": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Excise tax"
       }
      }
     },
     "localname": "ExciseTax",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_FinancingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing Lease Payments [Member]"
       }
      }
     },
     "localname": "FinancingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_GainOnForgivenessOfPppLoan": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "GainOnForgivenessOfPppLoan",
        "negatedLabel": "Gain on forgiveness of PPP loan"
       }
      }
     },
     "localname": "GainOnForgivenessOfPppLoan",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_HmcaOwnershipSizeOfImperialManagementServicesPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest rate.",
        "label": "The ownership interest of Imperial Management Services after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "HmcaOwnershipSizeOfImperialManagementServicesPercent",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_IncreaseDecreaseInCustomerAdvance": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInCustomerAdvance",
        "verboseLabel": "Customer deposits"
       }
      }
     },
     "localname": "IncreaseDecreaseInCustomerAdvance",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IncreaseDecreaseInFinancingLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInFinancingLiabilities",
        "negatedLabel": "Financing lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInFinancingLiabilities",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_InterestExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "InterestExpenses",
        "negatedLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenses",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_IntersegmentNetRevenues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of intersegment net revenues.",
        "label": "Inter-segment net revenues"
       }
      }
     },
     "localname": "IntersegmentNetRevenues",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_InvestorsOwnershipInterest": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investors ownership interest percentage"
       }
      }
     },
     "localname": "InvestorsOwnershipInterest",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_LesseeOperatingLeasesLiabilityMaturityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee Operating Leases Liability Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeasesLiabilityMaturityTableTextBlock",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ManagementAndOtherFees": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFees",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesNet",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFeesRelatedMedicalPracticesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees - related medical practices \u2013 net"
       }
      }
     },
     "localname": "ManagementAndOtherFeesRelatedMedicalPracticesNet",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementAndOtherFees_NonRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management and other fees receivable from MRI Centers owned by non-related parties - net of allowances for doubtful accounts.",
        "label": "Management and other fees receivable"
       }
      }
     },
     "localname": "ManagementAndOtherFees_NonRelatedParties",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ManagementOfDiagnosticImagingCentersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management of Diagnostic Imaging Centers - Member - Custom element",
        "label": "Management Of Diagnostic Imaging Centers"
       }
      }
     },
     "localname": "ManagementOfDiagnosticImagingCentersMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Management and other fees receivable \u2013 related medical practices \u2013 net",
        "verboseLabel": "Management and other fees receivable from related medical practices (\"PC&amp;#39;s\")"
       }
      }
     },
     "localname": "ManagmentAndOtherFeesReceivableRelatedMedicalPracticesNetAllowances",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Company maintains a self-funded health insurance program with a stop-loss umbrella policy with a third party insurer to limit the maximum potential liability for individual claims to $100,000 per person and for a maximum potential claim liability based on member enrollment. With respect to this program, the Company considers historical and projected medical utilization data when estimating its health insurance program liability and related expense.",
        "label": "Maximum limit for individual claims under stop-loss umbrella policy for health insurances"
       }
      }
     },
     "localname": "MaximumLimitForIndividualClaimsUnderStoplossUmbrellaPolicyForHealthInsurance",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical equipment - Member - Custom element",
        "label": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_MedicalReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical receivable \u2013 net",
        "verboseLabel": "Medical Receivables"
       }
      }
     },
     "localname": "MedicalReceivable",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails",
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_MedicareMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Medicaid",
        "label": "Medicare/Medicaid"
       }
      }
     },
     "localname": "MedicareMedicaidMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_NetRevenuesFromExternalCustomers": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances.",
        "label": "Net revenues from external customers"
       }
      }
     },
     "localname": "NetRevenuesFromExternalCustomers",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_OperatingLeasePaymentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease Payments [Member]"
       }
      }
     },
     "localname": "OperatingLeasePaymentsMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OtherRevenueSourceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue Source",
        "label": "Other"
       }
      }
     },
     "localname": "OtherRevenueSourceMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership interest rate.",
        "label": "The ownership interest of Health Management Corporation of America after reorganization of newly expanded HDM"
       }
      }
     },
     "localname": "OwnershipInterestAfterReorganizationForHealthManagementCorporationOfAmericaOfNewlyExpandedHdmPercent",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_OwnershipInterestOfOriginalInvestorsOfHdm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The ownership interest of the original investors of HDM"
       }
      }
     },
     "localname": "OwnershipInterestOfOriginalInvestorsOfHdm",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PatentsAndCopyrightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents and copyrights - Member - Custom elements",
        "label": "Patents and copyrights"
       }
      }
     },
     "localname": "PatentsAndCopyrightsMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Patient fee revenue, net of contractual allowances and discounts.",
        "label": "Patient fee revenue, net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscount",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PatientFeeRevenueNetOfContractualAllowancesAndDiscounts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Patient fee revenue \u2013 net of contractual allowances and discounts"
       }
      }
     },
     "localname": "PatientFeeRevenueNetOfContractualAllowancesAndDiscounts",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PercentageOfConsolidatedNetRevenueFromManagementFees": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of consolidated net revenue from management fees.",
        "label": "Percentage of consolidated net revenue from management fees charged to related party medical practices"
       }
      }
     },
     "localname": "PercentageOfConsolidatedNetRevenueFromManagementFees",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of PCs net revenue derived from nofault and personal injury protection claims.",
        "label": "Percentage of net revenue derived from no-fault and personal injury protection claim"
       }
      }
     },
     "localname": "PercentageOfPcsNetRevenueDerivedFromNofaultAndPersonalInjuryProtectionClaims",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "FONR_PresentValueDiscount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount.",
        "label": "Present value discount"
       }
      }
     },
     "localname": "PresentValueDiscount",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_PresentValueDiscountFinancingLease": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value discount financing lease.",
        "label": "PresentValueDiscountFinancingLease",
        "verboseLabel": "Present value discount"
       }
      }
     },
     "localname": "PresentValueDiscountFinancingLease",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProductSalesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Product sales \u2013 net"
       }
      }
     },
     "localname": "ProductSalesNet",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ProvisionForBadDebts": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision for bad debts"
       }
      }
     },
     "localname": "ProvisionForBadDebts",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ScheduleOfPatientFeeRevenueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule Of Patient Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPatientFeeRevenueTableTextBlock",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_ServiceAndRepairFeesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesNet",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_ServiceAndRepairFeesRelatedPartiesNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Service and repair fees - related parties \u2013 net"
       }
      }
     },
     "localname": "ServiceAndRepairFeesRelatedPartiesNet",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_StateIncomeTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "the value of state income taxes payable.",
        "label": "State income taxes payable"
       }
      }
     },
     "localname": "StateIncomeTaxesPayable",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_TotalFacilitiesOwnedOrManagedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Facilities Owned Or Managed"
       }
      }
     },
     "localname": "TotalFacilitiesOwnedOrManagedTableTextBlock",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "FONR_UnearnedRevenueOnServiceContractsRelatedParties": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unearned revenue on service contracts \u2013 related party"
       }
      }
     },
     "localname": "UnearnedRevenueOnServiceContractsRelatedParties",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "FONR_WeightedAverageNumberOfDilutedSharesOutstandings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Diluted Denominator: Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstandings",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    },
    "FONR_WorkersCompensationPersonalInjuryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers Compensation Personal Injury.",
        "label": "Workers Compensation/Personal Injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjuryMember",
     "nsuri": "http://fonar.com/20220930",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r336",
      "r338",
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "OTHER CURRENT LIABILITIES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r35",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accounts payable to related parties, due after one year or beyond the normal operating cycle, if longer.",
        "label": "Due to related medical practices"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableBilledForLongTermContractsOrPrograms": {
     "auth_ref": [
      "r284"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount billed to customers under long-term contracts or programs but not paid. Excludes amounts due that have been withheld because of retainage provisions in a contract.",
        "label": "Total"
       }
      }
     },
     "localname": "AccountsReceivableBilledForLongTermContractsOrPrograms",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Legal and other professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrentAndNoncurrent": {
     "auth_ref": [
      "r297",
      "r311"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.",
        "label": "Accounting fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r6",
      "r37"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued salaries, commissions and payroll taxes"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r22",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Paid-in capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r214",
      "r215",
      "r216",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r70",
      "r167",
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r14",
      "r84",
      "r130",
      "r135",
      "r142",
      "r156",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r248",
      "r254",
      "r262",
      "r277",
      "r279",
      "r292",
      "r306"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total Assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r4",
      "r34",
      "r84",
      "r156",
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r248",
      "r254",
      "r262",
      "r277",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total Current Assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r3",
      "r88",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "DESCRIPTION OF BUSINESS AND BASIS OF PRESENTATION"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r74",
      "r75",
      "r76"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r66",
      "r72",
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash Equivalents - End of Period",
        "periodStartLabel": "Cash and Cash Equivalents - Beginning of Period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": {
     "auth_ref": [
      "r66",
      "r263"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect",
        "totalLabel": "Net Decrease in Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r78"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "SUPPLEMENTAL CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r83",
      "r84",
      "r104",
      "r105",
      "r108",
      "r110",
      "r112",
      "r119",
      "r120",
      "r121",
      "r156",
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r262",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r180",
      "r181",
      "r182",
      "r183",
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than provided to Class A or B shares, representing ownership interest in a corporation.",
        "label": "Common Class C [Member]"
       }
      }
     },
     "localname": "CommonClassCMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r89",
      "r90",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r21",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r21",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Class A non-voting preferred stock $.0001 par value; 453 shares authorized at September 30, 2022 and June 30, 2022, 313 issued and outstanding at September 30, 2022 and June 30, 2022"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r80",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractReceivableDueOneToTwoYears": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2024"
       }
      }
     },
     "localname": "ContractReceivableDueOneToTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueThreeToFourYears": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2026"
       }
      }
     },
     "localname": "ContractReceivableDueThreeToFourYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractReceivableDueTwoToThreeYears": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of right to consideration in exchange for good or service transferred to customer under long-term contract or program when right to consideration is unconditional, excluding amount withheld under retainage provision in contract, to be collected in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2025"
       }
      }
     },
     "localname": "ContractReceivableDueTwoToThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails1"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total Costs and Expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTS AND EXPENSES"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r85",
      "r226",
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Income tax component - current"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentInterestRateDuringPeriod": {
     "auth_ref": [
      "r39",
      "r196",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average effective interest rate during the reporting period.",
        "label": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r85",
      "r227",
      "r233"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Income tax component - deferred"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r70",
      "r85",
      "r227",
      "r233",
      "r234",
      "r235"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred income tax \u2013 net"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences, after deferred tax asset, and other liabilities expected to be paid after one year or operating cycle, if longer.",
        "label": "Deferred income tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndOtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "verboseLabel": "Unearned revenue on service contracts"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsDeferredIncome": {
     "auth_ref": [
      "r224",
      "r225"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income.",
        "label": "Deferred income tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred tax asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus": {
     "auth_ref": [
      "r321"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability not recognized because of the exceptions to comprehensive recognition of deferred taxes related to a policyholders' surplus.",
        "label": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityPolicyholdersSurplus",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r70",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DoubtfulMember": {
     "auth_ref": [
      "r152",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A category of financing receivables that have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable.",
        "label": "Doubtful [Member]"
       }
      }
     },
     "localname": "DoubtfulMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r53",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r102",
      "r104",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r260",
      "r261",
      "r301",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Basic Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r53",
      "r94",
      "r95",
      "r96",
      "r97",
      "r98",
      "r104",
      "r110",
      "r111",
      "r112",
      "r115",
      "r116",
      "r260",
      "r261",
      "r301",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Diluted Net Income Per Common Share Available to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r113",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r47",
      "r48",
      "r49",
      "r89",
      "r90",
      "r91",
      "r93",
      "r99",
      "r101",
      "r118",
      "r157",
      "r201",
      "r202",
      "r214",
      "r215",
      "r216",
      "r229",
      "r230",
      "r259",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r276",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Direct ownership interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r273",
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "verboseLabel": "Total lease liability"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r273"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Financing lease liability - current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r273"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Financing lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r272"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Right-of-use Asset \u2013 financing lease"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r12",
      "r172"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Less: Accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r168",
      "r169",
      "r172",
      "r174",
      "r287",
      "r288"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r172",
      "r288"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Gross other intangible assets"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r168",
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r11",
      "r161",
      "r162",
      "r163",
      "r165",
      "r279",
      "r290"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesAxis": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major payor source of revenue for health care organizations.",
        "label": "Health Care Organization, Revenue Sources [Axis]"
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HealthCareOrganizationRevenueSourcesDomain": {
     "auth_ref": [
      "r205"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Major payor source of revenue for health care organizations."
       }
      }
     },
     "localname": "HealthCareOrganizationRevenueSourcesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperations": {
     "auth_ref": [
      "r55",
      "r71",
      "r94",
      "r95",
      "r96",
      "r97",
      "r109",
      "r112",
      "r246"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.",
        "label": "(Loss) Income from operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r130",
      "r134",
      "r138",
      "r141",
      "r144",
      "r289",
      "r299",
      "r302",
      "r314"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income Before Provision for Income Taxes and Noncontrolling Interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet": {
     "auth_ref": [],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, nonoperating income (expense) and income (loss) from equity method investments, before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of interest income (expense).",
        "label": "Income (Loss) from Continuing Operations before Interest Expense, Interest Income, Income Taxes, Noncontrolling Interests, Net",
        "totalLabel": "Income From Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r178",
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement."
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r86",
      "r219",
      "r220",
      "r222",
      "r231",
      "r236",
      "r238",
      "r239",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r100",
      "r101",
      "r129",
      "r218",
      "r232",
      "r237",
      "r315"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability": {
     "auth_ref": [
      "r228"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income tax expense (benefit) from continuing operations attributable to an adjustment of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity.",
        "label": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r67",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts, medical and management fee receivable(s)"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "(Increase) decrease in operating assets, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.",
        "label": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in operating liabilities, net:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current liabilities classified as other.",
        "label": "Increase (Decrease) in Other Current Liabilities",
        "verboseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.",
        "label": "Increase (Decrease) in Prepaid Expense",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Notes receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": {
     "auth_ref": [
      "r106",
      "r107",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.",
        "label": "Shares included upon conversion of Class C Common to calculate a diluted EPS"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r166",
      "r170"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Other intangible assets \u2013 net",
        "verboseLabel": "Other intangible assets-net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SupplementalCashFlowInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "INVENTORIES"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsAndWorkInProcess": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation reserves of merchandise or goods held by the entity that are readily available for sale and items held by the entity which are partially complete or in the process of being readied for sale.",
        "label": "Inventories",
        "totalLabel": "Total Inventories"
       }
      }
     },
     "localname": "InventoryFinishedGoodsAndWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeNet": {
     "auth_ref": [
      "r59",
      "r60"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income"
       }
      }
     },
     "localname": "InvestmentIncomeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r275"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "OPERATING &amp; FINANCING LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r36",
      "r84",
      "r136",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r249",
      "r254",
      "r255",
      "r262",
      "r277",
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total Liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r26",
      "r84",
      "r156",
      "r262",
      "r279",
      "r294",
      "r309"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r5",
      "r38",
      "r84",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r249",
      "r254",
      "r255",
      "r262",
      "r277",
      "r278",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total Current Liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r16",
      "r17",
      "r84",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r249",
      "r254",
      "r255",
      "r262",
      "r277",
      "r278"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "totalLabel": "Total Long-Term Liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "ACCOUNTS RECEIVABLE, MEDICAL RECEIVABLE AND MANAGEMENT AND OTHER FEES RECEIVABLE"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term debt and capital leases, less current portion"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as current.",
        "label": "Current portion of long-term debt and capital leases"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r44",
      "r84",
      "r156",
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r262",
      "r293",
      "r308"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions - Non controlling"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r66",
      "r68",
      "r71"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows from Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r2",
      "r45",
      "r46",
      "r49",
      "r52",
      "r71",
      "r84",
      "r92",
      "r94",
      "r95",
      "r96",
      "r97",
      "r100",
      "r101",
      "r109",
      "r130",
      "r134",
      "r138",
      "r141",
      "r144",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r261",
      "r262",
      "r300",
      "r312"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income \u2013 Attributable to FONAR",
        "terseLabel": "Basic Numerator: Net income available to common stockholders",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r45",
      "r46",
      "r49",
      "r100",
      "r101",
      "r252",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Income - Non controlling interests",
        "negatedLabel": "Net Income - Noncontrolling Interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r202",
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r273"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Total lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r273"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating lease liability - current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r273"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating lease liability \u2013 net of current portion"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r272"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Right-of-use Asset \u2013 operating lease"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Amortization on right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Accrued interest and penalty"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssets": {
     "auth_ref": [
      "r13",
      "r291",
      "r305"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets classified as other.",
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCostOfOperatingRevenue": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.",
        "label": "Costs related to patient fee revenue"
       }
      }
     },
     "localname": "OtherCostOfOperatingRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherDepreciationAndAmortization": {
     "auth_ref": [
      "r57",
      "r70",
      "r176"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense charged against earnings to allocate the cost of tangible and intangible assets over their remaining economic lives, classified as other.",
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "OtherDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventorySupplies": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://fonar.com/role/Inventories-InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryFinishedGoodsAndWorkInProcess",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of other supplies used within the manufacturing or production process expected to be consumed within one year or operating cycle, if longer.",
        "label": "Purchased parts, components and supplies"
       }
      }
     },
     "localname": "OtherInventorySupplies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/Inventories-InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilities": {
     "auth_ref": [
      "r298"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other.",
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other current liabilities",
        "totalLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r37",
      "r184"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 8.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other general &amp; administrative expenses"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfConvertiblePreferredStock": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire preferred stock originally issued and identified as a security that can be exchanged for another type of financial security. This repurchased stock is held in treasury.",
        "label": "Payments for Repurchase of Convertible Preferred Stock",
        "negatedLabel": "Purchase of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Cost of patents"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable preferred class A stock or outstanding convertible preferred class A stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Preferred Class A [Member]"
       }
      }
     },
     "localname": "PreferredClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.",
        "label": "Preferred Stock [Member]"
       }
      }
     },
     "localname": "PreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r20",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r20",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r20",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred stock $.001 par value; 567 shares authorized at September 30, 2022 and June 30, 2022, issued and outstanding \u2013 none"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r45",
      "r46",
      "r49",
      "r65",
      "r84",
      "r92",
      "r100",
      "r101",
      "r130",
      "r134",
      "r138",
      "r141",
      "r144",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r247",
      "r251",
      "r253",
      "r257",
      "r258",
      "r261",
      "r262",
      "r302"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net income",
        "totalLabel": "Net Income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r177",
      "r279",
      "r303",
      "r310"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property and equipment \u2013 net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r64"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of borrowings and capital lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r217",
      "r285",
      "r324"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r23",
      "r202",
      "r279",
      "r307",
      "r319",
      "r320"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r81",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenues"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r50",
      "r84",
      "r126",
      "r127",
      "r133",
      "r139",
      "r140",
      "r146",
      "r147",
      "r149",
      "r156",
      "r185",
      "r186",
      "r187",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r195",
      "r262",
      "r302"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues [Default Label]",
        "totalLabel": "Total Revenues \u2013 Net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "REVENUES"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SalesAndExciseTaxPayableCurrent": {
     "auth_ref": [
      "r35"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Sales tax payable"
       }
      }
     },
     "localname": "SalesAndExciseTaxPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r43"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivable-LongTermAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock": {
     "auth_ref": [
      "r151",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as noncurrent.",
        "label": "Financing Receivable, Noncurrent, Allowance for Credit Loss"
       }
      }
     },
     "localname": "ScheduleOfCreditLossesRelatedToFinancingReceivablesNoncurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/AccountsReceivableMedicalReceivableAndManagementAndOtherFeesReceivableTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r168",
      "r171",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails",
      "http://fonar.com/role/OtherIntangibleAssetsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Other Intangible Assets - Net"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r7",
      "r29",
      "r30",
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.",
        "label": "Quarterly Financial Data"
       }
      }
     },
     "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r130",
      "r131",
      "r137",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Summarized Segment Financial Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentOperatingActivitiesDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operations of an entity including continuing and discontinued operations."
       }
      }
     },
     "localname": "SegmentOperatingActivitiesDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r130",
      "r132",
      "r138",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146",
      "r148",
      "r149",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "SEGMENT AND RELATED INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self-funded health insurance reserve"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/OtherCurrentLiabilities-OtherCurrentLiabilities-Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome": {
       "order": 8.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Cancelled shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r33",
      "r295",
      "r296",
      "r304"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r79",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/OtherIntangibleAssets-OtherIntagibleAssetsNetOfAmoritizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r19",
      "r20",
      "r21",
      "r83",
      "r84",
      "r104",
      "r105",
      "r108",
      "r110",
      "r112",
      "r119",
      "r120",
      "r121",
      "r156",
      "r185",
      "r189",
      "r190",
      "r191",
      "r194",
      "r195",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r262",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r42",
      "r47",
      "r48",
      "r49",
      "r89",
      "r90",
      "r91",
      "r93",
      "r99",
      "r101",
      "r118",
      "r157",
      "r201",
      "r202",
      "r214",
      "r215",
      "r216",
      "r229",
      "r230",
      "r259",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r276",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOperatingActivitiesSegmentAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by continuing and discontinuing operations.",
        "label": "Operating Activities [Axis]"
       }
      }
     },
     "localname": "StatementOperatingActivitiesSegmentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r89",
      "r90",
      "r91",
      "r118",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/Cover",
      "http://fonar.com/role/DescriptionOfBusinessAndBasisOfPresentationDetailsNarrative",
      "http://fonar.com/role/OperatingFinancingLeases-LeasePaymentsDetails",
      "http://fonar.com/role/SegmentAndRelatedInformation-SumarizedSegments-Details",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock purchase plan"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r20",
      "r21",
      "r201",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Number of shares repurchased"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r20",
      "r21",
      "r201",
      "r202"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Number of shares repurchased, value",
        "negatedLabel": "Purchase of Treasury stock"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CommitmentsAndContingenciesDetailsNarrative",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r21",
      "r24",
      "r25",
      "r84",
      "r153",
      "r156",
      "r262",
      "r279"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Fonar Corporation\u2019s Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "STOCKHOLDERS' EQUITY:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r48",
      "r84",
      "r89",
      "r90",
      "r91",
      "r93",
      "r99",
      "r156",
      "r157",
      "r202",
      "r214",
      "r215",
      "r216",
      "r229",
      "r230",
      "r244",
      "r245",
      "r256",
      "r259",
      "r262",
      "r264",
      "r265",
      "r269",
      "r276",
      "r317",
      "r318"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance \u2013 September 30, 2021",
        "periodStartLabel": "Balance - June 30, 2021",
        "totalLabel": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets",
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r270",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r270",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r270",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r270",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r280",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r41",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r41",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r41",
      "r203",
      "r204"
     ],
     "calculation": {
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost \u2013 20 shares of common stock at September 30, 2022 and 12 shares of common stock at June 30, 2022"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r103",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Diluted Shares Outstanding - Common Stockholders"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r102",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted average basic and diluted",
        "verboseLabel": "Basic Denominator: Weighted average shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://fonar.com/role/CondensedConsolidatedStatementsOfIncome",
      "http://fonar.com/role/SummaryOfSignificantAccountingPolicies-EarningsPerShare-Details"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 4
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2029-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=d3e1280-108306"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6487024&loc=d3e29054-158556"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r325": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r326": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r327": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r328": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r329": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r331": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r332": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r333": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r334": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r335": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r336": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r337": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r338": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r339": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r341": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r342": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r343": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r344": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r345": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.13)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "https://asc.fasb.org/topic&trid=2134446"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>61
<FILENAME>0000355019-22-000055-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000355019-22-000055-xbrl.zip
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MN]CI6OZA[A G(PE%56/[&*E;9A'B*N(#-K7^"0]$4C2-UIV56+TX/7D-SCK
M5_'=_&;'A#!(Z?O5ZREX8\?Z!\^-3^MX7;,ZZG+VNA#^O'/> FC4[OQFU10;
M$I.F$4QUF;/ISM,*X<^?-F3-:FZ1WC!L<&C.R9.#,L9,-=RO"@O A?ATP]T
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M%8[TJG>*./<^,/D6B/Z]J'C.[!OW)3O^-O6;/3Q%&]&&O2ZI-'>&OY/#Q.K
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MHEUW"#U6817X(/VS6J;<R9>E*BC,'O1C$2RW,U_<!_JQ0HV4L :W?6>JD-%
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M;H-6Z>/G^;CGKQ<6;G&^7R# ^=)FZ6H^SY0$C>5S=3!T-*[/&6G!S/6#_9.
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M]MM&^C8.A'TGF-T*K'N7R,5>8U)\20Y$ 877UP 1P8BX.(2B6.;B\Z]R:Q%
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MQC7RRA'>)5&>J]DL]>[U8+?!1?J22A\LE)\X,-!PE/ _-YR$< %; P@-O."
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MS'7UHP[K/5LAZ_-$RJ/LZLS3XB1KI[.]6N7J:(M=YT=KE[/S$ *#'0L@Z%.
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MP'S_3%5&*@[.>KM=.#YWL5XKE6NM<@D/L]:JWU5+A789C;&-_KDOU]HM4*^
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M$#ZX5AYL,_,CD"5$C,5>GI-.,/V&G\:O"O,\5*1V1-;[C^@LU"!9MR#::_O
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M#PI9S_"P%JFVT]64_XT]B6-THCHEO[M.\7_UJO[UQW=A_/3U*_]$=,I:G1+
MNM=V.B6$IG_Q\/_\S"0=U?'[ ;%T.XFC N( UX? %$++Y=-!?63H!@(<QN',
M_R.)H^ 5MK<AG&OMLBMMZLRC/8.U$<8^TKWF%+IFT%[%#6Y/'?U[]-CZ-6C]
M%<69%G>(F\F711Y0>AXRE@!VHCVV:MV)VW>:D^/NV'-4?":13IU0C$_44 AJ
MJ.B#&O)]9]^?C/%R2Y5S7..)J*%#U5!HVP9=:BCM_P&PD7 UYZN>A<VXL8.
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M8VC&&8(U'O]'%1%6$T&,J"#21!")( 8IB+X?O!Q$NFW1KV(25,K_)%L$IYN
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M=U&<9TU+5F^9NO<R13C5!KI'")R?(1[L -GRD@"PV:QHF2A;WJDKV2(4=EY
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MB]=^)<AUQ<U(Z(CJO@)D(U,C%-AD:$JP9STP6SWAD#M^TAV0[A/862#0F)<
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M"C1()EH8Q^,JX(- 9!W^<M>BV]5[L"4&W69#'!(;]EG\7YR&K ;93)Z[DBF
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M34"(JRJ[1#-X6"_K"!9$G:I9P!A[T0574('9GZD6AX7,)NGS,<_HX3NB8<8
M=JG>N^MB*VV#F2<E6.<(O"3 5DVAZRO( ER-73U257XTM0GX2@9CVR)];5L5
MU5A;4"U/,1N+M]MN7"QW5QR5E6XOT4@XKJ/[=MQ:F1B.<22PU[/=FL&P:L$
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MWPZ#.G<-'RL:@QS-$-K^Q]TR8Z9,C9G_=C3NWZ\S)LUV;7,>:GG'))$\ 9)
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MZ^VZGU)",(O)M&KP)\7BFR(P '9=/.;_V0(!M^O"(-U&;60X"Y+O&;L?@15
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MX^"/H#U_?]YEVOE)GV20;$_[E>Y-]DXO3^\"A@7?3S(HMZ?YYE/ERAC=9^6
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MM B=-27V  ] AX^FP$;IB1@C'BG2B!$MK^M$U^U:1-U#WBP1K[M7>)6)9WV
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M6^9:A=_OH=9N'^1;!4G!=U%L4-U!/=-"L\AE4[%H(@LFME6K3&N/G:0&;3H
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MT%8:" 4;G[E*P;8MD!1AW'5\ZK9$7A(-CA;D3&KK'9]2IYK^5QT$'8<Z[;@
M!:L;Y:'@+5>Q&P_>W ]&J=PM]M'S.0^Q>?HL.EV&X#IT2!Z"N$I37;\0AO&_
M)S+\" ,_TTT@9)0C.%$E X$*70$RZF)!4\D(3Y7ILK0URMXR2Y+JZT*I3]6
MT@$3[K-SDNW1UE22=LQ)5V/#X>;"K48> >\^V"F'=+KC3SW5Y,>@2)8M;C-_
MJ6O(;O K2-X:11'(EXF5<G=&:T7$QY>7OD%]'*LEE+T98CLUCC'H4))9-$ZD
M2V$JBY11;U;5;E9GGA@2?CG.:8$#Q-H"TI23;BCB;*6-.U$FP>':(-:Y%WOI
MO0$/*O:8+J]'4Z9<T\#.(Q(:(F^FCV0 N(Z==D+FT4SS<<:8@,7RUZJJHJ'%
MRTOD('%3##CXBF^-%Z0,2ODPH6J)U<ZZ)M0U"LV2FV9]2Z:^@/MX1/-YCH<H
M'G;Y$@6;1='+$ EO+14]I0X-PV,A8])/-O+!N:_N&O[%GH.E\MBZTAK0*MT)
MX6/Q=PSQB!P%V^1\WDG1W*V4FZ]PSFI=,DA#-EUO;"VVJ<H)I#FEWJ_M<2T+
MWPXQ$*280<HHTQGG.;+1H<,4*$P5INGR[ [6^F5Q<%:+F70S$YM^*V76(E$I
MP8RWAT2NO3Y;6XU?8?;V(=K0=IS68_GC$56A^@+S\/39E4CV&N_J$:$WQVG9
MJJ':),+PY(HY4RL/,0U@SF N*-N,<\7,++KL(L@ANIH6+O/<XIU(M3JUAU+>
M9H3%_%7+&V9A,C]T=\D_/NJM_\K4\L5NY[__<4D>-[GA>[ ;O8"*D3ARFO9:
M[ R6E\ T7QK$6;2?C LMXTIKIX5\SV?L_EVYT=-B>_PDCR)-PQ$&+_$9Y\CN
MKT:;P2F"Z0UIBC"9%%AL'8ST"T2?##E"'SFA?UU8O?=L+O \ O7C%Y(S+J=2
MV)G.+NG;FFIETSJ2MJ!<LHJ"5@?K>+,J=E\I5&XO"I4_JU"YO2A4_@IUOE^@
M@??#6LGOYL!4N=4TVO$[%YIW;\I_*9$6%?V,]=CT#Q?'V _Z0*E+B [)W+E?
M3/W[#?P6<6YV&&)U&_USVS=E7&Q=+W?\CM8H8E@7<2<JZFPW0K]?<-57#N=X
M? 2 #V 4JY<YH[)/Q/T"M\4/C^4$Z2['5@N"5AOMN"F[D%EUIHI$'P&8SHM*
M:P78ZR"20OQO*>19_BVGWT=A<57NB+*C'0?ILX4STF@7PJ=U],*UVN:Z34D]
M<\QYVU5L[E<)9HCR17LU7_[DL%IROMR1_THG1(!MU**V_R+XY1U.D^0KQ1+=
M%VE@$5OW*1:*X?SFO^1_S&LDAR[_\WG-",'>&K9J(<TI41YLPU;HS]R;5_%<
MB>*L+VS)F'LQ0.H:#LT 09E"7C1HIE'<5.D<2E^ SG,N+W5=CZOW4=(:8*B2
M3EEFFDA>N)T,$NZXH<\?# 8)0D:E+$P90'J:+C+,7U<D\:WZ>)!S7RTN?GO%
MHS"SL.#C!Y2:BC!/)L4YJF_!5*):75>TRGF54&47;B=I48)[4NX.MD_':2M8
M<(KNU3.9+L,U:Y>Z(9*AI$+3C9O[L_N#*6CADW-3L:33C$R;GKZO;P>&AJ:@
M]]28S&N&1A0\KB(N>-JH_(B-(_@1S!7%"3K.@IJK2RTMO$]F(8TQF\@->;R,
MOK"*N$G$Z>14^P/\$7NH!F"6&:U*G23")&X0V$;V0*C?5=\@4G@*QMB?VN0,
M&5>/KF+)E5FDPT11IN'[+ER0'^6"5!G\3OW)-9^@T9[R QF[?*#WQ95J5EI\
MC'?-5J%[2/;##W2S@LMF+IJ0YBW8$E=]O+;Y\>9TFBGP%OD3* &+7(0D&*>4
M&3O3U2\R'F@-D=^0+1'\G%7ET$)@28)LD T6'V+CB6YW#:R9"W*20_O&X7[/
MG?\AUM!W"_HNX./5:CK*N]BY:BXOU6KL,.7_9=6;1_M75NW\H'YU1H'Y+_YF
M\Z<_39*92;'II%GV1?+P+)0':X7NFZ]B),&^D"S[!V5COIPC^X?*V*09IQ_Y
MV4_!3_(N&+L*KS\=YN-(\GH-T(\MX]?__,__J/R+;(ZE3([:P:;M011)3SJ,
MN YJQZDW(,9)13PG1EU3%]MY).S'SQ(-ZV!I^E)EDOC".604EEX@*E]'7TAR
M=A_#YG\P0X,%K .['0?A]&++[^B5AC^RY%?_M'9\HXJBW,(H=0L5-"'M A-A
M8Q*3D[9KTJKEVC<=9*9F%]Q A'KQ]#3<UI8#X<4/=R?_#@L@O[:\="7@\ZL,
MR..*6][/\*-D*S)<9P%;2E*]9#K(C5%(-4XY&T"/P$< 2@H(7;/JL[]?7FI[
MK.^CX".JW<! O&5PI30,+ Z%<%V;^T+')(TT U;A49X1L"5T<HK["?T57S5+
M8M>&=*Y"(#N2,F 2,N*3%C%KC$%P!O\X!X43"9"?L24:QT3E1Y5:,F"P>@)&
M*)I#(!@,P934M@!0%*P$'M]!.86<!&WP'.4!IHVQJMM#,#*MM#8J:M0&VLF5
MIG7]G;1*65/P-3D+%<E006)Y"<X0.U*SH0)1C8@2T2D35M()K"A8A'P_:-\6
M8-_NI9A11&(W&&0J32>JHV3>9J".5:4G35M70;\,C71D:.B)?-B:=8L0:;6]
MR HH(A\1+83_(I4/3(P8R&H2U1%P*U_.4&;6M-$C5J KR9O-&7I$.$[BRF'(
M%5;F,+?)-T<2'+H_K-0464ZO)0>3W>MA]BEV1.F'GZ*P:?SZZ)U(G5D!R&(4
MZN.-(U_TQ^<Q_@X+N+B&C 5^@EUB',M6%=X=B67/R&/HT@<?&$>0@.*5]23\
MM;H)+CA*]QD^!$2L)+,T%9<*I#.G$-DDG8:H_C98QIP!HTO1G\3Z!#:O$ZQ9
M#23!4OC\0*]SR3M;AX)[W$?FC1!-=L/%10S/.P+[V^Z[7"#J8^_+T%S^:1.0
M[K%OB_O$GA"2;!EOS/H@#K:.$W3;A26+8 >_LWH]% 3YIPR@_+.YQ^'] VKY
MQ\! ;]H!]H.U* TZ<KDE0F=-3;Y<6V1@U9?@4;O(-X/J5_T -CIUR N848$1
MD79&> 3@OP-R"=%LI,UP,$64M*3R2>+96(3AJDHZ2GUZ:EU ^/;XWZARF2-!
MOISUY#L\1\K=1+UF."Z1B8;2YRCI%<CGR_3LLT(JOQH%0V.'!"M:$/;0X?R>
MG";JSE]"J506*)6?A5*I+% J"Y3*W^;D+I'KR6R4;:+WNA)N$SC)*"[CT)#"
M?1*FDLPQD^UQ1Y! ^UBL$?Z1B-74?^78!'>QUQE.F[!GL!=V7+OG@T/@MN&8
M9 5NU::GRY2JAS#;07CK"(FFQ;18/&214>$3A!Z;^.!APE54:AWV)Y$+3H-O
M8NLA; H[?#HYJ9JE$::.':G&2B^D'KT>Z=A1@UVS:BIX_/K#-#N->*]I)R7!
M)E.)7)1GI7?$$6 M445F_.+FN9FC4TZ"T$B\8T4]FQ._8VSZS.B(^=3SQI&
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M$P5[%K6)-[TZN3,;JMG6]1/EQQ_^]E<%_GWX>Z.A= EV[$NE0ZV&[DWH]\H
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M#@OFO^(P%%/Q7L*,;%2 ^[$A)H%\?$2!>E/[S0_7[$%U-0$P:3-226$."0?
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M&44MLYK]Q^*>C1<BO@F<I 3[*0K8'_CE',4O"B4GB. X.$X1[+?L<EKZ"S^
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M;W[C^-%!0-%,EV=W9&Y-,20S/"E'J[(GR1"-E,S#66 C%_L,'43/?BK=S2Y
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MQ0T5N)H3P]]!<$$!2KC @(DA*H>XH)>2KU<)TI)>ZJQT9RCFE@%RD'T6]&4
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MADO:64#ODDXC#H9R9HRC";?F.\S $([.OCS'B>H-M#^[I-(05)<W]6]@2#(
M)&=$+>2]O.=I2=#%9&C!NX>DN9Z]A,F.[@8W<,%.U>VDJ;TS_2E3LQX8?HT
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M.-V1L5MU1B)+U9MXS8IN-_3:.M)?^S5I>>?;:*A#]GU)=;Y"7)]'IJS1\4[
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MP-+C&.,U"470LKW"1U&F/YT:9;KSIZ.OO$6=;DNSF20H95&'&2PH9:GWVV;
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M#W/D7M]B8K\A;F QH:S+GGC@)R\F )BA+R9$6MM=^CYN2$.B=_S+)="#B)_
M0S&]I1J5BYX(LNGNCK)#W +>V2D?SU@H9KUQIE/\P%2_2H#7A![5O+$N4A?%
M5]%U1"AC@9^_"(I!#/2]12F,'H&]\0X"P.JB^P0<L"86"A;$=V^LAY@C=\'K
M2J&I^#^QQ7YR/!)?G14Q3N:\ XL_\.WW\2]R)9-P.D7/8/\E#7; ?X@#DT^X
M,?272Z):DYZ['>A!ZQOKKC@,_KMV^99Z,+Q#MN:MM:-#GMR_; F<9V,O,XBB
M\^G<;N,S][/7$EWGE@1SYFY%/:/E312XXFT;5UPDIQ%OW'+?V2M\%%[G+YVK
MSJT;S#T:1(R(?_2GO<E@/!N,AB*2SLV7Z6#8GTX[W>%MYZ8['<3Q=<:3_K0_
MG'5%*9RH.NEMOSBFDN?.82$N%#(XHT3&6([&:O)FO%/<>,IM?YVZD"/JZ$DL
MV'Q]O+"3^$RCS<9AN]%RZJY\=^G.Q=%62?UJ&_UKT4:G7QX>NI-?A25.!Y^'
M@[M!KSN<=;J]WNC+<#88?NZ,1_>#WJ _?3/.$P)WJ9@"&"14_M*,T P7;,,K
MOPA]( O>>._P"SZ$/#B^LXK/%_@_XOO"=X14O2(],LSOBX:96N"T,^GW^H.O
MW9O[_G]T'OJWW#[O<[^+)].'[K#[.0Y9%_]S-/NI/^G<]?MY81SSS3VBU-MM
M96$<@Q7/^8/X8&#&G 7)F,RU\$ 6P'YK5H=LS@KR"G9\$ES89KV_,W:X$RQ<
M%]4SZ/6'HJ&.QOU)-YXI_X^SV?ZM<S<8=H<]\>_[?G=:<]Z47 ,^?%C6:(65
MB1I,*D"R/+XF(X?6)8V"F)A&#LN63%&OMB\0*-B&5/5P^LAVKHNV,QA^Y9/6
M:(*VO,R:O#LT"_+>42&$=3>\U"2 S:BED&<? #6E:]]Z$+!M))X7I=?/CJSE
M8VFFB==U@^&L._P\B-=^TVE_AF0YGRE=/+N>Q^?ZHCHFMF18#99UR5H&,C*
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M.PS_S7\#4$L! A0#%     @ NHEN54"6(K,0/@  CDL   X
M ( !     &9O;F%R+6QO9V\N:G!G4$L! A0#%     @ NHEN563SOR64'@$
M+_H,  T              ( !/#X  &9O;F%R7S$P<2YH=&U02P$"% ,4
M" "ZB6Y5#'_X4#D(   24@  %               @ '[7 $ 9F]N87)?97AH
M:6)I="TS,2YH=&U02P$"% ,4    " "ZB6Y5-B7//-\$  "V(P  %
M        @ %F90$ 9F]N87)?97AH:6)I="TS,BYH=&U02P$"% ,4    " "Z
MB6Y5AVX4XI,.   KC@  $0              @ %W:@$ 9F]N<BTR,#(R,#DS
M,"YX<V102P$"% ,4    " "ZB6Y52X&JN],3  #6_P  %0
M@ $Y>0$ 9F]N<BTR,#(R,#DS,%]C86PN>&UL4$L! A0#%     @ NHEN59PU
MSU)7(   V-\! !4              ( !/XT! &9O;G(M,C R,C Y,S!?9&5F
M+GAM;%!+ 0(4 Q0    ( +J);E4A0#[:P4D  ''A P 5              "
M <FM 0!F;VYR+3(P,C(P.3,P7VQA8BYX;6Q02P$"% ,4    " "ZB6Y5;;C'
MS.LP  !] @, %0              @ &]]P$ 9F]N<BTR,#(R,#DS,%]P<F4N
9>&UL4$L%!@     )  D 1@(  -LH @    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
